[
  {
    "author": [
      {
        "family": "Andrews",
        "given": "N.C."
      }
    ],
    "container-title": [
      "N Engl J Med"
    ],
    "date": [
      "1999"
    ],
    "pages": [
      "1986–95"
    ],
    "title": [
      "Disorders of iron metabolism"
    ],
    "type": "article-journal",
    "volume": [
      "341"
    ]
  },
  {
    "author": [
      {
        "family": "Brugnara",
        "given": "C."
      }
    ],
    "container-title": [
      "Crit Rev Clin Lab Sci"
    ],
    "date": [
      "2000"
    ],
    "pages": [
      "93–130"
    ],
    "title": [
      "Reticulocyte cellular indices: a new approach in the diagnosis of anemias and monitoring of erythropoietic function"
    ],
    "type": "article-journal",
    "volume": [
      "37"
    ]
  },
  {
    "author": [
      {
        "family": "Kuhn",
        "given": "L.C."
      },
      {
        "family": "Hentze",
        "given": "M.W."
      }
    ],
    "container-title": [
      "J Inorg Biochem"
    ],
    "date": [
      "1992"
    ],
    "pages": [
      "183–95"
    ],
    "title": [
      "Coordination of cellular iron metabolism by posttranscriptional gene regulation"
    ],
    "type": "article-journal",
    "volume": [
      "47"
    ]
  },
  {
    "author": [
      {
        "family": "Labbe",
        "given": "R.F."
      },
      {
        "others": true
      }
    ],
    "container-title": [
      "Clin Chem"
    ],
    "date": [
      "1999"
    ],
    "pages": [
      "2060–72"
    ],
    "title": [
      "Zinc protoporphyrin: A metabolite with a mission"
    ],
    "type": "article-journal",
    "volume": [
      "45"
    ]
  },
  {
    "author": [
      {
        "family": "Rettmer",
        "given": "R.L."
      },
      {
        "others": true
      }
    ],
    "container-title": [
      "Pediatrics"
    ],
    "date": [
      "1999"
    ],
    "pages": [
      "37"
    ],
    "title": [
      "Zinc protoporphyrin/heme ratio for diagnosis of preanemic iron deficiency"
    ],
    "type": "article-journal",
    "volume": [
      "104"
    ]
  },
  {
    "author": [
      {
        "family": "Tapiero",
        "given": "H."
      },
      {
        "others": true
      }
    ],
    "container-title": [
      "Biomed Pharmacother"
    ],
    "date": [
      "2001"
    ],
    "pages": [
      "324–32"
    ],
    "title": [
      "Iron: deficiencies and requirements"
    ],
    "type": "article-journal",
    "volume": [
      "55"
    ]
  },
  {
    "note": [
      "46 CHAPTER 2 Red cell disorders"
    ],
    "type": null
  },
  {
    "author": [
      {
        "family": "Bennett",
        "given": "J.M."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "1."
    ],
    "container-title": [
      "Annals of Internal Medicine"
    ],
    "date": [
      "1985"
    ],
    "pages": [
      "626–9"
    ],
    "title": [
      "Proposed revised criteria for the classification of acute myeloid leukaemia"
    ],
    "type": "article-journal",
    "volume": [
      "103"
    ]
  },
  {
    "author": [
      {
        "family": "Bennett",
        "given": "J.M."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "2."
    ],
    "container-title": [
      "Annals of Internal Medicine"
    ],
    "date": [
      "1985"
    ],
    "pages": [
      "460–2"
    ],
    "title": [
      "Criteria for the diagnosis of acute leukaemia of megakaryocytic lineage (M7). A report of the French-American-British Cooperative Group"
    ],
    "type": "article-journal",
    "volume": [
      "103"
    ]
  },
  {
    "author": [
      {
        "family": "Bennett",
        "given": "J.M."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "3."
    ],
    "container-title": [
      "British Journal of Haematology"
    ],
    "date": [
      "1991"
    ],
    "pages": [
      "325–9"
    ],
    "title": [
      "Proposals for the recognition of minimally differentiated acute myeloid leukaemia (AML-M0"
    ],
    "type": "article-journal",
    "volume": [
      "78"
    ]
  },
  {
    "author": [
      {
        "family": "Jaffe",
        "given": "E.S."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "4."
    ],
    "date": [
      "2001"
    ],
    "location": [
      "Lyon"
    ],
    "publisher": [
      "IARC Press"
    ],
    "title": [
      "Tumours of Haematopoietic and Lymphoid Tissues. World Health Organization Classification of Tumours"
    ],
    "type": "book"
  },
  {
    "author": [
      {
        "family": "Bain",
        "given": "B.J."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "5."
    ],
    "container-title": [
      "Clin Lab Haematol"
    ],
    "date": [
      "2002"
    ],
    "note": [
      "M"
    ],
    "pages": [
      "1–13"
    ],
    "title": [
      "Revised guideline on immunophenotyping in acute leukaemias and chronic lymphoproliferative disorders"
    ],
    "type": "article-journal",
    "url": [
      "http://www."
    ],
    "volume": [
      "24"
    ]
  },
  {
    "author": [
      {
        "family": "Dohner",
        "given": "K."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "6."
    ],
    "container-title": [
      "Blood"
    ],
    "date": [
      "2005"
    ],
    "pages": [
      "3740–6"
    ],
    "title": [
      "Mutant nucleophosmin (NPM1) predicts favorable prognosis in younger adults with acute myeloid leukaemia and normal cytogenetics: interaction with other gene mutations"
    ],
    "type": "article-journal",
    "volume": [
      "106"
    ]
  },
  {
    "author": [
      {
        "family": "Milligan",
        "given": "D.W."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "7."
    ],
    "container-title": [
      "British Journal of Haematology"
    ],
    "date": [
      "2006"
    ],
    "pages": [
      "450–74"
    ],
    "title": [
      "Guidelines on the management of acute myeloid leukaemia in adults"
    ],
    "type": "article-journal",
    "volume": [
      "135"
    ]
  },
  {
    "author": [
      {
        "family": "Finiewicz",
        "given": "K.J."
      },
      {
        "family": "Larson",
        "given": "R.A."
      }
    ],
    "citation-number": [
      "1."
    ],
    "container-title": [
      "Semin Oncol"
    ],
    "date": [
      "1999"
    ],
    "pages": [
      "6–20"
    ],
    "title": [
      "Dose-intensive therapy for adult acute lymphoblastic leukaemia"
    ],
    "type": "article-journal",
    "volume": [
      "26"
    ]
  },
  {
    "author": [
      {
        "family": "Thomas",
        "given": "X."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "2."
    ],
    "container-title": [
      "J Clin Oncol"
    ],
    "date": [
      "2004"
    ],
    "pages": [
      "4075–86"
    ],
    "title": [
      "Outcome of treatment of adults with acute lymphoblastic leukaemia: analysis of the LALA-94 trial"
    ],
    "type": "article-journal",
    "volume": [
      "22"
    ]
  },
  {
    "author": [
      {
        "family": "Pui",
        "given": "C.-H."
      },
      {
        "family": "Evans",
        "given": "W.E."
      }
    ],
    "citation-number": [
      "3."
    ],
    "container-title": [
      "N Engl J Med"
    ],
    "date": [
      "2006"
    ],
    "pages": [
      "166–78"
    ],
    "title": [
      "Treatment of acute lymphoblastic leukaemia"
    ],
    "type": "article-journal",
    "volume": [
      "354"
    ]
  },
  {
    "author": [
      {
        "family": "Wassmann",
        "given": "B."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "4."
    ],
    "container-title": [
      "Blood"
    ],
    "date": [
      "2006"
    ],
    "pages": [
      "1469–77"
    ],
    "title": [
      "Alternating versus concurrent schedules of imatinib and chemotherapy as front-line therapy for Philadelphia-positive acute lymphoblastic leukaemia (Ph+ ALL"
    ],
    "type": "article-journal",
    "volume": [
      "108"
    ]
  },
  {
    "author": [
      {
        "family": "Lee",
        "given": "E.J."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "5."
    ],
    "container-title": [
      "J Clin Oncol"
    ],
    "date": [
      "2001"
    ],
    "pages": [
      "4014–22"
    ],
    "title": [
      "Brief-duration high-intensity chemotherapy for patients with small noncleaved-cell lymphoma or FAB L3 acute lymphocytic leukaemia: results of cancer and leukaemia group B study 9251"
    ],
    "type": "article-journal",
    "volume": [
      "19"
    ]
  },
  {
    "author": [
      {
        "family": "Larson",
        "given": "R.A."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "6."
    ],
    "container-title": [
      "Blood"
    ],
    "date": [
      "1995"
    ],
    "location": [
      "Further reading"
    ],
    "pages": [
      "2025–37"
    ],
    "title": [
      "A five-drug remission induction regimen with intensive consolidation for adults with acute lymphoblastic leukaemia: cancer and leukaemia group B study 8811"
    ],
    "type": "article-journal",
    "volume": [
      "85"
    ]
  },
  {
    "author": [
      {
        "family": "Lukenbill",
        "given": "J."
      },
      {
        "others": true
      }
    ],
    "container-title": [
      "Curr Hematol Malig Rep"
    ],
    "date": [
      "2013"
    ],
    "issue": [
      "2"
    ],
    "pages": [
      "91–7"
    ],
    "title": [
      "The treatment of adolescents and young adults with acute lymphoblastic leukaemia"
    ],
    "type": "article-journal",
    "volume": [
      "8"
    ]
  },
  {
    "author": [
      {
        "given": "N.C.C.N."
      }
    ],
    "date": [
      "2013"
    ],
    "location": [
      "Fort Washington, PA"
    ],
    "publisher": [
      "NCCN. Mwww.NCCN.org"
    ],
    "title": [
      "NCCN Guidelines on ALL. Version 1.2013"
    ],
    "type": "book"
  },
  {
    "author": [
      {
        "family": "Salami",
        "given": "K."
      },
      {
        "others": true
      }
    ],
    "container-title": [
      "Hematol Oncol Stem Cell Ther"
    ],
    "date": [
      "2013"
    ],
    "issue": [
      "1"
    ],
    "pages": [
      "34–41"
    ],
    "title": [
      "Hematopoietic stem cell transplant versus chemotherapy plus tyrosine kinase inhibitor in the treatment of pediatric Philadelphia chromosome-positive acute lymphoblastic leukaemia (ALL"
    ],
    "type": "article-journal",
    "volume": [
      "6"
    ]
  },
  {
    "author": [
      {
        "family": "Swerdlow",
        "given": "S.H."
      },
      {
        "others": true
      }
    ],
    "date": [
      "2008"
    ],
    "edition": [
      "4th"
    ],
    "location": [
      "Lyon"
    ],
    "publisher": [
      "IARC"
    ],
    "title": [
      "WHO Classifications of Tumours of Haematopoietic and Lymphoid Tissues"
    ],
    "type": "book"
  },
  {
    "author": [
      {
        "family": "Wood",
        "given": "B.L."
      }
    ],
    "container-title": [
      "Methods Mol Biol"
    ],
    "date": [
      "2013"
    ],
    "pages": [
      "123–36"
    ],
    "title": [
      "Flow cytometric monitoring of residual disease in acute leukaemia"
    ],
    "type": "article-journal",
    "volume": [
      "999"
    ]
  },
  {
    "author": [
      {
        "family": "Jaffe",
        "given": "E.S."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "1."
    ],
    "date": [
      "2001"
    ],
    "location": [
      "Lyon"
    ],
    "publisher": [
      "IARC Press"
    ],
    "title": [
      "Tumours of Haematopoietic and Lymphoid Tissues. World Health Organization Classification of Tumours"
    ],
    "type": "book"
  },
  {
    "author": [
      {
        "family": "Hughes",
        "given": "T.P."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "2."
    ],
    "container-title": [
      "N Engl J Med"
    ],
    "date": [
      "2003"
    ],
    "pages": [
      "1421–32"
    ],
    "title": [
      "Frequency of major molecular responses to imatinib or interferon alfa plus cytarabine in newly diagnosed chronic myeloid leukaemia"
    ],
    "type": "article-journal",
    "volume": [
      "349"
    ]
  },
  {
    "author": [
      {
        "family": "O’Brien",
        "given": "S.G."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "3."
    ],
    "container-title": [
      "N Engl J Med"
    ],
    "date": [
      "2003"
    ],
    "pages": [
      "994–1004"
    ],
    "title": [
      "Imatinib compared with interferon and low dose cytarabine for newly diagnosed chronic phase chronic myeloid leukaemia"
    ],
    "type": "article-journal",
    "volume": [
      "348"
    ]
  },
  {
    "author": [
      {
        "family": "Druker",
        "given": "B.J."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "4."
    ],
    "container-title": [
      "N Engl J Med"
    ],
    "date": [
      "2006"
    ],
    "pages": [
      "2408–17"
    ],
    "title": [
      "Five-year follow-up of patients receiving imatinib for chronic myeloid leukaemia"
    ],
    "type": "article-journal",
    "volume": [
      "355"
    ]
  },
  {
    "author": [
      {
        "family": "Goldman",
        "given": "J."
      }
    ],
    "citation-number": [
      "5."
    ],
    "container-title": [
      "M"
    ],
    "date": [
      "2007"
    ],
    "title": [
      "Recommendations for the Management of BCR-ABL-Positive Chronic Myeloid Leukaemia"
    ],
    "type": "article-journal",
    "url": [
      "www.bcshguidelines.com/pdf/CML_guidelines_270707.pdf"
    ]
  },
  {
    "author": [
      {
        "family": "Guidelines",
        "given": "N.C.C.N.Practice"
      }
    ],
    "citation-number": [
      "6."
    ],
    "date": [
      "2007"
    ],
    "title": [
      "M"
    ],
    "type": null,
    "url": [
      "www.nccn.org/professionals/physician_gls/PDF/ cml.pdf"
    ]
  },
  {
    "author": [
      {
        "family": "Baccarani",
        "given": "M."
      },
      {
        "others": true
      }
    ],
    "container-title": [
      "Blood"
    ],
    "date": [
      "2013"
    ],
    "pages": [
      "872–84"
    ],
    "title": [
      "European LeukaemiaNet recommendations for the management of CML"
    ],
    "type": "article-journal",
    "volume": [
      "122"
    ]
  },
  {
    "author": [
      {
        "family": "Chahardouli",
        "given": "B."
      },
      {
        "others": true
      }
    ],
    "container-title": [
      "Haematology"
    ],
    "date": [
      "2013"
    ],
    "issue": [
      "3"
    ],
    "pages": [
      "158–62"
    ],
    "title": [
      "Evaluation of T315I mutation frequency in chronic myeloid leukaemia patients after imatinib resistance"
    ],
    "type": "article-journal",
    "volume": [
      "18"
    ]
  },
  {
    "author": [
      {
        "family": "Hasford",
        "given": "J."
      },
      {
        "others": true
      }
    ],
    "container-title": [
      "JNCI J Natl Cancer Inst"
    ],
    "date": [
      "1998"
    ],
    "issue": [
      "11"
    ],
    "pages": [
      "850–9"
    ],
    "title": [
      "New prognostic score for survival of patients with chronic myeloid leukaemia treated with interferon alfa. Writing Committee for the Collaborative CML Prognostic Factors Project Group"
    ],
    "type": "article-journal",
    "volume": [
      "90"
    ]
  },
  {
    "author": [
      {
        "family": "Jain",
        "given": "P."
      },
      {
        "others": true
      }
    ],
    "container-title": [
      "Blood"
    ],
    "date": [
      "2013"
    ],
    "issue": [
      "24"
    ],
    "pages": [
      "4867–74"
    ],
    "title": [
      "Early responses predict better outcomes in patients with newly diagnosed chronic myeloid leukaemia: results with four tyrosine kinase inhibitor modalities"
    ],
    "type": "article-journal",
    "volume": [
      "121"
    ]
  },
  {
    "author": [
      {
        "family": "Khan",
        "given": "A.M."
      },
      {
        "others": true
      }
    ],
    "container-title": [
      "Haematology"
    ],
    "date": [
      "2014"
    ],
    "issue": [
      "5"
    ],
    "pages": [
      "249–58"
    ],
    "title": [
      "BCR-ABL inhibitors: updates in the management of patients with chronic-phase chronic myeloid leukaemia"
    ],
    "type": "article-journal",
    "volume": [
      "19"
    ]
  },
  {
    "author": [
      {
        "family": "Radich",
        "given": "J.P."
      }
    ],
    "container-title": [
      "J Natl Compr Canc Netw"
    ],
    "date": [
      "2013"
    ],
    "issue": [
      "Suppl. 5"
    ],
    "pages": [
      "663–6"
    ],
    "title": [
      "Monitoring response to tyrosine kinase inhibitor therapy, mutational analysis, and new treatment options in chronic myelogenous leukaemia"
    ],
    "type": "article-journal",
    "volume": [
      "11"
    ]
  },
  {
    "author": [
      {
        "family": "Sokal",
        "given": "J.E."
      },
      {
        "others": true
      }
    ],
    "container-title": [
      "Blood"
    ],
    "date": [
      "1984"
    ],
    "issue": [
      "4"
    ],
    "pages": [
      "789–99"
    ],
    "title": [
      "Prognostic discrimination in “good-risk” chronic granulocytic leukaemia"
    ],
    "type": "article-journal",
    "volume": [
      "63"
    ]
  },
  {
    "pages": [
      "157"
    ],
    "publisher": [
      "CML"
    ],
    "title": [
      "CHRONIC MYELOID LEUKAEMIA"
    ],
    "type": "book"
  },
  {
    "author": [
      {
        "family": "Moreau",
        "given": "E.J."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "1."
    ],
    "container-title": [
      "Am J Clin Pathol"
    ],
    "date": [
      "1997"
    ],
    "pages": [
      "378–82"
    ],
    "title": [
      "Improvement of the chronic lymphocytic leukaemia scoring system with the monoclonal antibody SN8 (CD79b"
    ],
    "type": "article-journal",
    "volume": [
      "108"
    ]
  },
  {
    "author": [
      {
        "family": "Montserrat",
        "given": "E."
      }
    ],
    "citation-number": [
      "2."
    ],
    "container-title": [
      "Haematology"
    ],
    "date": [
      "2006",
      "2006"
    ],
    "pages": [
      "279–84"
    ],
    "title": [
      "New prognostic markers in CLL"
    ],
    "type": "article-journal"
  },
  {
    "author": [
      {
        "family": "Seiler",
        "given": "T."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "3."
    ],
    "container-title": [
      "Semin Oncol"
    ],
    "date": [
      "2006"
    ],
    "pages": [
      "186–94"
    ],
    "title": [
      "Risk stratification in chronic lymphocytic leukaemia"
    ],
    "type": "article-journal",
    "volume": [
      "33"
    ]
  },
  {
    "author": [
      {
        "family": "Cheson",
        "given": "B.D."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "4."
    ],
    "container-title": [
      "Blood"
    ],
    "date": [
      "1996"
    ],
    "pages": [
      "4990–7"
    ],
    "title": [
      "National Cancer Institute-Sponsored Working Group guidelines for chronic lymphocytic leukaemia: revised guidelines for diagnosis and treatment"
    ],
    "type": "article-journal",
    "volume": [
      "12"
    ]
  },
  {
    "author": [
      {
        "family": "Swerdlow",
        "given": "S.H."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "1."
    ],
    "date": [
      "2008"
    ],
    "edition": [
      "4th"
    ],
    "location": [
      "Lyon"
    ],
    "publisher": [
      "IARC"
    ],
    "title": [
      "WHO Classifications of Tumours of Haematopoietic and Lymphoid Tissues"
    ],
    "type": "book"
  },
  {
    "author": [
      {
        "family": "Campo",
        "given": "E."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "2."
    ],
    "container-title": [
      "Blood"
    ],
    "date": [
      "2011"
    ],
    "pages": [
      "5019–32"
    ],
    "title": [
      "The 2008 WHO classification of lymphoid neoplasms and beyond: evolving concepts and practical applications"
    ],
    "type": "article-journal",
    "volume": [
      "117"
    ]
  },
  {
    "author": [
      {
        "given": "Anonymous"
      }
    ],
    "citation-number": [
      "1."
    ],
    "container-title": [
      "N Engl J Med"
    ],
    "date": [
      "1993"
    ],
    "pages": [
      "987–94"
    ],
    "title": [
      "A predictive model for aggressive non-Hodgkin lymphoma. The international Non-Hodgkin Lymphoma Prognostic Factors"
    ],
    "type": "article-journal",
    "volume": [
      "329"
    ]
  },
  {
    "author": [
      {
        "family": "Sehn",
        "given": "L.H."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "2."
    ],
    "container-title": [
      "Blood"
    ],
    "date": [
      "2007"
    ],
    "pages": [
      "1857–61"
    ],
    "title": [
      "The revised International Prognostic Index (R-IPI) is a better predictor of outcome than the standard IPI for patients with diffuse large B-cell lymphoma treated with R-CHOP"
    ],
    "type": "article-journal",
    "volume": [
      "109"
    ]
  },
  {
    "author": [
      {
        "family": "Solal-Celigny",
        "given": "P."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "3."
    ],
    "container-title": [
      "Blood"
    ],
    "date": [
      "2004"
    ],
    "pages": [
      "1258–65"
    ],
    "title": [
      "Follicular lymphoma international prognostic index"
    ],
    "type": "article-journal",
    "volume": [
      "104"
    ]
  },
  {
    "author": [
      {
        "family": "Hoster",
        "given": "E."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "4."
    ],
    "container-title": [
      "Blood"
    ],
    "date": [
      "2008"
    ],
    "pages": [
      "558–65"
    ],
    "title": [
      "A new prognostic index (MIPI) for patients with advanced-stage mantle cell lymphoma"
    ],
    "type": "article-journal",
    "volume": [
      "111"
    ]
  },
  {
    "author": [
      {
        "family": "Arcaini",
        "given": "L."
      },
      {
        "others": true
      }
    ],
    "container-title": [
      "Blood"
    ],
    "date": [
      "2006"
    ],
    "pages": [
      "4643–9"
    ],
    "title": [
      "Splenic marginal zone lymphoma"
    ],
    "type": "article-journal",
    "volume": [
      "107"
    ]
  },
  {
    "author": [
      {
        "family": "Johansson",
        "given": "B."
      },
      {
        "others": true
      }
    ],
    "container-title": [
      "Leukemia"
    ],
    "date": [
      "1995"
    ],
    "issue": [
      "7"
    ],
    "pages": [
      "1136–8"
    ],
    "title": [
      "Waldenstrom’s macroglobulinemia with the AML/MDS-associated t(1;3)(p36;q21"
    ],
    "type": "article-journal",
    "volume": [
      "9"
    ]
  },
  {
    "author": [
      {
        "family": "Kastritis",
        "given": "E."
      },
      {
        "others": true
      }
    ],
    "container-title": [
      "Leukemia Res"
    ],
    "date": [
      "2010"
    ],
    "issue": [
      "10"
    ],
    "pages": [
      "1340"
    ],
    "title": [
      "Validation of the International Prognostic Scoring System (IPSS) for Waldenstrom’s macroglobulinemia (WM) and the importance of serum lactate dehydrogenase (LDH"
    ],
    "type": "article-journal",
    "volume": [
      "34"
    ]
  },
  {
    "author": [
      {
        "family": "Morel",
        "given": "P."
      },
      {
        "others": true
      }
    ],
    "container-title": [
      "XIth International Myeloma Workshop & IVth International Workshop on Waldenstrom’s Macroglobulinemia. Haematologica"
    ],
    "date": [
      "2007"
    ],
    "issue": [
      "6 suppl 2"
    ],
    "pages": [
      "1–229"
    ],
    "title": [
      "International Prognostic Scoring System for Waldenström’s Macroglobulinemia"
    ],
    "type": "article-journal",
    "volume": [
      "92"
    ]
  },
  {
    "author": [
      {
        "family": "Oscier",
        "given": "D."
      },
      {
        "others": true
      }
    ],
    "container-title": [
      "Blood Rev"
    ],
    "date": [
      "2005"
    ],
    "pages": [
      "39–51"
    ],
    "title": [
      "Splenic marginal zone lymphoma"
    ],
    "type": "article-journal",
    "volume": [
      "19"
    ]
  },
  {
    "author": [
      {
        "family": "Seiter",
        "given": "K."
      },
      {
        "others": true
      }
    ],
    "container-title": [
      "M"
    ],
    "date": [
      "2012"
    ],
    "title": [
      "Waldenstrom macroglobulinemia"
    ],
    "type": "article-journal",
    "url": [
      "http://emedicine.medscape.com/"
    ]
  },
  {
    "author": [
      {
        "family": "Marcus",
        "given": "R.E."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "1."
    ],
    "container-title": [
      "Blood"
    ],
    "date": [
      "2005"
    ],
    "pages": [
      "1417–23"
    ],
    "title": [
      "CVP chemotherapy plus rituximab compared with CVP as firstline treatment for advanced follicular lymphoma"
    ],
    "type": "article-journal",
    "volume": [
      "105"
    ]
  },
  {
    "author": [
      {
        "family": "Witzig",
        "given": "T.E."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "2."
    ],
    "container-title": [
      "J Clin Oncol"
    ],
    "date": [
      "2005"
    ],
    "pages": [
      "1103–8"
    ],
    "title": [
      "Rituximab therapy for patients with newly diagnosed, advanced stage, follicular grade I non-Hodgkin’s lymphoma: a phase II trial in North Central Cancer Treatment Group"
    ],
    "type": "article-journal",
    "volume": [
      "23"
    ]
  },
  {
    "author": [
      {
        "family": "Kaminski",
        "given": "M.S."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "3."
    ],
    "container-title": [
      "N Engl J Med"
    ],
    "date": [
      "2005"
    ],
    "pages": [
      "441–9"
    ],
    "title": [
      "131I-Tositumomab therapy as initial treatment for follicular lymphoma"
    ],
    "type": "article-journal",
    "volume": [
      "352"
    ]
  },
  {
    "author": [
      {
        "family": "Schouten",
        "given": "H.C."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "4."
    ],
    "container-title": [
      "J Clin Oncol"
    ],
    "date": [
      "2003"
    ],
    "pages": [
      "3918–27"
    ],
    "title": [
      "High dose therapy improves progression-free survival and survival in relapsed follicular non-Hodgkin’s lymphoma: results from the randomized European CUP trial"
    ],
    "type": "article-journal",
    "volume": [
      "21"
    ]
  },
  {
    "author": [
      {
        "family": "Morris",
        "given": "E."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "5."
    ],
    "container-title": [
      "Blood"
    ],
    "date": [
      "2004"
    ],
    "pages": [
      "3865–71"
    ],
    "title": [
      "Outcomes after alemtuzumab-containiing reduced-intensity allogeneic transplantation regimen for relapsed and refractory non-Hodgkin’s lymphoma"
    ],
    "type": "article-journal",
    "volume": [
      "104"
    ]
  },
  {
    "author": [
      {
        "family": "Gine",
        "given": "E."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "6."
    ],
    "container-title": [
      "Ann Onc"
    ],
    "date": [
      "2006"
    ],
    "pages": [
      "1539–45"
    ],
    "title": [
      "The Follicular Lymphoma Prognostic Index (FLIPI) and the histological subtype are the most important factors to predict histological transformation in follicular lymphoma"
    ],
    "type": "article-journal",
    "volume": [
      "17"
    ]
  },
  {
    "citation-number": [
      "1."
    ],
    "container-title": [
      "M"
    ],
    "title": [
      "NCCN Clinical Practice Guidelines in Oncology: Non-Hodgkin’s Lymphomas"
    ],
    "type": "article-journal",
    "url": [
      "http://"
    ]
  },
  {
    "author": [
      {
        "family": "Coiffier",
        "given": "B."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "2."
    ],
    "container-title": [
      "N Engl J Med"
    ],
    "date": [
      "2002"
    ],
    "pages": [
      "235–242"
    ],
    "title": [
      "CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma"
    ],
    "type": "article-journal",
    "volume": [
      "346"
    ]
  },
  {
    "author": [
      {
        "family": "Feugier",
        "given": "P."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "3."
    ],
    "container-title": [
      "J Clin Oncol"
    ],
    "date": [
      "2005"
    ],
    "pages": [
      "4117–26"
    ],
    "title": [
      "Long-term results of the R-CHOP study in the treatment of elderly patients with diffuse large B-cell lymphoma: a study of the Groupe d’Etude des Lymphomes de I’Adulte"
    ],
    "type": "article-journal",
    "volume": [
      "23"
    ]
  },
  {
    "author": [
      {
        "family": "Pfreundschuh",
        "given": "M."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "4."
    ],
    "container-title": [
      "Lancet Oncol"
    ],
    "date": [
      "2006"
    ],
    "pages": [
      "379–91"
    ],
    "title": [
      "CHOP-like chemotherapy plus rituximab versus CHOP-like chemotherapy alone in young patients with good-prognosis diffuse large B-cell lymphoma: a randomized controlled trial by the Mabthera International Trial (MinT) Group"
    ],
    "type": "article-journal",
    "volume": [
      "7"
    ]
  },
  {
    "author": [
      {
        "family": "Lenz",
        "given": "G."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "5."
    ],
    "container-title": [
      "J Clin Oncol"
    ],
    "date": [
      "2005"
    ],
    "pages": [
      "1984–92"
    ],
    "title": [
      "Immunochemotherapy with rituximab and cyclophosphamide, doxorubicin, vincristine and prednisolone significantly improves response and time to treatment failure but not long term outcome in patients with previously untreated mantle cell lymphoma: results of a prospective randomized trial of the German Low Grade Lymphoma Study Group (GLSG"
    ],
    "type": "article-journal",
    "volume": [
      "23"
    ]
  },
  {
    "author": [
      {
        "family": "Dreyling",
        "given": "M."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "6."
    ],
    "container-title": [
      "Blood"
    ],
    "date": [
      "2005"
    ],
    "pages": [
      "2677–84"
    ],
    "title": [
      "Early consolidation by myeloablative radiochemotherapy followed by autologous stem cell transplantation in first remission significantly prolongs progressionfree survival in mantle cell lymphoma: results of a prospective randomized trial of the European MCL Network"
    ],
    "type": "article-journal",
    "volume": [
      "105"
    ]
  },
  {
    "author": [
      {
        "family": "Greer",
        "given": "J."
      }
    ],
    "citation-number": [
      "7."
    ],
    "container-title": [
      "Hematology"
    ],
    "date": [
      "2006",
      "2006"
    ],
    "pages": [
      "331–7"
    ],
    "title": [
      "Therapy of peripheral T/NK neoplasms"
    ],
    "type": "article-journal"
  },
  {
    "author": [
      {
        "family": "Fisher",
        "given": "R.I."
      },
      {
        "others": true
      }
    ],
    "container-title": [
      "J Clin Oncol"
    ],
    "date": [
      "2006"
    ],
    "pages": [
      "4867–74"
    ],
    "title": [
      "Multicenter phase II study of bortezomib in patients with relapsed or refractory mantle cell lymphoma"
    ],
    "type": "article-journal",
    "volume": [
      "24"
    ]
  },
  {
    "author": [
      {
        "family": "Ganti",
        "given": "A.K."
      },
      {
        "others": true
      }
    ],
    "container-title": [
      "Ann Oncol"
    ],
    "date": [
      "2005"
    ],
    "pages": [
      "618–24"
    ],
    "title": [
      "Hematopoietic stem cell transplantation in mantle cell lymphoma"
    ],
    "type": "article-journal",
    "volume": [
      "16"
    ]
  },
  {
    "author": [
      {
        "family": "Geisler",
        "given": "C."
      },
      {
        "others": true
      }
    ],
    "container-title": [
      "Blood"
    ],
    "date": [
      "2008"
    ],
    "issue": [
      "7"
    ],
    "pages": [
      "2687–93"
    ],
    "title": [
      "Nordic Long-term progression-free survival of mantle cell lymphoma after intensive front-line immunochemotherapy with in vivo–purged stem cell rescue: a nonrandomized phase 2 multicenter study by the Nordic Lymphoma Group"
    ],
    "type": "article-journal",
    "volume": [
      "112"
    ]
  },
  {
    "author": [
      {
        "family": "Griffiths",
        "given": "R."
      },
      {
        "others": true
      }
    ],
    "date": [
      "2011"
    ],
    "pages": [
      "4808–16"
    ],
    "title": [
      "Addition of rituximab to chemotherapy alone as first-line therapy improves overall survival in elderly patients with mantle cell lymphoma Blood"
    ],
    "type": null,
    "volume": [
      "118"
    ]
  },
  {
    "author": [
      {
        "family": "Kenkre",
        "given": "V.P."
      },
      {
        "others": true
      }
    ],
    "container-title": [
      "Leuk Lymphoma"
    ],
    "date": [
      "2011"
    ],
    "issue": [
      "9"
    ],
    "pages": [
      "1675–80"
    ],
    "title": [
      "Maintenance rituximab following induction chemo-immunotherapy for mantle cell lymphoma: long-term follow-up of a pilot study from the Wisconsin Oncology Network"
    ],
    "type": "article-journal",
    "volume": [
      "52"
    ]
  },
  {
    "author": [
      {
        "family": "Raty",
        "given": "R."
      },
      {
        "others": true
      }
    ],
    "container-title": [
      "Lymphoma"
    ],
    "date": [
      "2012"
    ],
    "issue": [
      "10"
    ],
    "pages": [
      "1920–8"
    ],
    "title": [
      "Prolonged immunochemotherapy with rituximab, cytarabine and fludarabine added to cyclophosphamide, doxorubicin, vincristine and prednisolone and followed by rituximab maintenance in untreated elderly patients with mantle cell lymphoma: a prospective study by the Finnish Lymphoma Group"
    ],
    "type": "article-journal",
    "volume": [
      "53"
    ]
  },
  {
    "author": [
      {
        "family": "Romaguera",
        "given": "J.E."
      },
      {
        "others": true
      }
    ],
    "container-title": [
      "J Clin Oncol"
    ],
    "date": [
      "2005"
    ],
    "pages": [
      "7013–23"
    ],
    "title": [
      "High rate of durable remissions after treatment of newly diagnosed aggressive mantle-cell lymphoma with rituximab plus hyper-CVAD alternating with rituximab plus high-dose methotrexate and cytarabine"
    ],
    "type": "article-journal",
    "volume": [
      "23"
    ]
  },
  {
    "author": [
      {
        "family": "Schulz",
        "given": "H."
      },
      {
        "others": true
      }
    ],
    "date": [
      "2007"
    ],
    "note": [
      "J Natl Cancer Inst,"
    ],
    "title": [
      "Immunochemotherapy with rituximab and overall survival in patients with indolent or mantle cell lymphoma: a systematic review and meta-analysis"
    ],
    "type": null
  },
  {
    "author": [
      {
        "family": "DeAngelis",
        "given": "L.M."
      },
      {
        "family": "Iwamoto",
        "given": "F.M."
      }
    ],
    "citation-number": [
      "1."
    ],
    "container-title": [
      "Hematology Am Soc Hematol Educ Program"
    ],
    "date": [
      "2006",
      "2006"
    ],
    "pages": [
      "311–16"
    ],
    "title": [
      "An update on therapy for primary central nervous system lymphoma"
    ],
    "type": "article-journal"
  },
  {
    "author": [
      {
        "family": "Hochberg",
        "given": "F.H."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "2."
    ],
    "container-title": [
      "Nat Clin Pract Neurol"
    ],
    "date": [
      "2007"
    ],
    "pages": [
      "24–35"
    ],
    "title": [
      "Primary CNS lymphoma"
    ],
    "type": "article-journal",
    "volume": [
      "3"
    ]
  },
  {
    "author": [
      {
        "family": "Ferreri",
        "given": "A.J.M.",
        "particle": "Further reading"
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "3."
    ],
    "container-title": [
      "M",
      "Lancet"
    ],
    "date": [
      "2009"
    ],
    "pages": [
      "1512–20"
    ],
    "title": [
      "NCCN Clinical Practice Guidelines in Oncology: Central Nervous System Cancers",
      "High-dose cytarabine plus high-dose methotrexate versus highdose methotrexate alone in patients with primary CNS lymphoma: a randomised phase 2 trial"
    ],
    "type": "article-journal",
    "url": [
      "http://www.nccn.org/professionals/physician_gls/f_guidelines.asp#site"
    ],
    "volume": [
      "374"
    ]
  },
  {
    "note": [
      "References"
    ],
    "type": null
  },
  {
    "author": [
      {
        "family": "Hjalgrim",
        "given": "H."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "1."
    ],
    "container-title": [
      "N Engl J Med"
    ],
    "date": [
      "2003"
    ],
    "pages": [
      "1324–32"
    ],
    "title": [
      "Characteristics of Hodgkin’s lymphoma after infectious mononucleosis"
    ],
    "type": "article-journal",
    "volume": [
      "349"
    ]
  },
  {
    "author": [
      {
        "family": "Seam",
        "given": "P."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "2."
    ],
    "container-title": [
      "Blood"
    ],
    "date": [
      "2007"
    ],
    "pages": [
      "3507–16"
    ],
    "title": [
      "The role of FDG-PET scans in patients with lymphoma"
    ],
    "type": "article-journal",
    "volume": [
      "110"
    ]
  },
  {
    "author": [
      {
        "family": "Hutchings",
        "given": "M."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "3."
    ],
    "container-title": [
      "Blood"
    ],
    "date": [
      "2006"
    ],
    "pages": [
      "52–9"
    ],
    "title": [
      "FDG-PET after two cycles of chemotherapy predicts treatment failure and progression-free survival in Hodgkin lymphoma"
    ],
    "type": "article-journal",
    "volume": [
      "107"
    ]
  },
  {
    "note": [
      "HODGKIN LYMPHOMA (HL) 219"
    ],
    "type": null
  },
  {
    "author": [
      {
        "family": "Sasse",
        "given": "S."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "1."
    ],
    "container-title": [
      "Haematologica Reports"
    ],
    "date": [
      "2006"
    ],
    "pages": [
      "19–22"
    ],
    "title": [
      "Combined modality treatment for early stage Hodgkins lymphoma: the GHSG experience"
    ],
    "type": "article-journal",
    "volume": [
      "2"
    ]
  },
  {
    "citation-number": [
      "2."
    ],
    "container-title": [
      "M"
    ],
    "title": [
      "NCCN Clinical Practice Guidelines in Oncology: Hodgkin Lymphoma"
    ],
    "type": "article-journal",
    "url": [
      "www.nccn.org/ professionals/physician_gls/PDF/hodgkins.pdf"
    ]
  },
  {
    "author": [
      {
        "family": "Hasenclever",
        "given": "D."
      },
      {
        "family": "Diehl",
        "given": "V."
      }
    ],
    "citation-number": [
      "3."
    ],
    "container-title": [
      "N Engl J Med"
    ],
    "date": [
      "1998"
    ],
    "pages": [
      "1506–14"
    ],
    "title": [
      "A prognostic score for advanced Hodgkin’s disease. International Prognostic Factors Project on Advanced Hodgkin’s Disease"
    ],
    "type": "article-journal",
    "volume": [
      "339"
    ]
  },
  {
    "author": [
      {
        "family": "Straus",
        "given": "D.J."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "4."
    ],
    "container-title": [
      "Blood"
    ],
    "date": [
      "2004"
    ],
    "pages": [
      "3483–9"
    ],
    "title": [
      "Results of a prospective randomized clinical trial of doxorubicin, bleomycin, vinblastine and dacarbazine (ABVD) followed by radiation therapy (RT) versus ABVD alone for stages I, II and IIA nonbulky Hodgkin disease"
    ],
    "type": "article-journal",
    "volume": [
      "104"
    ]
  },
  {
    "author": [
      {
        "family": "Duggan",
        "given": "D.B."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "5."
    ],
    "container-title": [
      "J Clin Oncol"
    ],
    "date": [
      "2003"
    ],
    "pages": [
      "607–14"
    ],
    "title": [
      "Randomized comparison of ABVD and MOPP/ABV hybrid for the treatment of advanced Hodgkin’s disease: report of an intergroup trial"
    ],
    "type": "article-journal",
    "volume": [
      "21"
    ]
  },
  {
    "author": [
      {
        "family": "Bonnadonna",
        "given": "G."
      },
      {
        "family": "Santoro",
        "given": "A."
      }
    ],
    "citation-number": [
      "6."
    ],
    "container-title": [
      "Cancer Treatment Reviews"
    ],
    "date": [
      "1982"
    ],
    "pages": [
      "21–35"
    ],
    "title": [
      "ABVD chemotherapy in the treatment of Hodgkin’s disease"
    ],
    "type": "article-journal",
    "volume": [
      "9"
    ]
  },
  {
    "author": [
      {
        "family": "Federico",
        "given": "M."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "7."
    ],
    "container-title": [
      "J Clin Oncol"
    ],
    "date": [
      "2003"
    ],
    "pages": [
      "2320–5"
    ],
    "title": [
      "High-dose therapy and autologous stem cell transplantation versus conventional therapy for patients with advanced Hodgkin’s lymphoma responding to front-line therapy"
    ],
    "type": "article-journal",
    "volume": [
      "21"
    ]
  },
  {
    "author": [
      {
        "family": "Diehl",
        "given": "V."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "8."
    ],
    "container-title": [
      "J Clin Oncol"
    ],
    "date": [
      "1999"
    ],
    "pages": [
      "776–83"
    ],
    "title": [
      "Clinical presentation, course and prognostic factors in lymphocytepredominant Hodgkin’s disease and lymphocyte-rich classical Hodgkin’s disease"
    ],
    "type": "article-journal",
    "volume": [
      "17"
    ]
  },
  {
    "author": [
      {
        "family": "Josting",
        "given": "A."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "9."
    ],
    "container-title": [
      "Blood"
    ],
    "date": [
      "2000"
    ],
    "pages": [
      "1280–6"
    ],
    "title": [
      "Prognostic factors and treatment outcome in primary progressive Hodgkin’s lymphoma: a report from the German Hodgkin Lymphoma Study Group"
    ],
    "type": "article-journal",
    "volume": [
      "96"
    ]
  },
  {
    "author": [
      {
        "family": "Moskowitz",
        "given": "C.H."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "10."
    ],
    "container-title": [
      "Br J Haematol"
    ],
    "date": [
      "2004"
    ],
    "pages": [
      "645–52"
    ],
    "title": [
      "Effectiveness of high dose chemoradiotherapy and autologous stem cell transplantation for patients with biopsy-proven primary refractory Hodgkin’s disease"
    ],
    "type": "article-journal",
    "volume": [
      "124"
    ]
  },
  {
    "author": [
      {
        "family": "Linch",
        "given": "D.C."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "11."
    ],
    "container-title": [
      "Lancet"
    ],
    "date": [
      "1993"
    ],
    "pages": [
      "1051–4"
    ],
    "title": [
      "Dose intensification with autologous bone-marrow transplantation in relapsed and resistant Hodgkin’s disease: results of a BNLI randomized trial"
    ],
    "type": "article-journal",
    "volume": [
      "341"
    ]
  },
  {
    "author": [
      {
        "family": "Peggs",
        "given": "K.S."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "12."
    ],
    "container-title": [
      "Further reading NCCN Clinical Practice Guidelines in Oncology: Hodgkin Lymphoma. M",
      "Lancet"
    ],
    "date": [
      "2005"
    ],
    "pages": [
      "1934–41"
    ],
    "title": [
      "Clinical evidence of a graft-versus-Hodgkin’s lymphoma effect after reduced-intensity allogeneic transplantation"
    ],
    "type": "article-journal",
    "url": [
      "www.nccn.org/ professionals/physician_gls/PDF/hodgkins.pdf"
    ],
    "volume": [
      "365"
    ]
  },
  {
    "author": [
      {
        "family": "Seam",
        "given": "P."
      },
      {
        "others": true
      }
    ],
    "container-title": [
      "Blood"
    ],
    "date": [
      "2007"
    ],
    "pages": [
      "3507–16"
    ],
    "title": [
      "The role of FDG-PET scans in patients with lymphoma"
    ],
    "type": "article-journal",
    "volume": [
      "110"
    ]
  },
  {
    "author": [
      {
        "family": "Younes",
        "given": "A."
      },
      {
        "others": true
      }
    ],
    "container-title": [
      "J Clin Oncol"
    ],
    "date": [
      "2012"
    ],
    "issue": [
      "18"
    ],
    "pages": [
      "2183–9"
    ],
    "title": [
      "Results of a pivotal phase II study of brentuximab vedotin for patients with relapsed or refractory Hodgkin’s lymphoma"
    ],
    "type": "article-journal",
    "volume": [
      "30"
    ]
  },
  {
    "author": [
      {
        "family": "Swerdlow",
        "given": "S.H."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "1."
    ],
    "date": [
      "2008"
    ],
    "edition": [
      "4th"
    ],
    "location": [
      "Lyon"
    ],
    "publisher": [
      "IARC"
    ],
    "title": [
      "WHO Classifications of Tumours of Haematopoietic and Lymphoid Tissues"
    ],
    "type": "book"
  },
  {
    "author": [
      {
        "given": "N.C.C.N."
      }
    ],
    "citation-number": [
      "2."
    ],
    "date": [
      "2014"
    ],
    "location": [
      "Fort Washington, PA"
    ],
    "publisher": [
      "NCCN"
    ],
    "title": [
      "NCCN Practice Guidelines in Oncology: Myelodysplastic Syndromes, V2.2014"
    ],
    "type": "book"
  },
  {
    "author": [
      {
        "given": "Swerdlow"
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "3."
    ],
    "date": [
      "2008"
    ],
    "edition": [
      "4th"
    ],
    "location": [
      "Lyon"
    ],
    "publisher": [
      "IARC"
    ],
    "title": [
      "WHO classifications of Tumours of Haematopoietic and Lymphoid Tissues"
    ],
    "type": "book"
  },
  {
    "author": [
      {
        "family": "Vardiman",
        "given": "J.W."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "3."
    ],
    "container-title": [
      "Blood"
    ],
    "date": [
      "2009"
    ],
    "pages": [
      "937–51"
    ],
    "title": [
      "The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes"
    ],
    "type": "article-journal",
    "volume": [
      "114"
    ]
  },
  {
    "author": [
      {
        "family": "Germing",
        "given": "U."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "4."
    ],
    "container-title": [
      "Leukaemia Res"
    ],
    "date": [
      "2000"
    ],
    "pages": [
      "983–92"
    ],
    "title": [
      "Validation of the WHO proposals for a new classification of primary myelodysplastic syndromes: a retrospective analysis of 1600 patients"
    ],
    "type": "article-journal",
    "volume": [
      "24"
    ]
  },
  {
    "author": [
      {
        "family": "Malcovati",
        "given": "L."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "5."
    ],
    "container-title": [
      "J Clin Oncol"
    ],
    "date": [
      "2005"
    ],
    "pages": [
      "7594–603"
    ],
    "title": [
      "Prognostic factors and life expectancy in myelodysplastic syndromes classified according to WHO criteria: a basis for clinical decision making"
    ],
    "type": "article-journal",
    "volume": [
      "23"
    ]
  },
  {
    "author": [
      {
        "family": "Bowen",
        "given": "D."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "6."
    ],
    "container-title": [
      "Haematologica"
    ],
    "date": [
      "2006"
    ],
    "pages": [
      "1596–604"
    ],
    "title": [
      "Prospective validation of the WHO proposals for the classification of myelodysplastic syndromes"
    ],
    "type": "article-journal",
    "volume": [
      "91"
    ]
  },
  {
    "author": [
      {
        "family": "Bennett",
        "given": "J.M."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "7."
    ],
    "container-title": [
      "Br J Haematol"
    ],
    "date": [
      "1982"
    ],
    "pages": [
      "189–99"
    ],
    "title": [
      "Proposals for the classification of the myelodysplastic syndromes"
    ],
    "type": "article-journal",
    "volume": [
      "51"
    ]
  },
  {
    "author": [
      {
        "family": "Greenberg",
        "given": "P."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "1."
    ],
    "container-title": [
      "Blood"
    ],
    "date": [
      "1997"
    ],
    "pages": [
      "2079–88"
    ],
    "title": [
      "International scoring system for evaluating prognosis in myelodysplastic syndromes"
    ],
    "type": "article-journal",
    "volume": [
      "89"
    ]
  },
  {
    "author": [
      {
        "family": "Greenberg",
        "given": "P."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "2."
    ],
    "container-title": [
      "Blood"
    ],
    "date": [
      "2012"
    ],
    "pages": [
      "2454–65"
    ],
    "title": [
      "Revised International prognostic Scoring Sytem (IPSS-R) for myelodysplastic syndromes"
    ],
    "type": "article-journal",
    "volume": [
      "120"
    ]
  },
  {
    "author": [
      {
        "family": "Malcovati",
        "given": "L."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "3."
    ],
    "container-title": [
      "Haematologica"
    ],
    "date": [
      "2011"
    ],
    "pages": [
      "1433–40"
    ],
    "title": [
      "Impact of the degree of anemia on the outcome of patients with myelodysplastic syndrome and its integration into the WHO classification-based Prognostic Scoring System (WPSS"
    ],
    "type": "article-journal",
    "volume": [
      "96"
    ]
  },
  {
    "container-title": [
      "PROGNOSTIC FACTORS IN MDS 241 242 CHAPTER 6 Myelodysplasia"
    ],
    "type": "chapter"
  },
  {
    "author": [
      {
        "given": "N.C.C.N."
      }
    ],
    "citation-number": [
      "1."
    ],
    "date": [
      "2014"
    ],
    "location": [
      "Fort Washington, PA"
    ],
    "publisher": [
      "NCCN"
    ],
    "title": [
      "NCCN Practice Guidelines in Oncology: Myelodysplastic Syndromes, V2.2014"
    ],
    "type": "book"
  },
  {
    "author": [
      {
        "family": "Malcovati",
        "given": "L."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "2."
    ],
    "container-title": [
      "J Clin Oncol"
    ],
    "date": [
      "2005"
    ],
    "pages": [
      "7594–7603"
    ],
    "title": [
      "Prognostic factors and life expectancy in myelodysplastic syndromes classified according to WHO criteria: a basis for clinical decision making"
    ],
    "type": "article-journal",
    "volume": [
      "23"
    ]
  },
  {
    "author": [
      {
        "family": "Estey",
        "given": "E.H."
      }
    ],
    "citation-number": [
      "3."
    ],
    "container-title": [
      "Leukemia"
    ],
    "date": [
      "2013"
    ],
    "issue": [
      "9"
    ],
    "pages": [
      "1803–12"
    ],
    "title": [
      "Epigenetics in clinical practice: the examples of azacitidine and decitabine in myelodysplasia (MDS) and acute myeloid (AML"
    ],
    "type": "article-journal",
    "volume": [
      "27"
    ]
  },
  {
    "author": [
      {
        "family": "Cazzola",
        "given": "M."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "4."
    ],
    "container-title": [
      "Haematologica"
    ],
    "date": [
      "2005",
      "0769"
    ],
    "issue": [
      "Suppl. 2"
    ],
    "title": [
      "ICL670, a once daily iron chelator, is effective and well tolerated in patients with myelodysplastic syndrome (MDS) and iron overload"
    ],
    "type": "article-journal",
    "volume": [
      "90"
    ]
  },
  {
    "author": [
      {
        "family": "Killick",
        "given": "S.B."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "5."
    ],
    "container-title": [
      "Br J Haematol"
    ],
    "date": [
      "2003"
    ],
    "pages": [
      "6769–684"
    ],
    "title": [
      "A pilot study of antithymocyte globulin (ATG) in the treatment of patients with ‘low-risk’ myelodysplasia"
    ],
    "type": "article-journal",
    "volume": [
      "120"
    ]
  },
  {
    "note": [
      "248 CHAPTER 6 Myelodysplasia"
    ],
    "type": null
  },
  {
    "author": [
      {
        "family": "Lim",
        "given": "Z."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "6."
    ],
    "container-title": [
      "Blood"
    ],
    "date": [
      "2005"
    ],
    "pages": [
      "707"
    ],
    "title": [
      "European multi-centre study on the use of anti-thymocyte globulin in the treatment of myelodysplastic syndromes"
    ],
    "type": "article-journal",
    "volume": [
      "1056"
    ]
  },
  {
    "author": [
      {
        "family": "Shimamoto",
        "given": "T."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "7"
    ],
    "container-title": [
      "Leuk Res"
    ],
    "date": [
      "2003"
    ],
    "pages": [
      "783–8"
    ],
    "title": [
      "Cyclosporin A therapy for patients with myelodysplastic syndrome: multicentre pilot studies in Japan"
    ],
    "type": "article-journal",
    "volume": [
      "27"
    ]
  },
  {
    "author": [
      {
        "family": "Broliden",
        "given": "P."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "8."
    ],
    "container-title": [
      "Haematologica"
    ],
    "date": [
      "2006"
    ],
    "pages": [
      "667–70"
    ],
    "title": [
      "Antithymocyte globulin and cyclosporin A as combination therapy for low-risk non-sideroblastic myelodysplastic syndromes"
    ],
    "type": "article-journal",
    "volume": [
      "91"
    ]
  },
  {
    "author": [
      {
        "family": "List",
        "given": "A."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "9."
    ],
    "container-title": [
      "N Engl J Med"
    ],
    "date": [
      "2005"
    ],
    "pages": [
      "549–57"
    ],
    "title": [
      "Efficacy of lenalidomide in myelodysplastic syndromes"
    ],
    "type": "article-journal",
    "volume": [
      "352"
    ]
  },
  {
    "author": [
      {
        "family": "List",
        "given": "A."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "10."
    ],
    "container-title": [
      "N Engl J Med"
    ],
    "date": [
      "2006"
    ],
    "pages": [
      "1456–65"
    ],
    "title": [
      "Lenalidomide in the myelodysplastic syndrome with chromosome 5q deletion"
    ],
    "type": "article-journal",
    "volume": [
      "355"
    ]
  },
  {
    "author": [
      {
        "family": "Nimer",
        "given": "S.D."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "11."
    ],
    "container-title": [
      "J Clin Oncol"
    ],
    "date": [
      "2006"
    ],
    "pages": [
      "2576–82"
    ],
    "title": [
      "Clinical management of myelodysplastic syndromes with interstitial deletion of chromosome 5q"
    ],
    "type": "article-journal",
    "volume": [
      "24"
    ]
  },
  {
    "author": [
      {
        "family": "Melchert",
        "given": "M."
      },
      {
        "family": "List",
        "given": "A."
      }
    ],
    "citation-number": [
      "12."
    ],
    "container-title": [
      "Hematology"
    ],
    "date": [
      "2007",
      "2007"
    ],
    "pages": [
      "398–404"
    ],
    "title": [
      "Management of RBC-transfusion dependence"
    ],
    "type": "article-journal"
  },
  {
    "author": [
      {
        "family": "Silverman",
        "given": "L.R."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "13."
    ],
    "container-title": [
      "J Clin Oncol"
    ],
    "date": [
      "2006"
    ],
    "pages": [
      "3895–903"
    ],
    "title": [
      "Further analysis of trials with azacitidine in patients with myelodysplastic syndrome: studies 8421, 8921 and 9221 by the Cancer and Leukemia Group B"
    ],
    "type": "article-journal",
    "volume": [
      "24"
    ]
  },
  {
    "author": [
      {
        "family": "Oosterveld",
        "given": "M."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "14."
    ],
    "container-title": [
      "Br J Haematol"
    ],
    "date": [
      "2003"
    ],
    "pages": [
      "81–9"
    ],
    "title": [
      "The impact of intensive antileukaemic treatment strategies on prognosis of myelodysplastic syndrome patients aged less than 61 years according to International Prognostic Scoring System risk groups"
    ],
    "type": "article-journal",
    "volume": [
      "123"
    ]
  },
  {
    "author": [
      {
        "family": "Cutler",
        "given": "C.S."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "15."
    ],
    "container-title": [
      "Blood"
    ],
    "date": [
      "2004"
    ],
    "pages": [
      "579–85"
    ],
    "title": [
      "A decision analysis of allogeneic bone marrow transplantation for the myelodysplastic syndromes. Delayed transplantation for low risk myelodysplasia is associated with improved outcome"
    ],
    "type": "article-journal",
    "volume": [
      "104"
    ]
  },
  {
    "author": [
      {
        "family": "Ingram",
        "given": "W."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "16."
    ],
    "container-title": [
      "Blood Reviews"
    ],
    "date": [
      "2007"
    ],
    "location": [
      "Further reading"
    ],
    "pages": [
      "61–71"
    ],
    "title": [
      "Allogeneic transplantation for myelodysplastic syndrome (MDS"
    ],
    "type": "article-journal",
    "volume": [
      "21"
    ]
  },
  {
    "author": [
      {
        "family": "Khan",
        "given": "C."
      },
      {
        "others": true
      }
    ],
    "container-title": [
      "Ther Adv Hematol"
    ],
    "date": [
      "2012"
    ],
    "issue": [
      "6"
    ],
    "pages": [
      "355–73"
    ],
    "title": [
      "Azacitidine in the management of patients with myelodysplastic syndromes"
    ],
    "type": "article-journal",
    "volume": [
      "3"
    ]
  },
  {
    "author": [
      {
        "family": "Malcovati",
        "given": "L."
      },
      {
        "others": true
      }
    ],
    "container-title": [
      "Haematologica"
    ],
    "date": [
      "2011"
    ],
    "pages": [
      "1433–40"
    ],
    "title": [
      "Impact of the degree of anemia on the outcome of patients with myelodysplastic syndrome and its integration into the WHO classification-based Prognostic Scoring System (WPSS"
    ],
    "type": "article-journal",
    "volume": [
      "96"
    ]
  },
  {
    "author": [
      {
        "family": "Mishra",
        "given": "A."
      },
      {
        "others": true
      }
    ],
    "container-title": [
      "Am J Hematol"
    ],
    "date": [
      "2013"
    ],
    "issue": [
      "7"
    ],
    "pages": [
      "566–70"
    ],
    "title": [
      "Validation of the revised International Prognostic Scoring System in treated patients with myelodysplastic syndromes"
    ],
    "type": "article-journal",
    "volume": [
      "88"
    ]
  },
  {
    "author": [
      {
        "family": "Pierdomenico",
        "given": "F."
      },
      {
        "others": true
      }
    ],
    "container-title": [
      "Ann Hematol"
    ],
    "date": [
      "2013"
    ],
    "issue": [
      "9"
    ],
    "pages": [
      "1201–6"
    ],
    "title": [
      "Efficacy and tolerability of 5-day azacytidine dose-intensified regimen in higher-risk MDS"
    ],
    "type": "article-journal",
    "volume": [
      "92"
    ]
  },
  {
    "author": [
      {
        "family": "Cheson",
        "given": "B."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "1."
    ],
    "container-title": [
      "Blood"
    ],
    "date": [
      "2000"
    ],
    "pages": [
      "3671–4"
    ],
    "title": [
      "Report of an international working group to standardize response criteria for myelodysplastic syndromes"
    ],
    "type": "article-journal",
    "volume": [
      "96"
    ]
  },
  {
    "author": [
      {
        "family": "Cheson",
        "given": "B."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "2."
    ],
    "container-title": [
      "Blood"
    ],
    "date": [
      "2006"
    ],
    "pages": [
      "419–25"
    ],
    "title": [
      "Clinical application and proposal for modification of the International Working Group (IWG) response criteria in myelodysplasia"
    ],
    "type": "article-journal",
    "volume": [
      "108"
    ]
  },
  {
    "author": [
      {
        "family": "Jansen",
        "given": "A.J.G."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "3."
    ],
    "container-title": [
      "Br J Haematol"
    ],
    "date": [
      "2003"
    ],
    "location": [
      "Further reading"
    ],
    "pages": [
      "270–4"
    ],
    "title": [
      "Quality of life measurement in patients with transfusiondependent myelodysplastic syndromes"
    ],
    "type": "article-journal",
    "volume": [
      "121"
    ]
  },
  {
    "author": [
      {
        "family": "Swerdlow",
        "given": "S.H."
      },
      {
        "others": true
      }
    ],
    "date": [
      "2008"
    ],
    "edition": [
      "4th"
    ],
    "location": [
      "Lyon"
    ],
    "note": [
      "252 CHAPTER 6 Myelodysplasia"
    ],
    "publisher": [
      "IARC"
    ],
    "title": [
      "WHO Classifications of Tumours of Haematopoietic and Lymphoid Tissues"
    ],
    "type": null
  },
  {
    "author": [
      {
        "family": "Vardiman",
        "given": "J.W."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "1."
    ],
    "container-title": [
      "Pathology and genetics. Tumours of haematopoietic and lymphoid tissues"
    ],
    "date": [
      "2001"
    ],
    "editor": [
      {
        "family": "Jaffe",
        "given": "E.S."
      },
      {
        "others": true
      }
    ],
    "location": [
      "Lyon"
    ],
    "pages": [
      "46–59"
    ],
    "publisher": [
      "IARC Press"
    ],
    "title": [
      "Myelodysplastic / myeloproliferative diseases",
      "World Health Organization classification of tumours"
    ],
    "type": "article-journal",
    "volume": [
      "1"
    ]
  },
  {
    "author": [
      {
        "family": "Apperley",
        "given": "J.F."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "2."
    ],
    "container-title": [
      "N Engl J Med"
    ],
    "date": [
      "2002"
    ],
    "pages": [
      "481–7"
    ],
    "title": [
      "Response to imatinib mesylate in patients with chronic myeloproliferative diseases with rearrangements of the platelet-derived growth factor receptor beta"
    ],
    "type": "article-journal",
    "volume": [
      "347"
    ]
  },
  {
    "author": [
      {
        "family": "Wattel",
        "given": "E."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "3."
    ],
    "container-title": [
      "Blood"
    ],
    "date": [
      "1996"
    ],
    "pages": [
      "2480–7"
    ],
    "title": [
      "A randomized trial of hydroxyurea versus VP16 in adult chronic myelomonocytic leukemia"
    ],
    "type": "article-journal",
    "volume": [
      "88"
    ]
  },
  {
    "author": [
      {
        "family": "Kroger",
        "given": "N."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "4."
    ],
    "container-title": [
      "Br J Haematol"
    ],
    "date": [
      "2002"
    ],
    "pages": [
      "67–73"
    ],
    "title": [
      "Allogeneic stem cell transplantation of adult chronic myelomonocytic leukaemia: a report on behalf of the Chronic Leukaemia Working Party of the European Group for Blood and Marrow Transplantation (EBMT"
    ],
    "type": "article-journal",
    "volume": [
      "118"
    ]
  },
  {
    "author": [
      {
        "family": "Costello",
        "given": "R."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "5."
    ],
    "container-title": [
      "Leuk Lymphoma"
    ],
    "date": [
      "1997"
    ],
    "pages": [
      "225–32"
    ],
    "title": [
      "Clinical and biological aspects of Philadelphia-negative/BCR-negative chronic myeloid leukemia"
    ],
    "type": "article-journal",
    "volume": [
      "25"
    ]
  },
  {
    "author": [
      {
        "family": "Vardiman",
        "given": "J.W."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "6."
    ],
    "container-title": [
      "Pathology and genetics. Tumours of haematopoietic and lymphoid tissues"
    ],
    "date": [
      "2001"
    ],
    "editor": [
      {
        "family": "Jaffe",
        "given": "E.S."
      },
      {
        "others": true
      }
    ],
    "location": [
      "Lyon"
    ],
    "pages": [
      "55–7"
    ],
    "publisher": [
      "IARC Press"
    ],
    "title": [
      "Juvenile myelomonocytic leukaemia",
      "World Health Organization classification of tumours"
    ],
    "type": "article-journal",
    "volume": [
      "1"
    ]
  },
  {
    "author": [
      {
        "family": "Locatelli",
        "given": "F."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "7."
    ],
    "container-title": [
      "Blood"
    ],
    "date": [
      "2005"
    ],
    "pages": [
      "410–19"
    ],
    "title": [
      "Hematopoietic stem cell transplantation (HSCT) in children with juvenile myelomonocytic leukemia ( JMML): results of the EWOG-MDS/EBMT trial"
    ],
    "type": "article-journal",
    "volume": [
      "105"
    ]
  },
  {
    "author": [
      {
        "family": "Bain",
        "given": "B."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "8."
    ],
    "container-title": [
      "Pathology and genetics. Tumours of haematopoietic and lymphoid tissues"
    ],
    "date": [
      "2001"
    ],
    "editor": [
      {
        "family": "Jaffe",
        "given": "E.S."
      },
      {
        "others": true
      }
    ],
    "location": [
      "Lyon"
    ],
    "pages": [
      "46–59"
    ],
    "publisher": [
      "IARC Press"
    ],
    "title": [
      "Myelodysplastic / myeloproliferative disease, unclassifiable",
      "World Health Organization classification of tumours"
    ],
    "type": "article-journal",
    "volume": [
      "1"
    ]
  },
  {
    "author": [
      {
        "family": "Jones",
        "given": "A.V."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "9."
    ],
    "container-title": [
      "Blood"
    ],
    "date": [
      "2005"
    ],
    "location": [
      "Further reading"
    ],
    "pages": [
      "2162–8"
    ],
    "title": [
      "Widespread occurrence of the JAK2 V617F mutation in chronic myeloproliferative disorders"
    ],
    "type": "article-journal",
    "volume": [
      "106"
    ]
  },
  {
    "author": [
      {
        "family": "Costa",
        "given": "R."
      },
      {
        "others": true
      }
    ],
    "container-title": [
      "Cancer"
    ],
    "date": [
      "2011"
    ],
    "issue": [
      "12"
    ],
    "pages": [
      "2690–6"
    ],
    "title": [
      "Activity of azacitidine in chronic myelomonocytic leukemia"
    ],
    "type": "article-journal",
    "volume": [
      "117"
    ]
  },
  {
    "author": [
      {
        "family": "Thorpe",
        "given": "M."
      },
      {
        "others": true
      }
    ],
    "container-title": [
      "Leuk Res"
    ],
    "date": [
      "2012"
    ],
    "issue": [
      "8"
    ],
    "pages": [
      "1071–3"
    ],
    "title": [
      "Treatment of chronic myelomonocytic leukemia with 5-azacitidine: a case series and literature review"
    ],
    "type": "article-journal",
    "volume": [
      "36"
    ]
  },
  {
    "author": [
      {
        "family": "Swerdlow",
        "given": "S.H."
      },
      {
        "others": true
      }
    ],
    "date": [
      "2008"
    ],
    "edition": [
      "4th"
    ],
    "location": [
      "Lyon"
    ],
    "note": [
      "This page intentionally left blank"
    ],
    "publisher": [
      "IARC"
    ],
    "title": [
      "WHO Classifications of Tumours of Haematopoietic and Lymphoid Tissues"
    ],
    "type": null
  },
  {
    "author": [
      {
        "family": "Tefferi",
        "given": "A."
      },
      {
        "family": "Vardiman",
        "given": "J.W."
      }
    ],
    "citation-number": [
      "1"
    ],
    "container-title": [
      "Leukemia"
    ],
    "date": [
      "2008"
    ],
    "pages": [
      "14–22"
    ],
    "title": [
      "Classification and diagnosis of myeloproliferative neoplasms: the 2008 World Health Organization criteria and point-of-care diagnostic algorithms"
    ],
    "type": "article-journal",
    "volume": [
      "22"
    ]
  },
  {
    "author": [
      {
        "family": "Vardiman",
        "given": "J.W."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "2"
    ],
    "container-title": [
      "Blood"
    ],
    "date": [
      "2002"
    ],
    "pages": [
      "2292–2302"
    ],
    "title": [
      "The World Health Organization (WHO) classification of the myeloid neoplasms"
    ],
    "type": "article-journal",
    "volume": [
      "100"
    ]
  },
  {
    "author": [
      {
        "family": "Tefferin",
        "given": "A."
      },
      {
        "family": "Gilliland",
        "given": "D.G."
      }
    ],
    "citation-number": [
      "3"
    ],
    "container-title": [
      "Cell Cycle"
    ],
    "date": [
      "2007"
    ],
    "pages": [
      "550–66"
    ],
    "title": [
      "Oncogenes in myeloproferative disorders"
    ],
    "type": "article-journal",
    "volume": [
      "6"
    ]
  },
  {
    "author": [
      {
        "family": "Swerdlow",
        "given": "S.H."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "4."
    ],
    "date": [
      "2008"
    ],
    "edition": [
      "4th"
    ],
    "location": [
      "Lyon"
    ],
    "publisher": [
      "IARC"
    ],
    "title": [
      "WHO Classifications of Tumours of Haematopoietic and Lymphoid Tissues"
    ],
    "type": "book"
  },
  {
    "author": [
      {
        "family": "Levine",
        "given": "R.L."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "1."
    ],
    "container-title": [
      "Nat Rev Cancer"
    ],
    "date": [
      "2007"
    ],
    "pages": [
      "673–83"
    ],
    "title": [
      "Role of JAK2 in the pathogenesis and therapy of myeloproliferative disorders"
    ],
    "type": "article-journal",
    "volume": [
      "7"
    ]
  },
  {
    "author": [
      {
        "family": "Campbell",
        "given": "P.J."
      },
      {
        "family": "Green",
        "given": "A.R."
      }
    ],
    "citation-number": [
      "2."
    ],
    "container-title": [
      "N Engl J Med"
    ],
    "date": [
      "2006"
    ],
    "pages": [
      "2452–66"
    ],
    "title": [
      "The myeloproliferative disorders"
    ],
    "type": "article-journal",
    "volume": [
      "355"
    ]
  },
  {
    "author": [
      {
        "family": "Baxter",
        "given": "E.J."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "3."
    ],
    "container-title": [
      "Lancet"
    ],
    "date": [
      "2005"
    ],
    "pages": [
      "1054–61"
    ],
    "title": [
      "Acquired mutation of the tyrosine kinase JAK2 in human myeloproliferative disorders"
    ],
    "type": "article-journal",
    "volume": [
      "365"
    ]
  },
  {
    "author": [
      {
        "family": "Scott",
        "given": "L.M."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "4."
    ],
    "container-title": [
      "N Engl J Med"
    ],
    "date": [
      "2007"
    ],
    "pages": [
      "459–68"
    ],
    "title": [
      "JAK2 exon 12 mutations in polycythaemia vera and idiopathic erythrocytosis"
    ],
    "type": "article-journal",
    "volume": [
      "356"
    ]
  },
  {
    "author": [
      {
        "family": "Wernig",
        "given": "G."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "5."
    ],
    "container-title": [
      "Blood"
    ],
    "date": [
      "2006"
    ],
    "pages": [
      "4274–81"
    ],
    "title": [
      "Expression of Jak2V617F causes a polycythemia vera–like disease with associated myelofibrosis in a murine bone marrow transplant model"
    ],
    "type": "article-journal",
    "volume": [
      "107"
    ]
  },
  {
    "author": [
      {
        "family": "Landolfi",
        "given": "R."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "6."
    ],
    "container-title": [
      "Blood"
    ],
    "date": [
      "2007"
    ],
    "pages": [
      "2446–52"
    ],
    "title": [
      "Leukocytosis as a major thrombotic risk factor in patients with polycythemia vera"
    ],
    "type": "article-journal",
    "volume": [
      "109"
    ]
  },
  {
    "author": [
      {
        "family": "Carobbio",
        "given": "A."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "7."
    ],
    "container-title": [
      "Blood"
    ],
    "date": [
      "2007"
    ],
    "pages": [
      "2310–13"
    ],
    "title": [
      "Leukocytosis is a risk factor for thrombosis in essential thrombocythemia: interaction with treatment, standard risk factors, and Jak2 mutation status"
    ],
    "type": "article-journal",
    "volume": [
      "109"
    ]
  },
  {
    "author": [
      {
        "family": "Skoda",
        "given": "R."
      }
    ],
    "citation-number": [
      "8."
    ],
    "container-title": [
      "Hematology"
    ],
    "date": [
      "2007",
      "2007"
    ],
    "pages": [
      "1–10"
    ],
    "title": [
      "The genetic basis of myeloproliferative disorders"
    ],
    "type": "article-journal"
  },
  {
    "author": [
      {
        "family": "Szpurka",
        "given": "H."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "9."
    ],
    "container-title": [
      "Blood"
    ],
    "date": [
      "2006"
    ],
    "pages": [
      "2173–81"
    ],
    "title": [
      "Refractory anemia with ringed sideroblasts associated with marked thrombocytosis (RARS-T), another myeloproliferative condition characterized by JAK2 V617F mutation"
    ],
    "type": "article-journal",
    "volume": [
      "108"
    ]
  },
  {
    "author": [
      {
        "family": "Scott",
        "given": "L.M."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "10."
    ],
    "container-title": [
      "Blood"
    ],
    "date": [
      "2006"
    ],
    "pages": [
      "2435–7"
    ],
    "title": [
      "Progenitors homozygous for the V617F JAK2 mutation occur in most patients with polycythemia vera, but not essential thrombocythemia"
    ],
    "type": "article-journal",
    "volume": [
      "108"
    ]
  },
  {
    "author": [
      {
        "family": "Moliterno",
        "given": "A.R."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "11."
    ],
    "container-title": [
      "Blood"
    ],
    "date": [
      "2006"
    ],
    "pages": [
      "3913–5"
    ],
    "title": [
      "Molecular mimicry in the chronic myeloproliferative disorders: reciprocity between quantitative JAK2 V617F and Mpl expression"
    ],
    "type": "article-journal",
    "volume": [
      "108"
    ]
  },
  {
    "author": [
      {
        "family": "Campbell",
        "given": "P.J."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "12."
    ],
    "date": [
      "2005",
      "1945"
    ],
    "genre": [
      "Lancet,"
    ],
    "title": [
      "Definition of subtypes of essential thrombocythaemia and relation to polycythaemia vera based on JAK2 V617F mutation status: a prospective study"
    ],
    "type": null
  },
  {
    "author": [
      {
        "family": "Campbell",
        "given": "P.J."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "13."
    ],
    "container-title": [
      "Blood"
    ],
    "date": [
      "2006"
    ],
    "pages": [
      "2098–2100"
    ],
    "title": [
      "V617F mutation in JAK2 is associated with poorer survival in idiopathic myelofibrosis"
    ],
    "type": "article-journal",
    "volume": [
      "107"
    ]
  },
  {
    "author": [
      {
        "family": "Levine",
        "given": "R.L."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "14."
    ],
    "container-title": [
      "Blood"
    ],
    "date": [
      "2006"
    ],
    "pages": [
      "4039–41"
    ],
    "title": [
      "X-inactivation based clonality analysis and quantitative JAK2V617F assessment reveal an association between clonality and JAK2V617F in PV but not ET/ MMM, and identifies a subset of JAK2V617F–negative ET and MMM patients with clonal haematopoiesis"
    ],
    "type": "article-journal",
    "volume": [
      "107"
    ]
  },
  {
    "author": [
      {
        "family": "Pardanani",
        "given": "A.D."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "15."
    ],
    "container-title": [
      "Blood"
    ],
    "date": [
      "2006"
    ],
    "pages": [
      "3472–6"
    ],
    "title": [
      "MPL515 mutations in myeloproliferative and other myeloid disorders: a study of 118 patients"
    ],
    "type": "article-journal",
    "volume": [
      "108"
    ]
  },
  {
    "author": [
      {
        "family": "Buttner",
        "given": "C."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "16."
    ],
    "container-title": [
      "J Invest Dermatol"
    ],
    "date": [
      "1998"
    ],
    "pages": [
      "1227–31"
    ],
    "title": [
      "Identification of activating c-kit mutations in adult-, but not in childhood-onset indolent mastocytosis: a possible explanation for divergent clinical behaviour"
    ],
    "type": "article-journal",
    "volume": [
      "111"
    ]
  },
  {
    "author": [
      {
        "family": "Cools",
        "given": "J."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "17."
    ],
    "container-title": [
      "N Engl J Med"
    ],
    "date": [
      "2003"
    ],
    "pages": [
      "1201–14"
    ],
    "title": [
      "A tyrosine kinase created by fusion of the PDGFRA and FIP1L1 genes as a therapeutic target of imatinib in idiopathic eosinophilic syndrome"
    ],
    "type": "article-journal",
    "volume": [
      "348"
    ]
  },
  {
    "author": [
      {
        "family": "Baxter",
        "given": "E.J."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "1."
    ],
    "container-title": [
      "Lancet"
    ],
    "date": [
      "2005"
    ],
    "pages": [
      "1054–61"
    ],
    "title": [
      "Acquired mutation of the tyrosine kinase JAK2 in human myeloproliferative disorders"
    ],
    "type": "article-journal",
    "volume": [
      "365"
    ]
  },
  {
    "author": [
      {
        "family": "Levine",
        "given": "R.L."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "2."
    ],
    "container-title": [
      "Nat Rev Cancer"
    ],
    "date": [
      "2007"
    ],
    "pages": [
      "673–83"
    ],
    "title": [
      "Role of JAK2 in the pathogenesis and therapy of myeloproliferative disorders"
    ],
    "type": "article-journal",
    "volume": [
      "7"
    ]
  },
  {
    "author": [
      {
        "family": "Tefferi",
        "given": "A."
      },
      {
        "family": "Vardiman",
        "given": "J.W."
      }
    ],
    "citation-number": [
      "3."
    ],
    "container-title": [
      "Leukemia"
    ],
    "date": [
      "2008"
    ],
    "pages": [
      "14–22"
    ],
    "title": [
      "Classification and diagnosis of myeloproliferative neoplasms: The 2008 World Health Organization criteria and point-of-care diagnostic algorithms"
    ],
    "type": "article-journal",
    "volume": [
      "22"
    ]
  },
  {
    "author": [
      {
        "family": "Marchioli",
        "given": "R."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "1."
    ],
    "container-title": [
      "J Clin Oncol"
    ],
    "date": [
      "2005"
    ],
    "pages": [
      "2224–32"
    ],
    "title": [
      "Vascular and neoplastic risk in a large cohort of patients with polycythemia vera"
    ],
    "type": "article-journal",
    "volume": [
      "23"
    ]
  },
  {
    "author": [
      {
        "family": "Finazzi",
        "given": "G."
      },
      {
        "family": "Barbui",
        "given": "T."
      }
    ],
    "citation-number": [
      "2."
    ],
    "container-title": [
      "Blood"
    ],
    "date": [
      "2007"
    ],
    "pages": [
      "5104–11"
    ],
    "title": [
      "How I treat patients with polycythemia vera"
    ],
    "type": "article-journal",
    "volume": [
      "109"
    ]
  },
  {
    "author": [
      {
        "family": "Landolfi",
        "given": "R."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "3."
    ],
    "container-title": [
      "Blood"
    ],
    "date": [
      "2007"
    ],
    "pages": [
      "2446–52"
    ],
    "title": [
      "Leukocytosis as a major thrombotic risk factor in patients with polycythemia vera"
    ],
    "type": "article-journal",
    "volume": [
      "109"
    ]
  },
  {
    "author": [
      {
        "family": "Vannucchi",
        "given": "A.M."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "4."
    ],
    "container-title": [
      "Leukemia"
    ],
    "date": [
      "2007"
    ],
    "pages": [
      "1952–9"
    ],
    "title": [
      "Prospective identification of high risk polycythemia vera patients based on JAK2 allele burden"
    ],
    "type": "article-journal",
    "volume": [
      "21"
    ]
  },
  {
    "author": [
      {
        "family": "Passamonti",
        "given": "F."
      }
    ],
    "citation-number": [
      "5."
    ],
    "container-title": [
      "Blood"
    ],
    "date": [
      "2012"
    ],
    "pages": [
      "275–84"
    ],
    "title": [
      "How I treat polycythemia vera"
    ],
    "type": "article-journal",
    "volume": [
      "120"
    ]
  },
  {
    "note": [
      "272 CHAPTER 7 Myeloproliferative neoplasms"
    ],
    "type": null
  },
  {
    "author": [
      {
        "family": "Finazzi",
        "given": "G."
      },
      {
        "family": "Barbui",
        "given": "T."
      }
    ],
    "citation-number": [
      "1."
    ],
    "container-title": [
      "Blood"
    ],
    "date": [
      "2007"
    ],
    "pages": [
      "5104–11"
    ],
    "title": [
      "How I treat patients with polycythemia vera"
    ],
    "type": "article-journal",
    "volume": [
      "109"
    ]
  },
  {
    "author": [
      {
        "family": "Landolfi",
        "given": "R."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "2."
    ],
    "container-title": [
      "N Engl J Med"
    ],
    "date": [
      "2004"
    ],
    "pages": [
      "114–24"
    ],
    "title": [
      "Efficacy and safety of low dose aspirin in polycythemia vera"
    ],
    "type": "article-journal",
    "volume": [
      "350"
    ]
  },
  {
    "author": [
      {
        "family": "Budde",
        "given": "U."
      },
      {
        "family": "Genderen",
        "given": "P.J.",
        "particle": "van"
      }
    ],
    "citation-number": [
      "3."
    ],
    "container-title": [
      "SeminThromb Hemost"
    ],
    "date": [
      "1997"
    ],
    "pages": [
      "425–31"
    ],
    "title": [
      "Acquired von Willebrand disease in patients with high platelet counts"
    ],
    "type": "article-journal",
    "volume": [
      "23"
    ]
  },
  {
    "author": [
      {
        "family": "Berk",
        "given": "P.D."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "4."
    ],
    "container-title": [
      "Semin Hematol"
    ],
    "date": [
      "1986"
    ],
    "issue": [
      "2"
    ],
    "pages": [
      "132–43"
    ],
    "title": [
      "Therapeutic recommendations in polycythemia vera based on Polycythemia Vera Study Group protocols"
    ],
    "type": "article-journal",
    "volume": [
      "23"
    ]
  },
  {
    "author": [
      {
        "family": "Landolfi",
        "given": "R."
      },
      {
        "family": "Gennaro",
        "given": "L.",
        "particle": "Di"
      }
    ],
    "citation-number": [
      "5."
    ],
    "container-title": [
      "Haematologica"
    ],
    "date": [
      "2008"
    ],
    "pages": [
      "331–5"
    ],
    "title": [
      "Prevention of thrombosis in polycythemia vera and essential thrombocythemia"
    ],
    "type": "article-journal",
    "volume": [
      "93"
    ]
  },
  {
    "author": [
      {
        "family": "Finazzi",
        "given": "G."
      },
      {
        "family": "Barbui",
        "given": "T."
      }
    ],
    "citation-number": [
      "6."
    ],
    "container-title": [
      "Blood Rev"
    ],
    "date": [
      "2005"
    ],
    "pages": [
      "243–52"
    ],
    "title": [
      "Risk-adapted therapy in essential thrombocythemia and polycythemia vera"
    ],
    "type": "article-journal",
    "volume": [
      "19"
    ]
  },
  {
    "author": [
      {
        "family": "Cortelazzo",
        "given": "S."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "7."
    ],
    "container-title": [
      "N Engl J Med"
    ],
    "date": [
      "1995"
    ],
    "pages": [
      "1132–6"
    ],
    "title": [
      "Hydroxyurea in the treatment of patients with essential thrombocythemia at high risk of thrombosis: a prospective randomized trial"
    ],
    "type": "article-journal",
    "volume": [
      "332"
    ]
  },
  {
    "author": [
      {
        "family": "Harrison",
        "given": "C.N."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "8."
    ],
    "container-title": [
      "N Engl J Med"
    ],
    "date": [
      "2005"
    ],
    "pages": [
      "33–45"
    ],
    "title": [
      "Hydroxyurea compared with anagrelide in high-risk essential thrombocythemia"
    ],
    "type": "article-journal",
    "volume": [
      "353"
    ]
  },
  {
    "author": [
      {
        "family": "Finazzi",
        "given": "G."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "9."
    ],
    "container-title": [
      "Blood"
    ],
    "date": [
      "2005"
    ],
    "pages": [
      "2664–70"
    ],
    "title": [
      "Acute leukemia in polycythaemia vera: an analysis of 1638 patients enrolled in a prospective observational study"
    ],
    "type": "article-journal",
    "volume": [
      "105"
    ]
  },
  {
    "author": [
      {
        "family": "Lengfelder",
        "given": "E."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "10."
    ],
    "container-title": [
      "Ann Hematol"
    ],
    "date": [
      "2000"
    ],
    "pages": [
      "103–9"
    ],
    "title": [
      "Interferon alpha in the treatment of polycythemia vera"
    ],
    "type": "article-journal",
    "volume": [
      "79"
    ]
  },
  {
    "author": [
      {
        "family": "Silver",
        "given": "R.T."
      }
    ],
    "citation-number": [
      "11."
    ],
    "container-title": [
      "Cancer"
    ],
    "date": [
      "2006"
    ],
    "pages": [
      "451–8"
    ],
    "title": [
      "Long-term effects of the treatment of polycytemia vera with recombinant interferon alpha"
    ],
    "type": "article-journal",
    "volume": [
      "107"
    ]
  },
  {
    "author": [
      {
        "family": "Landolfi",
        "given": "R."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "12."
    ],
    "container-title": [
      "Best Pract Res Clin Hematol"
    ],
    "date": [
      "2006"
    ],
    "pages": [
      "617–33"
    ],
    "title": [
      "Thrombosis and bleeding in polycythemia vera and essential thrombocythemia: pathogenetic mechanisms and prevention"
    ],
    "type": "article-journal",
    "volume": [
      "19"
    ]
  },
  {
    "author": [
      {
        "family": "Robinson",
        "given": "S."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "13."
    ],
    "container-title": [
      "Haematologica"
    ],
    "date": [
      "2005"
    ],
    "pages": [
      "1477–83"
    ],
    "title": [
      "The management and outcome of 18 pregnancies in women with polycythemia vera"
    ],
    "type": "article-journal",
    "volume": [
      "90"
    ]
  },
  {
    "author": [
      {
        "family": "McMullin",
        "given": "M.F."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "14."
    ],
    "container-title": [
      "Brit J Haematol"
    ],
    "date": [
      "2005"
    ],
    "pages": [
      "174–95"
    ],
    "title": [
      "Guidelines for the diagnosis, investigation and management of polycythemia/erythrocytosis"
    ],
    "type": "article-journal",
    "volume": [
      "130"
    ]
  },
  {
    "author": [
      {
        "family": "Passamonti",
        "given": "F."
      }
    ],
    "citation-number": [
      "15."
    ],
    "container-title": [
      "Blood"
    ],
    "date": [
      "2012"
    ],
    "pages": [
      "275–84"
    ],
    "title": [
      "How I treat polycythemia vera"
    ],
    "type": "article-journal",
    "volume": [
      "120"
    ]
  },
  {
    "author": [
      {
        "family": "Verstovsek",
        "given": "S."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "16."
    ],
    "date": [
      "2010"
    ],
    "note": [
      "abstract]. Blood (ASH Annual Meeting Abstracts), 116, 313."
    ],
    "title": [
      "Durable responses with the JAK1/JAK2 inhibitor, INCB018424, in patients with polycythemia vera (PV) and essential thrombocythemia (ET) refractory or intolerant to hydroxyurea (HU"
    ],
    "type": null
  },
  {
    "author": [
      {
        "family": "Johansson",
        "given": "P."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "1."
    ],
    "container-title": [
      "J Intern Med"
    ],
    "date": [
      "2004"
    ],
    "pages": [
      "161–5"
    ],
    "title": [
      "Trends in the incidence of chronic Philadelphia chromosome negative (Ph−) myeloproliferative disorders in the city of Gothenberg, Sweden, during 1983–99"
    ],
    "type": "article-journal",
    "volume": [
      "256"
    ]
  },
  {
    "author": [
      {
        "family": "Baxter",
        "given": "E.J."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "2."
    ],
    "container-title": [
      "Lancet"
    ],
    "date": [
      "2005"
    ],
    "pages": [
      "1054–61"
    ],
    "title": [
      "Acquired mutation of the tyrosine kinase JAK2 in human myeloproliferative disorders"
    ],
    "type": "article-journal",
    "volume": [
      "365"
    ]
  },
  {
    "author": [
      {
        "family": "Scott",
        "given": "L.M."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "3."
    ],
    "container-title": [
      "Blood"
    ],
    "date": [
      "2006"
    ],
    "pages": [
      "2435–7"
    ],
    "title": [
      "Progenitors homozygous for the V617F JAK2 mutation occur in most patients with polycythemia vera, but not essential thrombocythemia"
    ],
    "type": "article-journal",
    "volume": [
      "108"
    ]
  },
  {
    "author": [
      {
        "family": "Kralovics",
        "given": "R."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "4."
    ],
    "container-title": [
      "Blood"
    ],
    "date": [
      "2006"
    ],
    "pages": [
      "1377–80"
    ],
    "title": [
      "Acquisition of the V617F mutation of JAK2 is a late genetic event in a subset of patients with myeloproliferative disorders"
    ],
    "type": "article-journal",
    "volume": [
      "108"
    ]
  },
  {
    "author": [
      {
        "family": "Moliterno",
        "given": "A.R."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "5."
    ],
    "container-title": [
      "Blood"
    ],
    "date": [
      "2006"
    ],
    "pages": [
      "3913–15"
    ],
    "title": [
      "Molecular mimicry in the chronic myeloproliferative disorders: reciprocity between quantitative JAK2 V617F and Mpl expression"
    ],
    "type": "article-journal",
    "volume": [
      "108"
    ]
  },
  {
    "author": [
      {
        "family": "Pardanani",
        "given": "A.D."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "6."
    ],
    "container-title": [
      "Blood"
    ],
    "date": [
      "2006"
    ],
    "pages": [
      "3472–6"
    ],
    "title": [
      "MPL515 mutations in myeloproliferative and other myeloid disorders: a study of 118 patients"
    ],
    "type": "article-journal",
    "volume": [
      "108"
    ]
  },
  {
    "author": [
      {
        "family": "Ding",
        "given": "J."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "7."
    ],
    "container-title": [
      "Blood"
    ],
    "date": [
      "2004"
    ],
    "pages": [
      "4198–200"
    ],
    "title": [
      "Familial essential thrombocythemia associated with a dominantpositive activating mutation of the c-MPL gene, which encodes for the receptor for thrombopoietin"
    ],
    "type": "article-journal",
    "volume": [
      "103"
    ]
  },
  {
    "author": [
      {
        "family": "Wiestner",
        "given": "A."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "8."
    ],
    "container-title": [
      "Nat Genet"
    ],
    "date": [
      "1998"
    ],
    "pages": [
      "49–52"
    ],
    "title": [
      "An activating splice donor mutation in the thrombopoietin gene causes hereditary thrombocythemia"
    ],
    "type": "article-journal",
    "volume": [
      "18"
    ]
  },
  {
    "author": [
      {
        "family": "Campbell",
        "given": "P.J."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "9."
    ],
    "container-title": [
      "Lancet"
    ],
    "date": [
      "2005"
    ],
    "pages": [
      "1945–53"
    ],
    "title": [
      "Definition of subtypes of essential thrombocythaemia and relation to polycythaemia vera based on JAK2 V617F mutation status: a prospective study"
    ],
    "type": "article-journal",
    "volume": [
      "366"
    ]
  },
  {
    "author": [
      {
        "family": "Elliot",
        "given": "M.A."
      },
      {
        "family": "Tefferi",
        "given": "A."
      }
    ],
    "citation-number": [
      "10."
    ],
    "container-title": [
      "Br J Haematol"
    ],
    "date": [
      "2005"
    ],
    "pages": [
      "275–90"
    ],
    "title": [
      "Thrombosis and haemorrhage in polycythemia vera and essential thrombocythaemia"
    ],
    "type": "article-journal",
    "volume": [
      "128"
    ]
  },
  {
    "author": [
      {
        "family": "Budde",
        "given": "U."
      },
      {
        "family": "Genderen",
        "given": "P.J.",
        "particle": "van"
      }
    ],
    "citation-number": [
      "11."
    ],
    "container-title": [
      "SeminThromb Hemost"
    ],
    "date": [
      "1997"
    ],
    "pages": [
      "425–31"
    ],
    "title": [
      "Acquired von Willebrand disease in patients with high platelet counts"
    ],
    "type": "article-journal",
    "volume": [
      "23"
    ]
  },
  {
    "author": [
      {
        "family": "Tefferi",
        "given": "A."
      },
      {
        "family": "Vardiman",
        "given": "J.W."
      }
    ],
    "citation-number": [
      "12."
    ],
    "container-title": [
      "Leukemia"
    ],
    "date": [
      "2008"
    ],
    "pages": [
      "14–22"
    ],
    "title": [
      "Classification and diagnosis of myeloproliferative neoplasms: The 2008 World Health Organization criteria and point-of-care diagnostic algorithms"
    ],
    "type": "article-journal",
    "volume": [
      "22"
    ]
  },
  {
    "author": [
      {
        "family": "Carobbio",
        "given": "A."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "13."
    ],
    "container-title": [
      "Blood"
    ],
    "date": [
      "2007"
    ],
    "pages": [
      "2310–13"
    ],
    "title": [
      "Leukocytosis is a risk factor for thrombosis in essential thrombocythemia: interaction with treatment, standard risk factors, and Jak2 mutation status"
    ],
    "type": "article-journal",
    "volume": [
      "109"
    ]
  },
  {
    "author": [
      {
        "family": "Finazzi",
        "given": "G."
      },
      {
        "family": "Barbui",
        "given": "T."
      }
    ],
    "citation-number": [
      "14."
    ],
    "container-title": [
      "Blood Rev"
    ],
    "date": [
      "2005"
    ],
    "pages": [
      "243–52"
    ],
    "title": [
      "Risk-adapted therapy in essential thrombocythemia and polycythemia vera"
    ],
    "type": "article-journal",
    "volume": [
      "19"
    ]
  },
  {
    "author": [
      {
        "family": "Passamonti",
        "given": "F."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "15."
    ],
    "container-title": [
      "Am J Med"
    ],
    "date": [
      "2004"
    ],
    "pages": [
      "755–61"
    ],
    "title": [
      "Life expectancy and prognostic factors for survival in patients with polycythemia vera and essential thrombocythemia"
    ],
    "type": "article-journal",
    "volume": [
      "117"
    ]
  },
  {
    "author": [
      {
        "family": "Vannucchi",
        "given": "A.M."
      },
      {
        "family": "Barbui",
        "given": "T."
      }
    ],
    "citation-number": [
      "16."
    ],
    "container-title": [
      "Thrombocytosis and thrombosis Hematology"
    ],
    "date": [
      "2007",
      "2007"
    ],
    "pages": [
      "363–70"
    ],
    "type": "article-journal"
  },
  {
    "author": [
      {
        "family": "Ruggeri",
        "given": "M."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "17."
    ],
    "container-title": [
      "Br J Haematol"
    ],
    "date": [
      "1998"
    ],
    "pages": [
      "772–7"
    ],
    "title": [
      "No treatment for low risk thrombocythaemia: results from a prospective study"
    ],
    "type": "article-journal",
    "volume": [
      "103"
    ]
  },
  {
    "author": [
      {
        "family": "Landolfi",
        "given": "R."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "18."
    ],
    "container-title": [
      "N Engl J Med"
    ],
    "date": [
      "2004"
    ],
    "pages": [
      "114–24"
    ],
    "title": [
      "Efficacy and safety of low dose aspirin in poilycythemia vera"
    ],
    "type": "article-journal",
    "volume": [
      "350"
    ]
  },
  {
    "author": [
      {
        "family": "Barbui",
        "given": "T."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "19."
    ],
    "container-title": [
      "Haematologica"
    ],
    "date": [
      "2004"
    ],
    "pages": [
      "215–32"
    ],
    "title": [
      "Practice guidelines for the therapy of essential thrombocythemia. A statement from the Italian Society of Hematology, the Italian Society of Experimental Hematology and the Italian Group for Bone Marrow Transplantation"
    ],
    "type": "article-journal",
    "volume": [
      "89"
    ]
  },
  {
    "author": [
      {
        "family": "Tefferi",
        "given": "A."
      },
      {
        "family": "Barbui",
        "given": "T."
      }
    ],
    "citation-number": [
      "20."
    ],
    "container-title": [
      "Mayo Clin Proc"
    ],
    "date": [
      "2005"
    ],
    "pages": [
      "1220–32"
    ],
    "title": [
      "bcr/abl–negative, classic myeloproliferative disorders: diagnosis and treatment"
    ],
    "type": "article-journal",
    "volume": [
      "80"
    ]
  },
  {
    "author": [
      {
        "family": "Campbell",
        "given": "P.J."
      },
      {
        "family": "Green",
        "given": "A.R."
      }
    ],
    "citation-number": [
      "21."
    ],
    "container-title": [
      "Hematology"
    ],
    "date": [
      "2005"
    ],
    "pages": [
      "201–8"
    ],
    "title": [
      "Management of polycythemia vera and essential thrombocythemia"
    ],
    "type": "article-journal",
    "volume": [
      "2005"
    ]
  },
  {
    "author": [
      {
        "family": "Landolfi",
        "given": "R."
      },
      {
        "family": "Gennaro",
        "given": "L.",
        "particle": "Di"
      }
    ],
    "citation-number": [
      "22."
    ],
    "container-title": [
      "Haematologica"
    ],
    "date": [
      "2008"
    ],
    "pages": [
      "331–5"
    ],
    "title": [
      "Prevention of thrombosis in polycythemia vera and essential thrombocythemia"
    ],
    "type": "article-journal",
    "volume": [
      "93"
    ]
  },
  {
    "author": [
      {
        "family": "McCarthy",
        "given": "L."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "23."
    ],
    "container-title": [
      "Transfusion"
    ],
    "date": [
      "2002"
    ],
    "pages": [
      "1245"
    ],
    "title": [
      "Erythromelalgia due to essential thrombocthemia"
    ],
    "type": "article-journal",
    "volume": [
      "42"
    ]
  },
  {
    "author": [
      {
        "family": "Cortelazzo",
        "given": "S."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "24."
    ],
    "container-title": [
      "N Engl J Med"
    ],
    "date": [
      "1995"
    ],
    "pages": [
      "1132–6"
    ],
    "title": [
      "Hydroxyurea for patients with essential thrombocythemia and a high risk of thrombosis"
    ],
    "type": "article-journal",
    "volume": [
      "332"
    ]
  },
  {
    "author": [
      {
        "family": "Harrison",
        "given": "C.N."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "25."
    ],
    "container-title": [
      "N Engl J Med"
    ],
    "date": [
      "2005"
    ],
    "pages": [
      "33–45"
    ],
    "title": [
      "Hydroxyurea compared with anagrelide in high-risk essential thrombocythemia"
    ],
    "type": "article-journal",
    "volume": [
      "353"
    ]
  },
  {
    "author": [
      {
        "family": "Finazzi",
        "given": "G."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "26."
    ],
    "container-title": [
      "Blood"
    ],
    "date": [
      "2005"
    ],
    "pages": [
      "2664–70"
    ],
    "title": [
      "Acute leukemia in polycythaemia vera: an analysis of 1638 patients enrolled in a prospective observational study"
    ],
    "type": "article-journal",
    "volume": [
      "105"
    ]
  },
  {
    "author": [
      {
        "family": "Barosi",
        "given": "G."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "27."
    ],
    "container-title": [
      "Leukemia"
    ],
    "date": [
      "2007",
      "1135"
    ],
    "genre": [
      "plus corrigenda 21,"
    ],
    "pages": [
      "277–80"
    ],
    "title": [
      "A unified definition of clinical resistance/intolerance to hydroxyurea in essential thrombocythemia: results of a consensus process by an international working group"
    ],
    "type": "article-journal",
    "volume": [
      "21"
    ]
  },
  {
    "author": [
      {
        "family": "Barbui",
        "given": "T."
      },
      {
        "family": "Finazzi",
        "given": "G."
      }
    ],
    "citation-number": [
      "28."
    ],
    "container-title": [
      "Hematology"
    ],
    "date": [
      "2006",
      "2006"
    ],
    "pages": [
      "246–52"
    ],
    "title": [
      "Myeloproliferative disease in pregnancy and other management issues"
    ],
    "type": "article-journal"
  },
  {
    "author": [
      {
        "family": "Passamonti",
        "given": "F."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "29."
    ],
    "container-title": [
      "Blood"
    ],
    "date": [
      "2007"
    ],
    "pages": [
      "485–9"
    ],
    "title": [
      "Increased risk of pregnancy complications in patients with essential thrombocythemia carrying the JAK2 (617V>F) mutation"
    ],
    "type": "article-journal",
    "volume": [
      "110"
    ]
  },
  {
    "author": [
      {
        "family": "Harrison",
        "given": "C."
      }
    ],
    "citation-number": [
      "30."
    ],
    "container-title": [
      "Br J Haematol"
    ],
    "date": [
      "2005"
    ],
    "pages": [
      "293–306"
    ],
    "title": [
      "Pregnancy and its management in the Philadelphia-negative myeloproliferative diseases"
    ],
    "type": "article-journal",
    "volume": [
      "129"
    ]
  },
  {
    "author": [
      {
        "family": "Beer",
        "given": "P."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "31."
    ],
    "container-title": [
      "Blood"
    ],
    "date": [
      "2011"
    ],
    "pages": [
      "1472–82"
    ],
    "title": [
      "How I treat essential thrombocythemia"
    ],
    "type": "article-journal",
    "volume": [
      "117"
    ]
  },
  {
    "author": [
      {
        "family": "Baxter",
        "given": "E.J."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "1."
    ],
    "container-title": [
      "Lancet"
    ],
    "date": [
      "2005"
    ],
    "pages": [
      "1054–61"
    ],
    "title": [
      "Acquired mutation of the tyrosine kinase JAK2 in human myeloproliferative disorders"
    ],
    "type": "article-journal",
    "volume": [
      "365"
    ]
  },
  {
    "author": [
      {
        "family": "Scott",
        "given": "L.M."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "2."
    ],
    "container-title": [
      "Blood"
    ],
    "date": [
      "2006"
    ],
    "pages": [
      "2435–7"
    ],
    "title": [
      "Progenitors homozygous for the V617F JAK2 mutation occur in most patients with polycythemia vera, but not essential thrombocythemia"
    ],
    "type": "article-journal",
    "volume": [
      "108"
    ]
  },
  {
    "author": [
      {
        "family": "Mesa",
        "given": "R."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "3."
    ],
    "container-title": [
      "Haematologica"
    ],
    "date": [
      "2006"
    ],
    "pages": [
      "415–6"
    ],
    "title": [
      "A longitudinal study of the JAK2V617F mutation in myelofibrosis with myeloid metaplasia: analysis at two time points"
    ],
    "type": "article-journal",
    "volume": [
      "91"
    ]
  },
  {
    "author": [
      {
        "family": "Campbell",
        "given": "P.J."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "4."
    ],
    "container-title": [
      "Blood"
    ],
    "date": [
      "2006"
    ],
    "pages": [
      "2098–100"
    ],
    "title": [
      "V617F mutation in JAK2 is associated with poorer survival in idiopathic myelofibrosis"
    ],
    "type": "article-journal",
    "volume": [
      "107"
    ]
  },
  {
    "author": [
      {
        "family": "Tefferi",
        "given": "A."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "5."
    ],
    "container-title": [
      "Cancer"
    ],
    "date": [
      "2006"
    ],
    "pages": [
      "1739–43"
    ],
    "title": [
      "Respective clustering of unfavorable and favorable cytogenetic clones in myelofibrosis with myeloid metaplasia with homozygosity for JAK2V617F and response to erythropoietin therapy"
    ],
    "type": "article-journal",
    "volume": [
      "106"
    ]
  },
  {
    "author": [
      {
        "family": "Pardanani",
        "given": "A.D."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "6."
    ],
    "container-title": [
      "Blood"
    ],
    "date": [
      "2006"
    ],
    "pages": [
      "3472–6"
    ],
    "title": [
      "MPL515 mutations in myeloproliferative and other myeloid disorders: a study of 118 patients"
    ],
    "type": "article-journal",
    "volume": [
      "108"
    ]
  },
  {
    "author": [
      {
        "family": "Lasho",
        "given": "T.L."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "7."
    ],
    "container-title": [
      "Br J Haematol"
    ],
    "date": [
      "2006"
    ],
    "pages": [
      "683–7"
    ],
    "title": [
      "Concurrent MPL515 and JAK2V617F mutations in myelofibrosis: chronology of clonal emergence and changes in mutant allele burden over time"
    ],
    "type": "article-journal",
    "volume": [
      "135"
    ]
  },
  {
    "author": [
      {
        "family": "Guglielmelli",
        "given": "P."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "8."
    ],
    "container-title": [
      "Br J Haematol"
    ],
    "date": [
      "2007"
    ],
    "pages": [
      "244–7"
    ],
    "title": [
      "GIMEMA –Italian Registry of Myelofibrosis; MPD Research Consortium. Anemia characterizes patients with myelofibrosis harbouring Mpl mutation"
    ],
    "type": "article-journal",
    "volume": [
      "137"
    ]
  },
  {
    "author": [
      {
        "family": "Al-Assar",
        "given": "O."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "9."
    ],
    "container-title": [
      "Br J Haematol"
    ],
    "date": [
      "2005"
    ],
    "pages": [
      "66–71"
    ],
    "title": [
      "Gains on 9p are common genomic aberrations in idiopathic myelofibrosis: a comparative genomic hybridization study"
    ],
    "type": "article-journal",
    "volume": [
      "129"
    ]
  },
  {
    "author": [
      {
        "family": "Dong",
        "given": "M."
      },
      {
        "family": "Blobe",
        "given": "G.C."
      }
    ],
    "citation-number": [
      "10."
    ],
    "container-title": [
      "Blood"
    ],
    "date": [
      "2006"
    ],
    "pages": [
      "4589–96"
    ],
    "title": [
      "Role of transforming growth factor-beta in hematologic malignancies"
    ],
    "type": "article-journal",
    "volume": [
      "107"
    ]
  },
  {
    "author": [
      {
        "family": "Massa",
        "given": "M."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "11."
    ],
    "container-title": [
      "J Clin Oncol"
    ],
    "date": [
      "2005"
    ],
    "pages": [
      "5688–95"
    ],
    "title": [
      "Circulating CD34+, CD133+ and vascular endothelial growth factor receptor 2-positive endothelial progenitor cells in myelofibrosis with myeloid metaplasia"
    ],
    "type": "article-journal",
    "volume": [
      "23"
    ]
  },
  {
    "author": [
      {
        "family": "Thiele",
        "given": "J."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "12."
    ],
    "container-title": [
      "Ann Hematol"
    ],
    "date": [
      "2001"
    ],
    "pages": [
      "160–5"
    ],
    "title": [
      "Clinical and morphological criteria for the diagnosis of prefibrotic idiopathic (primary) myelofibrosis"
    ],
    "type": "article-journal",
    "volume": [
      "80"
    ]
  },
  {
    "author": [
      {
        "family": "Tefferi",
        "given": "A."
      },
      {
        "family": "Barbui",
        "given": "T."
      }
    ],
    "citation-number": [
      "13."
    ],
    "container-title": [
      "Mayo Clin Proc"
    ],
    "date": [
      "2005"
    ],
    "pages": [
      "1220–32"
    ],
    "title": [
      "bcr/abl–negative, classic myeloproliferative disorders: diagnosis and treatment"
    ],
    "type": "article-journal",
    "volume": [
      "80"
    ]
  },
  {
    "author": [
      {
        "family": "Tefferi",
        "given": "A."
      },
      {
        "family": "Vardiman",
        "given": "J.W."
      }
    ],
    "citation-number": [
      "14."
    ],
    "container-title": [
      "Leukemia"
    ],
    "date": [
      "2008"
    ],
    "pages": [
      "14–22"
    ],
    "title": [
      "Classification and diagnosis of myeloproliferative neoplasms: The 2008 World Health Organization criteria and point-of-care diagnostic algorithms"
    ],
    "type": "article-journal",
    "volume": [
      "22"
    ]
  },
  {
    "author": [
      {
        "family": "Dupriez",
        "given": "B."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "15."
    ],
    "container-title": [
      "Blood"
    ],
    "date": [
      "1996"
    ],
    "pages": [
      "1013–8"
    ],
    "title": [
      "Prognostic factors in agnogenic myeloid metaplasia: a report on 195 cases with a new scoring system"
    ],
    "type": "article-journal",
    "volume": [
      "88"
    ]
  },
  {
    "author": [
      {
        "family": "Cerbantes",
        "given": "F."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "16."
    ],
    "container-title": [
      "Blood"
    ],
    "date": [
      "2009"
    ],
    "issue": [
      "13"
    ],
    "pages": [
      "2895–901"
    ],
    "title": [
      "New prognostic scoring system for primary myelofibrosis based on a study of the International Working Group for Myelofibrosis Research and Treatment"
    ],
    "type": "article-journal",
    "volume": [
      "113"
    ]
  },
  {
    "author": [
      {
        "family": "Passamonti",
        "given": "F."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "17."
    ],
    "container-title": [
      "Blood"
    ],
    "date": [
      "2010"
    ],
    "issue": [
      "9"
    ],
    "pages": [
      "1703–8"
    ],
    "title": [
      "A dynamic prognostic model to predict survival in primary myelofibrosis: a study by the IWG-MRT (International Working Group for Myeloproliferative Neoplasms Research and Treatment"
    ],
    "type": "article-journal",
    "volume": [
      "115"
    ]
  },
  {
    "author": [
      {
        "family": "Gangat",
        "given": "N."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "18."
    ],
    "container-title": [
      "J Clin Oncol"
    ],
    "date": [
      "2011"
    ],
    "issue": [
      "4"
    ],
    "pages": [
      "392–7"
    ],
    "title": [
      "DIPSS-Plus: a refined Dynamic International Prognostic Scoring System (DIPSS) for primary myelofibrosis that incorporates prognostic information from karyotype, platelet count and transfusion status"
    ],
    "type": "article-journal",
    "volume": [
      "29"
    ]
  },
  {
    "author": [
      {
        "family": "Group",
        "given": "Nordic M.P.D.Study"
      }
    ],
    "citation-number": [
      "19."
    ],
    "container-title": [
      "M"
    ],
    "date": [
      "2007"
    ],
    "title": [
      "Guidelines for the diagnosis and treatment of patients with polycythemia vera, essential thrombocythemia and idiopathic myelofibrosis"
    ],
    "type": "article-journal",
    "url": [
      "www. sfhem.se/filarkiv/files/vardprogram/NMPDGuidelines2007.pdf"
    ]
  },
  {
    "author": [
      {
        "family": "Cervantes",
        "given": "F."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "20."
    ],
    "container-title": [
      "Br J Haematol"
    ],
    "date": [
      "2005"
    ],
    "pages": [
      "771–5"
    ],
    "title": [
      "Efficacy and tolerability of danazol as a treatment for the anemia of myelofibrosis with myeloid metaplasia: long-term results in 30 patients"
    ],
    "type": "article-journal",
    "volume": [
      "129"
    ]
  },
  {
    "author": [
      {
        "family": "Hasselbalch",
        "given": "H.C."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "21."
    ],
    "container-title": [
      "Am J Hematol"
    ],
    "date": [
      "2002"
    ],
    "pages": [
      "92–9"
    ],
    "title": [
      "Successful treatment of anemia in idiopathic myelofibrosis with recombinant human erythropoietin"
    ],
    "type": "article-journal",
    "volume": [
      "70"
    ]
  },
  {
    "author": [
      {
        "family": "Cervantes",
        "given": "F."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "22."
    ],
    "container-title": [
      "Br J Haematol"
    ],
    "date": [
      "2004"
    ],
    "pages": [
      "399–403"
    ],
    "title": [
      "Erythropoietin treatment of the anemia of myelofibrosis with myeloid metaplasia: results in 20 patients and review of the literature"
    ],
    "type": "article-journal",
    "volume": [
      "127"
    ]
  },
  {
    "author": [
      {
        "family": "Cervantes",
        "given": "F."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "23."
    ],
    "container-title": [
      "Br J Haematol"
    ],
    "date": [
      "2006"
    ],
    "pages": [
      "184–6"
    ],
    "title": [
      "Darbepoetin-alpha for the anemia of myelofibrosis with myeloid metaplasia"
    ],
    "type": "article-journal",
    "volume": [
      "134"
    ]
  },
  {
    "author": [
      {
        "family": "Faoro",
        "given": "L.N."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "24."
    ],
    "container-title": [
      "Eur J Haematol"
    ],
    "date": [
      "2005"
    ],
    "pages": [
      "117–20"
    ],
    "title": [
      "Long-term analysis of the palliative benefit of 2-chlorodeoxyadenosine for myelofibrosis with myeloid metaplasia"
    ],
    "type": "article-journal",
    "volume": [
      "74"
    ]
  },
  {
    "note": [
      "302 CHAPTER 7 Myeloproliferative neoplasms"
    ],
    "type": null
  },
  {
    "author": [
      {
        "family": "Arana-Yi",
        "given": "C."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "25."
    ],
    "container-title": [
      "Oncologist"
    ],
    "date": [
      "2006"
    ],
    "pages": [
      "929–43"
    ],
    "title": [
      "Advances in the therapy of chronic idiopathic myelofibrosis"
    ],
    "type": "article-journal",
    "volume": [
      "11"
    ]
  },
  {
    "author": [
      {
        "family": "Mesa",
        "given": "R.A."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "26."
    ],
    "container-title": [
      "Blood"
    ],
    "date": [
      "2003"
    ],
    "pages": [
      "2534–41"
    ],
    "title": [
      "A phase 2 trial of combination low-dose thalidomide and prednisone for the treatment of myelofibrosis with myeloid metaplasia"
    ],
    "type": "article-journal",
    "volume": [
      "101"
    ]
  },
  {
    "author": [
      {
        "family": "Tefferi",
        "given": "A."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "27."
    ],
    "container-title": [
      "Blood"
    ],
    "date": [
      "2006"
    ],
    "pages": [
      "1158–64"
    ],
    "title": [
      "Lenalidomide therapy in myelofibrosis with myeloid metaplasia"
    ],
    "type": "article-journal",
    "volume": [
      "108"
    ]
  },
  {
    "author": [
      {
        "family": "Tefferi",
        "given": "A."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "28."
    ],
    "container-title": [
      "Leukemia"
    ],
    "date": [
      "2007"
    ],
    "pages": [
      "1158–64"
    ],
    "title": [
      "Lenalidomide therapy in del(5)(q31)-associated myelofibrosis: cytogenetic and JAK2v617F molecular remissions"
    ],
    "type": "article-journal",
    "volume": [
      "108"
    ]
  },
  {
    "author": [
      {
        "family": "Mesa",
        "given": "R.A."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "29."
    ],
    "container-title": [
      "Cancer"
    ],
    "date": [
      "2006"
    ],
    "pages": [
      "361–70"
    ],
    "title": [
      "Palliative goals, patient selection and perioperative platelet management: outcomes and lessons from 3 decades of splenectomy for myelofibrosis with myeloid metaplasia at the Mayo Clinic"
    ],
    "type": "article-journal",
    "volume": [
      "107"
    ]
  },
  {
    "author": [
      {
        "family": "Elliot",
        "given": "M.A."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "30."
    ],
    "container-title": [
      "Br J Haematol"
    ],
    "date": [
      "1998"
    ],
    "pages": [
      "505–11"
    ],
    "title": [
      "Splenic irradiation for symptomatic splenomegaly associated with myelofibrosis with myeloid metaplasia"
    ],
    "type": "article-journal",
    "volume": [
      "103"
    ]
  },
  {
    "author": [
      {
        "family": "Hoffman",
        "given": "R."
      },
      {
        "family": "Rondelli",
        "given": "D."
      }
    ],
    "citation-number": [
      "31."
    ],
    "container-title": [
      "Hematology"
    ],
    "date": [
      "2007",
      "2007"
    ],
    "pages": [
      "346–354"
    ],
    "title": [
      "Biology and treatment of primary myelofibrosis"
    ],
    "type": "article-journal"
  },
  {
    "author": [
      {
        "family": "Guardiola",
        "given": "P."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "32."
    ],
    "container-title": [
      "N Engl J Med"
    ],
    "date": [
      "2000"
    ],
    "pages": [
      "659"
    ],
    "title": [
      "Myelofibrosis with myeloid metaplasia"
    ],
    "type": "article-journal",
    "volume": [
      "343"
    ]
  },
  {
    "author": [
      {
        "family": "Tefferi",
        "given": "A."
      }
    ],
    "citation-number": [
      "33."
    ],
    "container-title": [
      "Blood"
    ],
    "date": [
      "2011"
    ],
    "pages": [
      "3494–504"
    ],
    "title": [
      "How I treat myelofibrosis"
    ],
    "type": "article-journal",
    "volume": [
      "117"
    ]
  },
  {
    "author": [
      {
        "family": "Verstovsek",
        "given": "S."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "34."
    ],
    "container-title": [
      "Br J Haematol"
    ],
    "date": [
      "2013"
    ],
    "issue": [
      "4"
    ],
    "pages": [
      "508–16"
    ],
    "title": [
      "The clinical benefit of ruxolitinib across patient subgroups: analysis of a placebo-controlled, Phase III study in patients with myelofibrosis"
    ],
    "type": "article-journal",
    "volume": [
      "161"
    ]
  },
  {
    "author": [
      {
        "family": "Imbert",
        "given": "M."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "1."
    ],
    "container-title": [
      "Pathology and Genetics. Tumours of Haematopoietic and Lymphoid Tissues"
    ],
    "date": [
      "2001"
    ],
    "editor": [
      {
        "family": "Jaffe",
        "given": "E.S."
      },
      {
        "others": true
      }
    ],
    "location": [
      "Lyon"
    ],
    "pages": [
      "27–8"
    ],
    "publisher": [
      "IARC Press"
    ],
    "title": [
      "Chronic neutrophilic leukaemia",
      "World Health Organization Classification of Tumours"
    ],
    "type": "article-journal",
    "volume": [
      "1"
    ]
  },
  {
    "author": [
      {
        "family": "Reilly",
        "given": "J.T."
      }
    ],
    "citation-number": [
      "2."
    ],
    "container-title": [
      "Br J Haematol"
    ],
    "date": [
      "2002"
    ],
    "pages": [
      "10–18"
    ],
    "title": [
      "Chronic neutrophilic leukaemia: a distinct clinical entity?"
    ],
    "type": "article-journal",
    "volume": [
      "116"
    ]
  },
  {
    "author": [
      {
        "family": "Tefferi",
        "given": "A."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "3."
    ],
    "container-title": [
      "Mayo Clin Proc"
    ],
    "date": [
      "2006"
    ],
    "pages": [
      "553–63"
    ],
    "title": [
      "Atypical myeloproliferative disorders: diagnosis and treatment"
    ],
    "type": "article-journal",
    "volume": [
      "81"
    ]
  },
  {
    "author": [
      {
        "family": "Elliot",
        "given": "M.A."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "4."
    ],
    "container-title": [
      "Leukemia"
    ],
    "date": [
      "2001"
    ],
    "pages": [
      "35–40"
    ],
    "title": [
      "Chronic neutrophilic leukemia (CNL): a clinical, pathologic and cytogenetic study"
    ],
    "type": "article-journal",
    "volume": [
      "15"
    ]
  },
  {
    "author": [
      {
        "family": "Hasle",
        "given": "H."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "5."
    ],
    "container-title": [
      "Br J Haematol"
    ],
    "date": [
      "1996"
    ],
    "pages": [
      "628–30"
    ],
    "title": [
      "Chronic neutrophilic leukaemia in adolesence and young adulthood"
    ],
    "type": "article-journal",
    "volume": [
      "9"
    ]
  },
  {
    "author": [
      {
        "family": "Pilotis",
        "given": "E."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "6."
    ],
    "container-title": [
      "Leuk Lymphoma"
    ],
    "date": [
      "2002"
    ],
    "pages": [
      "2051–4"
    ],
    "title": [
      "Allogeneic bone marrow transplantation in the management of chronic neutrophilic leukemia"
    ],
    "type": "article-journal",
    "volume": [
      "43"
    ]
  },
  {
    "author": [
      {
        "family": "Tefferi",
        "given": "A."
      },
      {
        "family": "Vardiman",
        "given": "J.W."
      }
    ],
    "citation-number": [
      "1."
    ],
    "container-title": [
      "Leukemia"
    ],
    "date": [
      "2008"
    ],
    "pages": [
      "14–22"
    ],
    "title": [
      "Classification and diagnosis of myeloproliferative neoplasms: The 2008 World Health Organization criteria and point-of-care diagnostic algorithms"
    ],
    "type": "article-journal",
    "volume": [
      "22"
    ]
  },
  {
    "author": [
      {
        "family": "Gotlib",
        "given": "J."
      }
    ],
    "citation-number": [
      "2."
    ],
    "container-title": [
      "Am J Hematol"
    ],
    "date": [
      "2012"
    ],
    "issue": [
      "9"
    ],
    "pages": [
      "903–14"
    ],
    "title": [
      "World Health Organization-defined eosinophilic disorders: 2012 update on diagnosis, risk stratification, and management"
    ],
    "type": "article-journal",
    "volume": [
      "87"
    ]
  },
  {
    "author": [
      {
        "family": "Cools",
        "given": "J."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "3."
    ],
    "container-title": [
      "N Engl J Med"
    ],
    "date": [
      "2003"
    ],
    "pages": [
      "1201–14"
    ],
    "title": [
      "A tyrosine kinase created by fusion of the PDGFRA and FIP1L1 genes as a therapeutic target of imatinib in idiopathic eosinophilic syndrome"
    ],
    "type": "article-journal",
    "volume": [
      "348"
    ]
  },
  {
    "author": [
      {
        "family": "P",
        "given": "Vandenberghe"
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "4."
    ],
    "container-title": [
      "Leukemia"
    ],
    "date": [
      "2004"
    ],
    "pages": [
      "734–42"
    ],
    "title": [
      "Clinical and molecular features of FIP1L1-PDGFRA (+) chronic eosinophilic leukemias"
    ],
    "type": "article-journal",
    "volume": [
      "18"
    ]
  },
  {
    "author": [
      {
        "family": "Pardanani",
        "given": "A."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "5."
    ],
    "container-title": [
      "Blood"
    ],
    "date": [
      "2004"
    ],
    "pages": [
      "3038–45"
    ],
    "title": [
      "FIP1L1-PDGFRA fusion: prevalence and clinicopathologic correlatesin 89 consecutive patients with moderate to severe eosinophilia"
    ],
    "type": "article-journal",
    "volume": [
      "104"
    ]
  },
  {
    "author": [
      {
        "family": "Trempat",
        "given": "P."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "6."
    ],
    "container-title": [
      "Oncogene"
    ],
    "date": [
      "2003"
    ],
    "pages": [
      "5702–6"
    ],
    "title": [
      "Chronic myeloproliferative disorders with rearrangement of the platelet-derived growth factor alpha receptor: a new clinical target for STI571/Glivec"
    ],
    "type": "article-journal",
    "volume": [
      "22"
    ]
  },
  {
    "author": [
      {
        "family": "Tefferi",
        "given": "A."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "7."
    ],
    "container-title": [
      "Mayo Clin Proc"
    ],
    "date": [
      "2006"
    ],
    "pages": [
      "553–63"
    ],
    "title": [
      "Atypical myeloproliferative disorders: diagnosis and treatment"
    ],
    "type": "article-journal",
    "volume": [
      "81"
    ]
  },
  {
    "author": [
      {
        "family": "Elliot",
        "given": "M.A."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "8."
    ],
    "container-title": [
      "Leukemia"
    ],
    "date": [
      "2004"
    ],
    "pages": [
      "1027–9"
    ],
    "title": [
      "Immmunophenotypic normalization of aberrant mast cells accompanies histological remission in imatinib-treated patients with eosinophilia-associated mastocytosis"
    ],
    "type": "article-journal",
    "volume": [
      "18"
    ]
  },
  {
    "author": [
      {
        "family": "Klion",
        "given": "A.D."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "9."
    ],
    "container-title": [
      "Blood"
    ],
    "date": [
      "2003"
    ],
    "pages": [
      "473–8"
    ],
    "title": [
      "Molecular remission and reversal of myelofibrosis in response to imatinib mesylate treatment in patients with the myeloproliferative variant of hypereosinophilic syndrome"
    ],
    "type": "article-journal",
    "volume": [
      "103"
    ]
  },
  {
    "author": [
      {
        "family": "Steer",
        "given": "E.J."
      },
      {
        "family": "Cross",
        "given": "N.C."
      }
    ],
    "citation-number": [
      "10."
    ],
    "container-title": [
      "Acta Haematol"
    ],
    "date": [
      "2002"
    ],
    "pages": [
      "113–22"
    ],
    "title": [
      "Myeloproliferative disorders with translocations of chromosome 5q31–35: role of the platelet-derived growth factor beta"
    ],
    "type": "article-journal",
    "volume": [
      "107"
    ]
  },
  {
    "author": [
      {
        "family": "Apperley",
        "given": "J.F."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "11."
    ],
    "container-title": [
      "N Engl J Med"
    ],
    "date": [
      "2002"
    ],
    "pages": [
      "481–7"
    ],
    "title": [
      "Response to imatinib mesylate in patients with chronic myeloproliferative diseases with rearrangements of the platelet-derived growth factor receptor beta"
    ],
    "type": "article-journal",
    "volume": [
      "347"
    ]
  },
  {
    "author": [
      {
        "family": "Macdonald",
        "given": "D."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "12."
    ],
    "container-title": [
      "Acta Haematol"
    ],
    "date": [
      "2002"
    ],
    "pages": [
      "101–7"
    ],
    "title": [
      "The 8p11 myeloproliferative syndrome: a distinct clinical entity caused by constitutive activation of FGFR1"
    ],
    "type": "article-journal",
    "volume": [
      "107"
    ]
  },
  {
    "author": [
      {
        "family": "Butterfield",
        "given": "J.H."
      }
    ],
    "citation-number": [
      "13."
    ],
    "container-title": [
      "Acta Haematol"
    ],
    "date": [
      "2005"
    ],
    "pages": [
      "26–40"
    ],
    "title": [
      "Interferon treatment for hypereosinophilic syndromes and systemic mastocytosis"
    ],
    "type": "article-journal",
    "volume": [
      "114"
    ]
  },
  {
    "author": [
      {
        "family": "Bain",
        "given": "B."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "14."
    ],
    "container-title": [
      "Pathology and Genetics. Tumours of Haematopoietic and Lymphoid Tissues"
    ],
    "date": [
      "2001"
    ],
    "editor": [
      {
        "family": "Jaffe",
        "given": "E.S."
      },
      {
        "others": true
      }
    ],
    "location": [
      "Lyon"
    ],
    "pages": [
      "29–31"
    ],
    "publisher": [
      "IARC Press"
    ],
    "title": [
      "Chronic eosinophilic leukaemia and the hypereosinophilic syndrome",
      "World Health Organization Classification of Tumours"
    ],
    "type": "article-journal",
    "volume": [
      "1"
    ]
  },
  {
    "author": [
      {
        "family": "Simon",
        "given": "H.U."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "15."
    ],
    "container-title": [
      "N Engl J Med"
    ],
    "date": [
      "1999"
    ],
    "pages": [
      "1112–20"
    ],
    "title": [
      "Abnormal clones of interleukin-5-producing T cells in idiopathic eosinophilia"
    ],
    "type": "article-journal",
    "volume": [
      "341"
    ]
  },
  {
    "author": [
      {
        "family": "Gleich",
        "given": "G.J."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "16."
    ],
    "container-title": [
      "N Engl J Med"
    ],
    "date": [
      "1984"
    ],
    "pages": [
      "1621–6"
    ],
    "title": [
      "Episodic angioedema associated with eosinbophilia"
    ],
    "type": "article-journal",
    "volume": [
      "310"
    ]
  },
  {
    "author": [
      {
        "family": "Gotlib",
        "given": "J."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "17."
    ],
    "container-title": [
      "Blood"
    ],
    "date": [
      "2004"
    ],
    "pages": [
      "2879–91"
    ],
    "title": [
      "The FIP1L1-PDGFRA fusion tyrosine kinase in hypereosinophilic syndrome and chronic eosinophilic leukemia: implications for diagnosis, classification and management"
    ],
    "type": "article-journal",
    "volume": [
      "103"
    ]
  },
  {
    "author": [
      {
        "family": "Klion",
        "given": "A.D."
      }
    ],
    "citation-number": [
      "18."
    ],
    "container-title": [
      "Hematology"
    ],
    "date": [
      "2005"
    ],
    "pages": [
      "209–14"
    ],
    "title": [
      "Recent advances in the diagnosis and treatment of hypereosinophilic syndromes"
    ],
    "type": "article-journal",
    "volume": [
      "2005"
    ]
  },
  {
    "author": [
      {
        "family": "Bain",
        "given": "B."
      }
    ],
    "citation-number": [
      "19."
    ],
    "container-title": [
      "Haematologica"
    ],
    "date": [
      "2004"
    ],
    "pages": [
      "133–7"
    ],
    "title": [
      "The idiopathic hypereosinophilic syndrome and eosinophilic leukemias"
    ],
    "type": "article-journal",
    "volume": [
      "89"
    ]
  },
  {
    "author": [
      {
        "family": "Swerdlow",
        "given": "S.H."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "1."
    ],
    "date": [
      "2008"
    ],
    "edition": [
      "4th"
    ],
    "location": [
      "Lyon"
    ],
    "publisher": [
      "IARC"
    ],
    "title": [
      "WHO Classifications of Tumours of Haematopoietic and Lymphoid Tissues"
    ],
    "type": "book"
  },
  {
    "author": [
      {
        "family": "Valent",
        "given": "P."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "2."
    ],
    "container-title": [
      "Pathology and Genetics. Tumours of Haematopoietic and Lymphoid Tissues"
    ],
    "date": [
      "2001"
    ],
    "editor": [
      {
        "family": "Jaffe",
        "given": "E.S."
      },
      {
        "others": true
      }
    ],
    "location": [
      "Lyon"
    ],
    "pages": [
      "291–302"
    ],
    "publisher": [
      "IARC Press"
    ],
    "title": [
      "Mastocytosis (mast cell disease",
      "World Health Organization Classification of Tumours"
    ],
    "type": "article-journal",
    "volume": [
      "1"
    ]
  },
  {
    "author": [
      {
        "family": "C",
        "given": "Buttner"
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "3."
    ],
    "container-title": [
      "J Invest Dermatol"
    ],
    "date": [
      "1998"
    ],
    "pages": [
      "1227–31"
    ],
    "title": [
      "Identification of activating c-kit mutations in adult-, but not in childhood-onset indolent mastocytosis: a possible explanation for divergent clinical behaviour"
    ],
    "type": "article-journal",
    "volume": [
      "111"
    ]
  },
  {
    "author": [
      {
        "family": "Fritsche-Polanz",
        "given": "R."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "4."
    ],
    "container-title": [
      "Br J Haematol"
    ],
    "date": [
      "2001"
    ],
    "pages": [
      "357–64"
    ],
    "title": [
      "Mutation analysis of C-KIT in patients with myelodysplastic syndromes without mastocytosis and cases of systemic mastocytosis"
    ],
    "type": "article-journal",
    "volume": [
      "113"
    ]
  },
  {
    "author": [
      {
        "family": "Orfao",
        "given": "A."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "5."
    ],
    "container-title": [
      "Br J Haematol"
    ],
    "date": [
      "2007"
    ],
    "pages": [
      "12–30"
    ],
    "title": [
      "Recent advances in the understanding of mastocytosis: the role of KIT mutations"
    ],
    "type": "article-journal",
    "volume": [
      "138"
    ]
  },
  {
    "author": [
      {
        "family": "Valent",
        "given": "P."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "6."
    ],
    "container-title": [
      "Eur J Clin Invest"
    ],
    "date": [
      "2007"
    ],
    "pages": [
      "435–53"
    ],
    "title": [
      "Standards and standardization in mastocytosis: Consensus statements on diagnostics, treatment recommendations and response criteria"
    ],
    "type": "article-journal",
    "volume": [
      "37"
    ]
  },
  {
    "author": [
      {
        "family": "Valent",
        "given": "P."
      },
      {
        "family": "Metcalfe",
        "given": "D.D."
      }
    ],
    "citation-number": [
      "7."
    ],
    "container-title": [
      "Hematology"
    ],
    "date": [
      "2004",
      "2004"
    ],
    "pages": [
      "153–62"
    ],
    "title": [
      "Mast cell proliferative disorders: diagnosis, classification and therapy"
    ],
    "type": "article-journal"
  },
  {
    "author": [
      {
        "family": "Wolff",
        "given": "K."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "8."
    ],
    "container-title": [
      "Leuk Res"
    ],
    "date": [
      "2001"
    ],
    "pages": [
      "519–28"
    ],
    "title": [
      "Clinical and histopathological aspects of cutaneous mastocytosis"
    ],
    "type": "article-journal",
    "volume": [
      "25"
    ]
  },
  {
    "author": [
      {
        "family": "Horny",
        "given": "H.P."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "9."
    ],
    "container-title": [
      "Pathobiology"
    ],
    "date": [
      "2007"
    ],
    "pages": [
      "121–32"
    ],
    "title": [
      "Mastocytosis: state of the art"
    ],
    "type": "article-journal",
    "volume": [
      "74"
    ]
  },
  {
    "note": [
      "316 CHAPTER 7 Myeloproliferative neoplasms"
    ],
    "type": null
  },
  {
    "author": [
      {
        "family": "Valent",
        "given": "P."
      },
      {
        "family": "Metcalfe",
        "given": "D.D."
      }
    ],
    "citation-number": [
      "1."
    ],
    "container-title": [
      "Hematology"
    ],
    "date": [
      "2004",
      "2004"
    ],
    "pages": [
      "153–62"
    ],
    "title": [
      "Mast cell proliferative disorders: diagnosis, classification and therapy"
    ],
    "type": "article-journal"
  },
  {
    "author": [
      {
        "family": "Valent",
        "given": "P."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "2."
    ],
    "container-title": [
      "Pathology and Genetics. Tumours of Haematopoietic and Lymphoid Tissues"
    ],
    "date": [
      "2001"
    ],
    "editor": [
      {
        "family": "Jaffe",
        "given": "E.S."
      },
      {
        "others": true
      }
    ],
    "location": [
      "Lyon"
    ],
    "pages": [
      "291–302"
    ],
    "publisher": [
      "IARC Press"
    ],
    "title": [
      "Mastocytosis (mast cell disease",
      "World Health Organization Classification of Tumours"
    ],
    "type": "article-journal",
    "volume": [
      "1"
    ]
  },
  {
    "author": [
      {
        "family": "Valent",
        "given": "P."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "3."
    ],
    "container-title": [
      "Eur J Clin Invest"
    ],
    "date": [
      "2007"
    ],
    "pages": [
      "435–53"
    ],
    "title": [
      "Standards and standardization in mastocytosis: Consensus statements on diagnostics, treatment recommendations and response criteria"
    ],
    "type": "article-journal",
    "volume": [
      "37"
    ]
  },
  {
    "author": [
      {
        "family": "Swerdlow",
        "given": "S.H."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "4."
    ],
    "date": [
      "2008"
    ],
    "edition": [
      "4th"
    ],
    "location": [
      "Lyon"
    ],
    "publisher": [
      "IARC"
    ],
    "title": [
      "WHO Classifications of Tumours of Haematopoietic and Lymphoid Tissues"
    ],
    "type": "book"
  },
  {
    "author": [
      {
        "family": "Valent",
        "given": "P."
      },
      {
        "family": "Metcalfe",
        "given": "D.D."
      }
    ],
    "citation-number": [
      "5."
    ],
    "container-title": [
      "Hematology"
    ],
    "date": [
      "2004",
      "2004"
    ],
    "pages": [
      "153–62"
    ],
    "title": [
      "Mast cell proliferative disorders: diagnosis, classification and therapy"
    ],
    "type": "article-journal"
  },
  {
    "author": [
      {
        "family": "Horny",
        "given": "H.P."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "6."
    ],
    "container-title": [
      "Pathobiology"
    ],
    "date": [
      "2007"
    ],
    "pages": [
      "121–32"
    ],
    "title": [
      "Mastocytosis: state of the art"
    ],
    "type": "article-journal",
    "volume": [
      "74"
    ]
  },
  {
    "author": [
      {
        "family": "Tefferi",
        "given": "A."
      },
      {
        "family": "Vardiman",
        "given": "J.W."
      }
    ],
    "citation-number": [
      "7."
    ],
    "container-title": [
      "Leukemia"
    ],
    "date": [
      "2008"
    ],
    "pages": [
      "14–22"
    ],
    "title": [
      "Classification and diagnosis of myeloproliferative neoplasms: The 2008 World Health Organization criteria and point-of-care diagnostic algorithms"
    ],
    "type": "article-journal",
    "volume": [
      "22"
    ]
  },
  {
    "author": [
      {
        "family": "Orfao",
        "given": "A."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "8."
    ],
    "container-title": [
      "Br J Haematol"
    ],
    "date": [
      "2007"
    ],
    "pages": [
      "12–30"
    ],
    "title": [
      "Recent advances in the understanding of mastocytosis: the role of KIT mutations"
    ],
    "type": "article-journal",
    "volume": [
      "138"
    ]
  },
  {
    "author": [
      {
        "family": "Valent",
        "given": "P."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "9."
    ],
    "container-title": [
      "Blood"
    ],
    "date": [
      "2010"
    ],
    "pages": [
      "5812–17"
    ],
    "title": [
      "How I treat patients with advanced systemic mastocytosis"
    ],
    "type": "article-journal",
    "volume": [
      "116"
    ]
  },
  {
    "author": [
      {
        "family": "Bouvier",
        "given": "S."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "10."
    ],
    "container-title": [
      "Blood"
    ],
    "date": [
      "2013"
    ],
    "issue": [
      "7"
    ],
    "location": [
      "Further reading"
    ],
    "pages": [
      "1071"
    ],
    "title": [
      "Systemic mastocytosis"
    ],
    "type": "article-journal",
    "volume": [
      "121"
    ]
  },
  {
    "author": [
      {
        "family": "Valent",
        "given": "P."
      },
      {
        "others": true
      }
    ],
    "container-title": [
      "Am J Blood Res"
    ],
    "date": [
      "2013"
    ],
    "issue": [
      "2"
    ],
    "pages": [
      "174–80"
    ],
    "title": [
      "Guidelines and diagnostic algorithm for patients with suspected systemic mastocytosis: a proposal of the Austrian competence network (AUCNM"
    ],
    "type": "article-journal",
    "volume": [
      "3"
    ]
  },
  {
    "author": [
      {
        "family": "Valent",
        "given": "P."
      }
    ],
    "container-title": [
      "Am J Cancer Res"
    ],
    "date": [
      "2013"
    ],
    "issue": [
      "2"
    ],
    "pages": [
      "159–72"
    ],
    "title": [
      "Mastocytosis: a paradigmatic example of a rare disease with complex biology and pathology"
    ],
    "type": "article-journal",
    "volume": [
      "3"
    ]
  },
  {
    "author": [
      {
        "family": "Thiele",
        "given": "J."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "1."
    ],
    "container-title": [
      "Pathology and Genetics. Tumours of Haematopoietic and Lymphoid Tissues"
    ],
    "date": [
      "2001"
    ],
    "editor": [
      {
        "family": "Jaffe",
        "given": "E.S."
      },
      {
        "others": true
      }
    ],
    "location": [
      "Lyon"
    ],
    "pages": [
      "42–4"
    ],
    "publisher": [
      "IARC Press"
    ],
    "title": [
      "Chronic myeloproliferative disease, unclassifiable",
      "World Health Organization Classification of Tumours"
    ],
    "type": "article-journal",
    "volume": [
      "1"
    ]
  },
  {
    "author": [
      {
        "family": "Swerdlow",
        "given": "S.H."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "2."
    ],
    "date": [
      "2008"
    ],
    "edition": [
      "4th"
    ],
    "location": [
      "Lyon"
    ],
    "note": [
      "This page intentionally left blank"
    ],
    "publisher": [
      "IARC"
    ],
    "title": [
      "WHO Classifications of Tumours of Haematopoietic and Lymphoid Tissues"
    ],
    "type": null
  },
  {
    "author": [
      {
        "family": "Agarwal",
        "given": "A."
      },
      {
        "others": true
      }
    ],
    "container-title": [
      "Clin Cancer Res"
    ],
    "date": [
      "2013"
    ],
    "issue": [
      "5"
    ],
    "pages": [
      "985–94"
    ],
    "title": [
      "Monoclonal gammopathy of undetermined significance and smoldering multiple myeloma: a review of the current understanding of epidemiology, biology, risk stratification, and management of myeloma precursor disease"
    ],
    "type": "article-journal",
    "volume": [
      "19"
    ]
  },
  {
    "author": [
      {
        "family": "Caers",
        "given": "J."
      },
      {
        "others": true
      }
    ],
    "container-title": [
      "For the Multiple Myeloma Study Group of the Belgian Hematological Society. Ann Med"
    ],
    "date": [
      "2013"
    ],
    "issue": [
      "5–6"
    ],
    "pages": [
      "413–22"
    ],
    "title": [
      "Diagnosis and follow-up of monoclonal gammopathies of undetermined significance; information for referring physicians"
    ],
    "type": "article-journal",
    "volume": [
      "45"
    ]
  },
  {
    "author": [
      {
        "family": "Chng",
        "given": "W.J."
      },
      {
        "others": true
      }
    ],
    "container-title": [
      "Best Practice and Res Clin Haematol"
    ],
    "date": [
      "2007"
    ],
    "pages": [
      "571–96"
    ],
    "title": [
      "Genetic events in the pathogenesis of multiple myeloma"
    ],
    "type": "article-journal",
    "volume": [
      "20"
    ]
  },
  {
    "author": [
      {
        "family": "Kyle",
        "given": "R.A."
      },
      {
        "others": true
      }
    ],
    "container-title": [
      "N Engl J Med"
    ],
    "date": [
      "2002"
    ],
    "pages": [
      "564–69"
    ],
    "title": [
      "A long-term study of prognosis in monoclonal gammopathy of undetermined significance"
    ],
    "type": "article-journal",
    "volume": [
      "346"
    ]
  },
  {
    "author": [
      {
        "family": "Kyle",
        "given": "R.A."
      },
      {
        "others": true
      }
    ],
    "container-title": [
      "Mayo Clinic Proceedings"
    ],
    "date": [
      "2004"
    ],
    "pages": [
      "859–66"
    ],
    "title": [
      "Long-term follow-up of 241 patients with monoclonal gammopathy of undetermined significance: the original Mayo Clinic series 25 years later"
    ],
    "type": "article-journal",
    "volume": [
      "79"
    ]
  },
  {
    "author": [
      {
        "family": "Kyle",
        "given": "R.A."
      },
      {
        "others": true
      }
    ],
    "container-title": [
      "N Engl J Med"
    ],
    "date": [
      "2006"
    ],
    "pages": [
      "1362–9"
    ],
    "title": [
      "Prevalence of monoclonal gammopathy of undetermined significance"
    ],
    "type": "article-journal",
    "volume": [
      "354"
    ]
  },
  {
    "author": [
      {
        "family": "Kyle",
        "given": "R.A."
      },
      {
        "family": "Rajkumar",
        "given": "S.V."
      }
    ],
    "container-title": [
      "Best Pract Res Clin Haematol"
    ],
    "date": [
      "2007"
    ],
    "pages": [
      "637–64"
    ],
    "title": [
      "Epidemiology of the plasma cell disorders"
    ],
    "type": "article-journal",
    "volume": [
      "20"
    ]
  },
  {
    "author": [
      {
        "family": "Morris Brown",
        "given": "L."
      },
      {
        "others": true
      }
    ],
    "container-title": [
      "Blood"
    ],
    "date": [
      "2007"
    ],
    "pages": [
      "3388–94"
    ],
    "title": [
      "Risk of multiple myeloma and monoclonal gammopathy of undetermined significance among white and black male United States veterans with prior autoimmune, infectious, inflammatory and allergic disorders"
    ],
    "type": "article-journal",
    "volume": [
      "111"
    ]
  },
  {
    "author": [
      {
        "family": "Rajkumar",
        "given": "S.V."
      },
      {
        "others": true
      }
    ],
    "container-title": [
      "Blood Reviews"
    ],
    "date": [
      "2007"
    ],
    "pages": [
      "255–65"
    ],
    "title": [
      "Monoclonal gammopathy of undetermined significance and smoldering multiple myeloma"
    ],
    "type": "article-journal",
    "volume": [
      "21"
    ]
  },
  {
    "author": [
      {
        "family": "Swerdlow",
        "given": "S.H."
      },
      {
        "others": true
      }
    ],
    "date": [
      "2008"
    ],
    "edition": [
      "4th"
    ],
    "location": [
      "Lyon"
    ],
    "note": [
      "332 CHAPTER 8 Paraproteinaemias"
    ],
    "publisher": [
      "IARC"
    ],
    "title": [
      "WHO Classifications of Tumours of Haematopoietic and Lymphoid Tissues"
    ],
    "type": null
  },
  {
    "note": [
      "References"
    ],
    "type": null
  },
  {
    "author": [
      {
        "family": "Mateos",
        "given": "M.V."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "1."
    ],
    "container-title": [
      "N. Eng J Med"
    ],
    "date": [
      "2013"
    ],
    "issue": [
      "5"
    ],
    "pages": [
      "438–47"
    ],
    "title": [
      "Lenalidomide plus dexamethasone for high-risk smoldering multiple myeloma"
    ],
    "type": "article-journal",
    "volume": [
      "369"
    ]
  },
  {
    "author": [
      {
        "family": "Group",
        "given": "International Myeloma Working"
      }
    ],
    "citation-number": [
      "2."
    ],
    "container-title": [
      "Brit J Haematol"
    ],
    "date": [
      "2003"
    ],
    "pages": [
      "749–57"
    ],
    "title": [
      "Criteria for the classification of monoclonal gammopathies, multiple myeloma and related disorders: a report of the International Myeloma Working Group"
    ],
    "type": "article-journal",
    "volume": [
      "121"
    ]
  },
  {
    "author": [
      {
        "family": "Weber",
        "given": "D."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "3."
    ],
    "container-title": [
      "Hematol J"
    ],
    "date": [
      "2003"
    ],
    "issue": [
      "1"
    ],
    "pages": [
      "31–2"
    ],
    "title": [
      "Risk factors for early progression of asymptomatic multiple myeloma"
    ],
    "type": "article-journal",
    "volume": [
      "4"
    ]
  },
  {
    "author": [
      {
        "family": "Dispenzieri",
        "given": "A."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "4."
    ],
    "container-title": [
      "Blood"
    ],
    "date": [
      "2008"
    ],
    "location": [
      "Further reading"
    ],
    "pages": [
      "785–9"
    ],
    "title": [
      "Immunoglobulin free light chain ratio is an independent risk factor for progression of smoldering (asymptomatic) multiple myeloma"
    ],
    "type": "article-journal",
    "volume": [
      "111"
    ]
  },
  {
    "author": [
      {
        "family": "Agarwal",
        "given": "A."
      },
      {
        "others": true
      }
    ],
    "container-title": [
      "Clin Cancer Res"
    ],
    "date": [
      "2013"
    ],
    "issue": [
      "5"
    ],
    "pages": [
      "985–94"
    ],
    "title": [
      "Monoclonal gammopathy of undetermined significance and smoldering multiple myeloma: a review of the current understanding of epidemiology, biology, risk stratification, and management of myeloma precursor disease"
    ],
    "type": "article-journal",
    "volume": [
      "19"
    ]
  },
  {
    "author": [
      {
        "family": "Kyle",
        "given": "R.A."
      },
      {
        "others": true
      }
    ],
    "container-title": [
      "N Engl J Med"
    ],
    "date": [
      "2007"
    ],
    "pages": [
      "2582–90"
    ],
    "title": [
      "Clinical course and prognosis of smoldering (asymptomatic) multiple myeloma"
    ],
    "type": "article-journal",
    "volume": [
      "356"
    ]
  },
  {
    "author": [
      {
        "family": "Rajkumar",
        "given": "S.V."
      },
      {
        "others": true
      }
    ],
    "container-title": [
      "Blood Reviews"
    ],
    "date": [
      "2007"
    ],
    "pages": [
      "255–65"
    ],
    "title": [
      "Monoclonal gammopathy of undeter-mined significance and smoldering multiple myeloma"
    ],
    "type": "article-journal",
    "volume": [
      "21"
    ]
  },
  {
    "author": [
      {
        "family": "Swerdlow",
        "given": "S.H."
      },
      {
        "others": true
      }
    ],
    "date": [
      "2008"
    ],
    "edition": [
      "4th"
    ],
    "location": [
      "Lyon"
    ],
    "publisher": [
      "IARC"
    ],
    "title": [
      "WHO Classifications of Tumours of Haematopoietic and Lymphoid Tissues"
    ],
    "type": "book"
  },
  {
    "author": [
      {
        "family": "Kyle",
        "given": "R.A."
      },
      {
        "family": "Rajkumar",
        "given": "S.V."
      }
    ],
    "citation-number": [
      "1."
    ],
    "container-title": [
      "Best Pract Res Clin Haematol"
    ],
    "date": [
      "2007"
    ],
    "pages": [
      "637–64"
    ],
    "title": [
      "Epidemiology of the plasma cell disorders"
    ],
    "type": "article-journal",
    "volume": [
      "20"
    ]
  },
  {
    "author": [
      {
        "family": "Chn",
        "given": "g W.J."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "2."
    ],
    "container-title": [
      "Best Pract Res Clin Haematol"
    ],
    "date": [
      "2007"
    ],
    "pages": [
      "571–96"
    ],
    "title": [
      "Genetic events in the pathogenesis of multiple myeloma"
    ],
    "type": "article-journal",
    "volume": [
      "20"
    ]
  },
  {
    "author": [
      {
        "family": "Podar",
        "given": "K."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "3."
    ],
    "container-title": [
      "Best Pract Res Clin Haematol"
    ],
    "date": [
      "2007"
    ],
    "pages": [
      "597–612"
    ],
    "title": [
      "The malignant clone and the bone-marrow environment"
    ],
    "type": "article-journal",
    "volume": [
      "20"
    ]
  },
  {
    "author": [
      {
        "family": "Forum",
        "given": "U.K.Myeloma"
      },
      {
        "family": "Group",
        "given": "Nordic Myeloma Study"
      }
    ],
    "citation-number": [
      "4."
    ],
    "container-title": [
      "Br J Haematol"
    ],
    "date": [
      "2005"
    ],
    "note": [
      "M"
    ],
    "pages": [
      "410–51"
    ],
    "title": [
      "Guidelines on the diagnosis and management of multiple myeloma 2005"
    ],
    "type": "article-journal",
    "url": [
      "http://www."
    ],
    "volume": [
      "132"
    ]
  },
  {
    "citation-number": [
      "5."
    ],
    "container-title": [
      "NCCN Clinical Practice Guidelines in Oncology Multiple Myeloma V.2.2008 M"
    ],
    "type": "chapter",
    "url": [
      "http://www."
    ]
  },
  {
    "author": [
      {
        "family": "D’Sa",
        "given": "S."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "6."
    ],
    "container-title": [
      "Brit J Haematol"
    ],
    "date": [
      "2007"
    ],
    "note": [
      "M"
    ],
    "pages": [
      "49–63"
    ],
    "title": [
      "Guidelines for the use of imaging in the management of myeloma"
    ],
    "type": "article-journal",
    "url": [
      "http://www.bcshguidelines.com/pdf/myeloma_management_"
    ],
    "volume": [
      "137"
    ]
  },
  {
    "author": [
      {
        "family": "Pratt",
        "given": "G."
      }
    ],
    "citation-number": [
      "7."
    ],
    "container-title": [
      "Br J Haematol"
    ],
    "date": [
      "2008"
    ],
    "pages": [
      "413–22"
    ],
    "title": [
      "The evolving use of serum free light chain assays in hematology"
    ],
    "type": "article-journal",
    "volume": [
      "141"
    ]
  },
  {
    "author": [
      {
        "family": "Group",
        "given": "International Myeloma Working"
      }
    ],
    "citation-number": [
      "8."
    ],
    "container-title": [
      "Brit J Haematol"
    ],
    "date": [
      "2003"
    ],
    "pages": [
      "749–57"
    ],
    "title": [
      "Criteria for the classification of monoclonal gammopathies, multiple myeloma and related disorders: a report of the International Myeloma Working Group"
    ],
    "type": "article-journal",
    "volume": [
      "121"
    ]
  },
  {
    "author": [
      {
        "family": "Swerdlow",
        "given": "S.H."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "9."
    ],
    "date": [
      "2008"
    ],
    "edition": [
      "4th"
    ],
    "location": [
      "Lyon"
    ],
    "publisher": [
      "IARC"
    ],
    "title": [
      "WHO Classifications of Tumours of Haematopoietic and Lymphoid Tissues"
    ],
    "type": "book"
  },
  {
    "author": [
      {
        "family": "Avet-Loiseau",
        "given": "H."
      }
    ],
    "citation-number": [
      "10."
    ],
    "container-title": [
      "Best Practice and Res Clin Haematol"
    ],
    "date": [
      "2007"
    ],
    "pages": [
      "625–35"
    ],
    "title": [
      "Role of genetics in prognostication in myeloma"
    ],
    "type": "article-journal",
    "volume": [
      "20"
    ]
  },
  {
    "author": [
      {
        "family": "Dispenzieri",
        "given": "A."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "11."
    ],
    "container-title": [
      "Mayo Clin Proc"
    ],
    "date": [
      "2007"
    ],
    "pages": [
      "323–41"
    ],
    "title": [
      "Treatment of newly diagnosed multiple myeloma based on Mayo stratification of myeloma and risk-adapted therapy (mSMART): consensus statement"
    ],
    "type": "article-journal",
    "volume": [
      "82"
    ]
  },
  {
    "author": [
      {
        "family": "Durie",
        "given": "B.G."
      },
      {
        "family": "Salmon",
        "given": "S.E."
      }
    ],
    "citation-number": [
      "12."
    ],
    "container-title": [
      "Cancer"
    ],
    "date": [
      "1975"
    ],
    "pages": [
      "842–54"
    ],
    "title": [
      "A clinical staging system for multiple myeloma. Correlation of measured myeloma cell mass with presenting clinical features, response to treatment, and survival"
    ],
    "type": "article-journal",
    "volume": [
      "36"
    ]
  },
  {
    "author": [
      {
        "family": "Greipp",
        "given": "P.R."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "13."
    ],
    "container-title": [
      "J Clin Oncol"
    ],
    "date": [
      "2005"
    ],
    "pages": [
      "3412–20"
    ],
    "title": [
      "International staging system for multiple myeloma"
    ],
    "type": "article-journal",
    "volume": [
      "23"
    ]
  },
  {
    "author": [
      {
        "family": "Durie",
        "given": "B.G.M."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "14."
    ],
    "container-title": [
      "Leukemia"
    ],
    "date": [
      "2006",
      "1467"
    ],
    "title": [
      "International uniform response criteria for multiple myeloma"
    ],
    "type": "article-journal"
  },
  {
    "citation-number": [
      "360"
    ],
    "genre": [
      "CHAPTER 8 Paraproteinaemias"
    ],
    "type": null
  },
  {
    "author": [
      {
        "family": "Bladé",
        "given": "J."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "15."
    ],
    "container-title": [
      "Brit J Haematol"
    ],
    "date": [
      "1998"
    ],
    "pages": [
      "1115–23"
    ],
    "title": [
      "Criteria for evaluating disease response and progression in patients with multiple myeloma treated by high dose therapy and haemopoietic stem cell transplantation"
    ],
    "type": "article-journal",
    "volume": [
      "102"
    ]
  },
  {
    "author": [
      {
        "family": "MacLennan",
        "given": "I.C.M."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "16."
    ],
    "container-title": [
      "Lancet"
    ],
    "date": [
      "1992"
    ],
    "pages": [
      "200–5"
    ],
    "title": [
      "Combined chemotherapy with ABCM versus melphalan for treatment of myelomatosis"
    ],
    "type": "article-journal",
    "volume": [
      "339"
    ]
  },
  {
    "author": [
      {
        "family": "Bergsagel",
        "given": "D.E."
      }
    ],
    "citation-number": [
      "17."
    ],
    "container-title": [
      "Baillieres Clin Haematol"
    ],
    "date": [
      "1995"
    ],
    "pages": [
      "783–94"
    ],
    "title": [
      "The role of chemotherapy in the treatment of multiple myeloma"
    ],
    "type": "article-journal",
    "volume": [
      "8"
    ]
  },
  {
    "author": [
      {
        "family": "Palumbo",
        "given": "A."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "18."
    ],
    "container-title": [
      "Lancet"
    ],
    "date": [
      "2006"
    ],
    "pages": [
      "825–31"
    ],
    "title": [
      "Oral melphalan and prednisolone chemotherapy plus thalidomide compared with melphalan and prednisolone alone in elderly patients with multiple myeloma: randomized controlled trial"
    ],
    "type": "article-journal",
    "volume": [
      "367"
    ]
  },
  {
    "author": [
      {
        "family": "Facon",
        "given": "T."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "19."
    ],
    "container-title": [
      "Lancet"
    ],
    "date": [
      "2007"
    ],
    "pages": [
      "1209–18"
    ],
    "title": [
      "Melphalan and prednisolone plus thalidomide versus melphalan and prednisolone alone or reduced-intensity autologous stem cell transplantation in elderly patients with multiple myeloma (IFM 99-06): a randomized trial"
    ],
    "type": "article-journal",
    "volume": [
      "370"
    ]
  },
  {
    "author": [
      {
        "family": "Jagannath",
        "given": "S."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "20."
    ],
    "container-title": [
      "Blood"
    ],
    "date": [
      "2006"
    ],
    "pages": [
      "238"
    ],
    "title": [
      "Long term follow-up of patients treated with bortzomib alone and in combination with dexamethasone as frontline therapy for multiple myeloma"
    ],
    "type": "article-journal",
    "volume": [
      "108"
    ]
  },
  {
    "author": [
      {
        "family": "Orlowski",
        "given": "R.Z."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "21."
    ],
    "container-title": [
      "J Clin Oncol"
    ],
    "date": [
      "2007"
    ],
    "pages": [
      "3892–901"
    ],
    "title": [
      "Randomized phase III study of pegylated liposomal doxorubicin plus bortezomib compared with bortezomib alone in relapsed or refractory multiple myeloma: combination therapy improves time to progression"
    ],
    "type": "article-journal",
    "volume": [
      "25"
    ]
  },
  {
    "author": [
      {
        "family": "Cavo",
        "given": "M."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "22."
    ],
    "container-title": [
      "Blood"
    ],
    "date": [
      "2007"
    ],
    "pages": [
      "30"
    ],
    "title": [
      "Bortezomib (Velcade)-thalidomide-dexamethasone (VTD) vs thalidomide-dexamethasone (TD) in preparation for autologous stem cell (SC) transplantation (ASCT) in newly diagnosed multiple myeloma"
    ],
    "type": "article-journal",
    "volume": [
      "110"
    ]
  },
  {
    "author": [
      {
        "family": "Wang",
        "given": "M."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "23."
    ],
    "container-title": [
      "Hematology"
    ],
    "date": [
      "2007"
    ],
    "pages": [
      "235–9"
    ],
    "title": [
      "Bortezomib in combination with thalidomide-dexamethasone for previously untreated multiple myeloma"
    ],
    "type": "article-journal",
    "volume": [
      "12"
    ]
  },
  {
    "author": [
      {
        "family": "Popat",
        "given": "R."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "24."
    ],
    "container-title": [
      "Brit J Haematol"
    ],
    "date": [
      "2008"
    ],
    "pages": [
      "512–16"
    ],
    "title": [
      "Bortezomib, doxorubicin and dexamethasone (PAD) front-line treatment of multiple myeloma: updated results after long-term follow-up"
    ],
    "type": "article-journal",
    "volume": [
      "141"
    ]
  },
  {
    "author": [
      {
        "family": "Richardson",
        "given": "P.G."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "25."
    ],
    "container-title": [
      "J Clin Oncol"
    ],
    "date": [
      "2008"
    ],
    "pages": [
      "459 8520"
    ],
    "title": [
      "Safety and efficacy of lenalidomide (len), bortezomib (Bz) and dexamethasone (Dex) in patients with newly diagnosed multiple myeloma: a phase I/II study"
    ],
    "type": "article-journal",
    "volume": [
      "25"
    ]
  },
  {
    "author": [
      {
        "family": "Palumbo",
        "given": "A."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "26."
    ],
    "container-title": [
      "J Clin Oncol"
    ],
    "date": [
      "2007"
    ],
    "pages": [
      "4459–65"
    ],
    "title": [
      "Melphalan, predsisolone and lenalidomide treatment for newly diagnosed myeloma: a report from the GIMEMA-Italian Multiple Myeloma Network"
    ],
    "type": "article-journal",
    "volume": [
      "25"
    ]
  },
  {
    "author": [
      {
        "family": "Alexanian",
        "given": "R."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "27."
    ],
    "container-title": [
      "Blood"
    ],
    "date": [
      "1992"
    ],
    "pages": [
      "887–90"
    ],
    "title": [
      "Primary dexamethasone treatment of multiple myeloma"
    ],
    "type": "article-journal",
    "volume": [
      "80"
    ]
  },
  {
    "author": [
      {
        "family": "Kumar",
        "given": "S."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "28."
    ],
    "container-title": [
      "Blood"
    ],
    "date": [
      "2002"
    ],
    "pages": [
      "432"
    ],
    "title": [
      "Single agent dexamethasone for induction in patients with multiple myeloma undergoing autologous stem cell transplants"
    ],
    "type": "article-journal",
    "volume": [
      "100"
    ]
  },
  {
    "author": [
      {
        "family": "Cavo",
        "given": "M."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "29."
    ],
    "container-title": [
      "Blood"
    ],
    "date": [
      "2005"
    ],
    "pages": [
      "35–9"
    ],
    "title": [
      "Superiority of thalidomide and dexamethasone over vincristinedoxorubicin-dexamethasone (VAD) as primary therapy in preparation for autologous transplantation for multiple myeloma"
    ],
    "type": "article-journal",
    "volume": [
      "106"
    ]
  },
  {
    "author": [
      {
        "family": "Rajkumar",
        "given": "S.V."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "30."
    ],
    "container-title": [
      "J Clin Oncol"
    ],
    "date": [
      "2006"
    ],
    "pages": [
      "431–6"
    ],
    "title": [
      "Phase III clinical trial of thalidomise plus dexamethasone alone in newly diagnosed multiple myeloma: a clinical trial conducted by the Eastern Cooperative Oncology Group"
    ],
    "type": "article-journal",
    "volume": [
      "24"
    ]
  },
  {
    "author": [
      {
        "family": "Rajkumar",
        "given": "S.V."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "31."
    ],
    "container-title": [
      "Blood"
    ],
    "date": [
      "2005"
    ],
    "pages": [
      "3050–3"
    ],
    "title": [
      "Combination therapy with lenalidamide plus dexamethasone (Rev/Dex) for newly diagnosed myeloma"
    ],
    "type": "article-journal",
    "volume": [
      "106"
    ]
  },
  {
    "author": [
      {
        "family": "Rajkumar",
        "given": "S.V."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "32."
    ],
    "container-title": [
      "Blood"
    ],
    "date": [
      "2007"
    ],
    "pages": [
      "31"
    ],
    "title": [
      "A randomized trial of lenalidomide plus high-dose dexamethasone versus lenalidomide plus low-dose dexamethasone in newly diagnosed multiple myeloma: a trial co-ordinated by the Eastern Co-operative Oncology Group"
    ],
    "type": "article-journal",
    "volume": [
      "110"
    ]
  },
  {
    "author": [
      {
        "family": "McCloskey",
        "given": "E.V."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "33."
    ],
    "container-title": [
      "Br J Haematol"
    ],
    "date": [
      "2001"
    ],
    "pages": [
      "1035–43"
    ],
    "title": [
      "Long-term follow-up of a prospective, double-bind, placebocontrolled randomized trial of clodronate in multiple myeloma"
    ],
    "type": "article-journal",
    "volume": [
      "113"
    ]
  },
  {
    "author": [
      {
        "family": "Berenson",
        "given": "J.R."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "34."
    ],
    "container-title": [
      "J Clin Oncol"
    ],
    "date": [
      "1998"
    ],
    "pages": [
      "593–602"
    ],
    "title": [
      "Long-term pamidronate treatment of advanced multiple myeloma patients reduces skeletal events"
    ],
    "type": "article-journal",
    "volume": [
      "16"
    ]
  },
  {
    "author": [
      {
        "family": "Berenson",
        "given": "J.R."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "35."
    ],
    "container-title": [
      "Cancer"
    ],
    "date": [
      "2001"
    ],
    "pages": [
      "1191–1200"
    ],
    "title": [
      "Zoledronic acid reduces skeletal events in patients with osteolytic metastases"
    ],
    "type": "article-journal",
    "volume": [
      "91"
    ]
  },
  {
    "author": [
      {
        "family": "Kyle",
        "given": "R.A."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "36."
    ],
    "container-title": [
      "J Clin Oncol"
    ],
    "date": [
      "2007"
    ],
    "pages": [
      "2464–72"
    ],
    "title": [
      "American Society of Clinical Oncology 2007 clinical practice update on the role of bisphosphonates in multiple myeloma"
    ],
    "type": "article-journal",
    "volume": [
      "25"
    ]
  },
  {
    "author": [
      {
        "family": "Palumbo",
        "given": "A."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "37."
    ],
    "container-title": [
      "Leukemia"
    ],
    "date": [
      "2008"
    ],
    "pages": [
      "414–23"
    ],
    "title": [
      "Prevention of thalidomide- and lenalidomide-associated thrombosis in myeloma"
    ],
    "type": "article-journal",
    "volume": [
      "22"
    ]
  },
  {
    "author": [
      {
        "family": "Attal",
        "given": "M."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "38."
    ],
    "container-title": [
      "Intergroupe Francais du Myelome. N Engl J Med"
    ],
    "date": [
      "1996"
    ],
    "pages": [
      "91–7"
    ],
    "title": [
      "A prospective randomized trial of autologous bone marrow transplantation and chemotherapy in multiple myeloma"
    ],
    "type": "article-journal",
    "volume": [
      "335"
    ]
  },
  {
    "author": [
      {
        "family": "Child",
        "given": "J.A."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "39."
    ],
    "container-title": [
      "N Engl J Med"
    ],
    "date": [
      "2003"
    ],
    "pages": [
      "1875–83"
    ],
    "title": [
      "High-dose chemotherapy with hematopoietic stem-cell rescue for multiple myeloma"
    ],
    "type": "article-journal",
    "volume": [
      "348"
    ]
  },
  {
    "author": [
      {
        "family": "Moreau",
        "given": "P."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "40."
    ],
    "container-title": [
      "Blood"
    ],
    "date": [
      "2002"
    ],
    "pages": [
      "731–5"
    ],
    "title": [
      "Comparison of 200mg/m2 melphalan and 8Gy total body irradiation plus 140mg/m2 melphalan as conditioning regimens for peripheral blood stem cell transplantation in patients with newly diagnosed multiple myeloma: final analysis of the Intergroupe Francophone du Myelome 9502 randomized trial"
    ],
    "type": "article-journal",
    "volume": [
      "99"
    ]
  },
  {
    "author": [
      {
        "family": "Attal",
        "given": "M."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "41."
    ],
    "container-title": [
      "N Engl J Med"
    ],
    "date": [
      "2003"
    ],
    "pages": [
      "2495–2502"
    ],
    "title": [
      "Single versus double autologous stem cell transplantation for multiple myeloma"
    ],
    "type": "article-journal",
    "volume": [
      "349"
    ]
  },
  {
    "author": [
      {
        "family": "Fermand",
        "given": "J.P."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "42."
    ],
    "date": [
      "1998"
    ],
    "pages": [
      "3131–6"
    ],
    "title": [
      "High dose therapy and autologous peripheral blood stem cell transplantation in multiple myeloma: up-front or rescue treatment? Results of a multicenter sequential randomized clinical trial Blood"
    ],
    "type": null,
    "volume": [
      "92"
    ]
  },
  {
    "author": [
      {
        "family": "Garban",
        "given": "F."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "43."
    ],
    "container-title": [
      "Blood"
    ],
    "date": [
      "2006"
    ],
    "pages": [
      "3474–80"
    ],
    "title": [
      "Prospective comparison of autologous stem cell transplantation followed by dose reduced allograft (IFM99-03 trial) with tandem autologous stem cell transplantation (IFM99-04) in high risk de novo multiple myeloma"
    ],
    "type": "article-journal",
    "volume": [
      "107"
    ]
  },
  {
    "author": [
      {
        "family": "Kröger",
        "given": "N."
      }
    ],
    "citation-number": [
      "44."
    ],
    "container-title": [
      "Leuk Lymphoma"
    ],
    "date": [
      "2005"
    ],
    "pages": [
      "813–21"
    ],
    "title": [
      "Autologous-allogeneic tandem stem cell transplantation in patients with multiple myeloma"
    ],
    "type": "article-journal",
    "volume": [
      "46"
    ]
  },
  {
    "author": [
      {
        "family": "Crawley",
        "given": "C."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "45."
    ],
    "container-title": [
      "Blood"
    ],
    "date": [
      "2005"
    ],
    "pages": [
      "4532–9"
    ],
    "title": [
      "Outcome for reduced intensity allogeneic transplantation for multiple myeloma: an analysis of prognostic factors for the Chronic Leukemia Working Party of the EBMT"
    ],
    "type": "article-journal",
    "volume": [
      "105"
    ]
  },
  {
    "author": [
      {
        "family": "Attal",
        "given": "M."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "46."
    ],
    "container-title": [
      "Blood"
    ],
    "date": [
      "2006"
    ],
    "pages": [
      "3289–94"
    ],
    "title": [
      "Maintenance therapy with thalidomide improves survival in patients with multiple myeloma"
    ],
    "type": "article-journal",
    "volume": [
      "108"
    ]
  },
  {
    "author": [
      {
        "family": "Bird",
        "given": "J.M."
      },
      {
        "others": true
      }
    ],
    "date": [
      "2014"
    ],
    "location": [
      "London"
    ],
    "publisher": [
      "British Society for Haematology"
    ],
    "title": [
      "The Diagnosis and Management of Multiple Myeloma"
    ],
    "type": "book"
  },
  {
    "author": [
      {
        "family": "Herndon",
        "given": "T."
      },
      {
        "others": true
      }
    ],
    "container-title": [
      "Clin Cancer Res"
    ],
    "date": [
      "2013"
    ],
    "issue": [
      "17"
    ],
    "pages": [
      "4559–63"
    ],
    "title": [
      "U.S. Food and Drug Administration Approval: Carfilzomib for the Treatment of Multiple Myeloma"
    ],
    "type": "article-journal",
    "volume": [
      "19"
    ]
  },
  {
    "author": [
      {
        "family": "Kortuem",
        "given": "K.M."
      },
      {
        "others": true
      }
    ],
    "container-title": [
      "Blood"
    ],
    "date": [
      "2013"
    ],
    "issue": [
      "6"
    ],
    "pages": [
      "893–7"
    ],
    "title": [
      "Carfilzomib"
    ],
    "type": "article-journal",
    "volume": [
      "121"
    ]
  },
  {
    "author": [
      {
        "family": "Kuhn",
        "given": "D.J."
      },
      {
        "others": true
      }
    ],
    "container-title": [
      "Curr Cancer Drug Targets"
    ],
    "date": [
      "2011"
    ],
    "issue": [
      "3"
    ],
    "pages": [
      "285–95"
    ],
    "title": [
      "Second generation proteasome inhibitors: carfilzomib and immunoproteasome-specific inhibitors (IPSIs"
    ],
    "type": "article-journal",
    "volume": [
      "11"
    ]
  },
  {
    "date": [
      "2013"
    ],
    "location": [
      "Fort Washington, PA"
    ],
    "publisher": [
      "NCCN"
    ],
    "title": [
      "National Comprehensive Cancer Network",
      "Multiple Myeloma"
    ],
    "type": "book"
  },
  {
    "author": [
      {
        "family": "Terpos",
        "given": "E."
      },
      {
        "others": true
      }
    ],
    "container-title": [
      "Onco Targets Ther"
    ],
    "date": [
      "2013"
    ],
    "pages": [
      "531–8"
    ],
    "title": [
      "Pomalidomide: a novel drug to treat relapsed and refractory multiple myeloma"
    ],
    "type": "article-journal",
    "volume": [
      "6"
    ]
  },
  {
    "author": [
      {
        "family": "Wang",
        "given": "T.F."
      },
      {
        "others": true
      }
    ],
    "container-title": [
      "Leuk Lymphoma"
    ],
    "date": [
      "2013"
    ],
    "issue": [
      "2"
    ],
    "pages": [
      "337–41"
    ],
    "title": [
      "The characteristics and outcomes of patients with multiple myeloma dual refractory or intolerant to bortezomib and lenalidomide in the era of carfilzomib and pomalidomide"
    ],
    "type": "article-journal",
    "volume": [
      "55"
    ]
  },
  {
    "author": [
      {
        "family": "Alexiou",
        "given": "C."
      },
      {
        "others": true
      }
    ],
    "container-title": [
      "Cancer"
    ],
    "date": [
      "1999"
    ],
    "pages": [
      "2305–14"
    ],
    "title": [
      "Extramedullary plasmacytoma: tumor occurrence and therapeutic concepts"
    ],
    "type": "article-journal",
    "volume": [
      "85"
    ]
  },
  {
    "author": [
      {
        "given": "B.C.S.H./U.K.M.F."
      }
    ],
    "container-title": [
      "Br J Haematol"
    ],
    "date": [
      "2004"
    ],
    "note": [
      "M"
    ],
    "pages": [
      "717–26"
    ],
    "title": [
      "Guidelines on the diagnosis and management of solitary plasmacytoma of bone and solitary extramedullary plasmacytoma"
    ],
    "type": "article-journal",
    "url": [
      "http://www."
    ],
    "volume": [
      "124"
    ]
  },
  {
    "author": [
      {
        "family": "Group",
        "given": "International Myeloma Working"
      }
    ],
    "container-title": [
      "Br J Haematol"
    ],
    "date": [
      "2003"
    ],
    "pages": [
      "749–57"
    ],
    "title": [
      "Criteria for the classification of monoclonal gammopathies, multiple myeloma and related disorders: a report of the International Myeloma Working Group"
    ],
    "type": "article-journal",
    "volume": [
      "121"
    ]
  },
  {
    "author": [
      {
        "family": "Liebross",
        "given": "R.H."
      },
      {
        "others": true
      }
    ],
    "container-title": [
      "Int J Radiat Oncol Biol Phys"
    ],
    "date": [
      "1998"
    ],
    "pages": [
      "1063–7"
    ],
    "title": [
      "Solitary bone plasmacytoma: outcome and prognostic factors following radiotherapy"
    ],
    "type": "article-journal",
    "volume": [
      "41"
    ]
  },
  {
    "author": [
      {
        "family": "Swerdlow",
        "given": "S.H."
      },
      {
        "others": true
      }
    ],
    "date": [
      "2008"
    ],
    "edition": [
      "4th"
    ],
    "location": [
      "Lyon"
    ],
    "publisher": [
      "IARC"
    ],
    "title": [
      "WHO Classifications of Tumours of Haematopoietic and Lymphoid Tissues"
    ],
    "type": "book"
  },
  {
    "author": [
      {
        "family": "Tsang",
        "given": "R.W."
      },
      {
        "others": true
      }
    ],
    "container-title": [
      "Int J Radiat Oncol Biol Phys"
    ],
    "date": [
      "2001"
    ],
    "pages": [
      "113–20"
    ],
    "title": [
      "Solitary plasmacytoma treated with radiotherapy: impact of tumor size on outcome"
    ],
    "type": "article-journal",
    "volume": [
      "50"
    ]
  },
  {
    "citation-number": [
      "368"
    ],
    "genre": [
      "CHAPTER 8 Paraproteinaemias"
    ],
    "type": null
  },
  {
    "citation-number": [
      "1."
    ],
    "container-title": [
      "NCCN Guidelines on Waldenström’s Macroglobulinaemia/Lymphoplasmacytic Lymphoma. Version 2.2013. M"
    ],
    "type": "chapter",
    "url": [
      "www.NCCN.org"
    ]
  },
  {
    "author": [
      {
        "family": "Rajkumar",
        "given": "S.V."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "2."
    ],
    "container-title": [
      "Mayo Clin Proc"
    ],
    "date": [
      "2006"
    ],
    "pages": [
      "693–703"
    ],
    "title": [
      "Monoclonal gammopathy of undetermined significance, Waldenström macroglobulinemia, AL amyloidosis and related plasma cell disorders: diagnosis and treatment"
    ],
    "type": "article-journal",
    "volume": [
      "81"
    ]
  },
  {
    "author": [
      {
        "family": "Treon",
        "given": "S.P."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "3."
    ],
    "container-title": [
      "Clin Lymph Myeloma Leukemia"
    ],
    "date": [
      "2011"
    ],
    "pages": [
      "69–73"
    ],
    "title": [
      "Report from the Sixth International Workshop on Waldenström’s Macroglobulinemia"
    ],
    "type": "article-journal",
    "volume": [
      "11"
    ]
  },
  {
    "author": [
      {
        "family": "Buskard",
        "given": "N.A."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "4."
    ],
    "container-title": [
      "Can Med Assoc J"
    ],
    "date": [
      "1977"
    ],
    "pages": [
      "135–7"
    ],
    "title": [
      "Plasma exchange in the long-term management of Waldenström’s macroglobulinemia"
    ],
    "type": "article-journal",
    "volume": [
      "117"
    ]
  },
  {
    "author": [
      {
        "family": "Johnson",
        "given": "S.A."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "5."
    ],
    "container-title": [
      "Br J Haematol"
    ],
    "date": [
      "2006"
    ],
    "note": [
      "M"
    ],
    "pages": [
      "683–97"
    ],
    "title": [
      "Guidelines on the management of Waldenström macroglobulinaemia"
    ],
    "type": "article-journal",
    "url": [
      "http://www.bcshguidelines.com/pdf/"
    ],
    "volume": [
      "132"
    ]
  },
  {
    "author": [
      {
        "family": "Fonseca",
        "given": "R."
      },
      {
        "family": "Hayman",
        "given": "S."
      }
    ],
    "citation-number": [
      "6."
    ],
    "container-title": [
      "Br J Haematol"
    ],
    "date": [
      "2007"
    ],
    "pages": [
      "700–20"
    ],
    "title": [
      "Waldenström macroglobulinaemia"
    ],
    "type": "article-journal",
    "volume": [
      "138"
    ]
  },
  {
    "author": [
      {
        "family": "Vijay",
        "given": "A."
      },
      {
        "family": "Gertz",
        "given": "M."
      }
    ],
    "citation-number": [
      "7."
    ],
    "container-title": [
      "Blood"
    ],
    "date": [
      "2007"
    ],
    "pages": [
      "5096–103"
    ],
    "title": [
      "Waldenström macroglobulinemia"
    ],
    "type": "article-journal",
    "volume": [
      "109"
    ]
  },
  {
    "author": [
      {
        "family": "Dimopoulos",
        "given": "M.A."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "8."
    ],
    "container-title": [
      "J Clin Oncol"
    ],
    "date": [
      "2002"
    ],
    "pages": [
      "2327–33"
    ],
    "title": [
      "Treatment of Waldenström’s macroglobulinemia with rituximab"
    ],
    "type": "article-journal",
    "volume": [
      "20"
    ]
  },
  {
    "author": [
      {
        "family": "Treon",
        "given": "S.P."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "9."
    ],
    "container-title": [
      "Ann Oncol"
    ],
    "date": [
      "2005"
    ],
    "pages": [
      "132–8"
    ],
    "title": [
      "Extended rituximab therapy in Waldenström’s macroglobulinemia"
    ],
    "type": "article-journal",
    "volume": [
      "16"
    ]
  },
  {
    "author": [
      {
        "family": "Treon",
        "given": "S.P."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "10."
    ],
    "container-title": [
      "Clinical Lymphoma"
    ],
    "date": [
      "2005"
    ],
    "pages": [
      "273–7"
    ],
    "title": [
      "CHOP plus rituximab therapy in Waldenström’s macroglobulinemia"
    ],
    "type": "article-journal",
    "volume": [
      "5"
    ]
  },
  {
    "author": [
      {
        "family": "Tamburini",
        "given": "J."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "11."
    ],
    "container-title": [
      "Leukemia"
    ],
    "date": [
      "2005"
    ],
    "pages": [
      "1831–4"
    ],
    "title": [
      "Fludarabine plus cyclophosphamide in Waldenström’s macroglobulinemia: results in 49 patients"
    ],
    "type": "article-journal",
    "volume": [
      "19"
    ]
  },
  {
    "author": [
      {
        "family": "Tam",
        "given": "C.S."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "12."
    ],
    "container-title": [
      "Cancer"
    ],
    "date": [
      "2006"
    ],
    "pages": [
      "2412–20"
    ],
    "title": [
      "Fludarabine, cyclophosphamide and rituximab for the treatment of chronic lymphocytic leukemia or indolent non-Hodgkin lymphoma"
    ],
    "type": "article-journal",
    "volume": [
      "106"
    ]
  },
  {
    "author": [
      {
        "family": "Hensel",
        "given": "M."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "13."
    ],
    "container-title": [
      "Clin Lymphoma Myeloma"
    ],
    "date": [
      "2005"
    ],
    "pages": [
      "131–5"
    ],
    "title": [
      "Pentostatin/cyclophosphamide with or without rituximab: an effective regimen for patients with Waldenström’s macroglobulinemia/lymphoplasmacytic lymphoma"
    ],
    "type": "article-journal",
    "volume": [
      "6"
    ]
  },
  {
    "author": [
      {
        "family": "Weber",
        "given": "D."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "14."
    ],
    "container-title": [
      "Semin Oncol"
    ],
    "date": [
      "2003"
    ],
    "pages": [
      "243–7"
    ],
    "title": [
      "2-chlorodeoxyadenosine alone and in combination for previously untreated Waldenström’s macroglobulinemia"
    ],
    "type": "article-journal",
    "volume": [
      "30"
    ]
  },
  {
    "author": [
      {
        "family": "Treon",
        "given": "S."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "15."
    ],
    "container-title": [
      "Blood"
    ],
    "date": [
      "2006"
    ],
    "pages": [
      "2765"
    ],
    "title": [
      "Bortezomib, dexamethasone and rituximab (BDR) is a highly active regimen in the primary therapy of Waldenström’s macroglobulinemia: planned interim results of WMCTG Clinical Trial 05-180"
    ],
    "type": "article-journal",
    "volume": [
      "108"
    ]
  },
  {
    "author": [
      {
        "family": "Treon",
        "given": "S.P."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "16."
    ],
    "container-title": [
      "Clin Cancer Res"
    ],
    "date": [
      "2007"
    ],
    "pages": [
      "3320–5"
    ],
    "title": [
      "Multicentre clinical trial of bortezomib in relapsed/refractory Waldenström’s macroglobulinemia: results of WMCTG Trial 03-248"
    ],
    "type": "article-journal",
    "volume": [
      "13"
    ]
  },
  {
    "author": [
      {
        "family": "Dimopoulos",
        "given": "M.A."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "17."
    ],
    "container-title": [
      "Semin Oncol"
    ],
    "date": [
      "2003"
    ],
    "pages": [
      "265–9"
    ],
    "title": [
      "Treatment of Waldenström’s macroglobulinemia with single-agent thalidomide or with the combination of clarithromycin, thalidomide and dexamethasone"
    ],
    "type": "article-journal",
    "volume": [
      "30"
    ]
  },
  {
    "author": [
      {
        "family": "Anagnostopoulos",
        "given": "A."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "18."
    ],
    "container-title": [
      "Biol Blood Marrow Transplant"
    ],
    "date": [
      "2006"
    ],
    "pages": [
      "845–54"
    ],
    "title": [
      "Autologous or allogeneic stem cell transplantation in patients with Waldenström’s macroglobulinemia"
    ],
    "type": "article-journal",
    "volume": [
      "12"
    ]
  },
  {
    "citation-number": [
      "19."
    ],
    "container-title": [
      "NCCN Clinical Practice Guidelines in Oncology Multiple Myeloma V.2.2008. M"
    ],
    "type": "chapter",
    "url": [
      "http://www.nccn.org/professionals/physician_gls/PDF/myeloma.pdf"
    ]
  },
  {
    "author": [
      {
        "family": "Kyle",
        "given": "R.A."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "20."
    ],
    "container-title": [
      "Semin Oncol"
    ],
    "date": [
      "2003"
    ],
    "location": [
      "Further reading"
    ],
    "pages": [
      "116–120"
    ],
    "title": [
      "Prognostic markers and criteria to initiate therapy in Waldenström’s macroglobulinemia: consensus panel recommendations from the Second International Workshop on Waldenström’s Macroglobulinemia"
    ],
    "type": "article-journal",
    "volume": [
      "30"
    ]
  },
  {
    "author": [
      {
        "family": "Anderson",
        "given": "K.C."
      },
      {
        "others": true
      }
    ],
    "container-title": [
      "J Natl Compr Canc Netw"
    ],
    "date": [
      "2012"
    ],
    "pages": [
      "1211–19"
    ],
    "title": [
      "Waldenström’s macroglobulinemia/lymphoplasmacytic lymphoma, version 2.2013"
    ],
    "type": "article-journal",
    "volume": [
      "10"
    ]
  },
  {
    "author": [
      {
        "family": "Kastritis",
        "given": "E."
      },
      {
        "others": true
      }
    ],
    "container-title": [
      "Expert Opin Emerg Drugs"
    ],
    "date": [
      "2011"
    ],
    "issue": [
      "1"
    ],
    "pages": [
      "45–57"
    ],
    "title": [
      "Emerging drugs for Waldenström’s macroglobulinemia"
    ],
    "type": "article-journal",
    "volume": [
      "16"
    ]
  },
  {
    "author": [
      {
        "family": "Varghese",
        "given": "A.M."
      },
      {
        "others": true
      }
    ],
    "container-title": [
      "Clin Lymph Myeloma"
    ],
    "date": [
      "2009"
    ],
    "pages": [
      "53–5"
    ],
    "title": [
      "Assessment of bone marrow response in Waldenström’s macroglobulinemia"
    ],
    "type": "article-journal",
    "volume": [
      "9"
    ]
  },
  {
    "citation-number": [
      "378"
    ],
    "genre": [
      "CHAPTER 8 Paraproteinaemias"
    ],
    "type": null
  },
  {
    "author": [
      {
        "family": "Rajkumar",
        "given": "S.V."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "1."
    ],
    "container-title": [
      "Mayo Clin Proc"
    ],
    "date": [
      "2006"
    ],
    "pages": [
      "693–703"
    ],
    "title": [
      "Monoclonal gammopathy of undetermined significance, Waldenström macroglobulinemia, AL amyloidosis and related plasma cell disorders: diagnosis and treatment"
    ],
    "type": "article-journal",
    "volume": [
      "81"
    ]
  },
  {
    "author": [
      {
        "family": "Wechalekar",
        "given": "A.D."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "2."
    ],
    "container-title": [
      "Br J Haematol"
    ],
    "date": [
      "2008"
    ],
    "pages": [
      "365–77"
    ],
    "title": [
      "Perspectives in treatment of AL amyloidosis"
    ],
    "type": "article-journal",
    "volume": [
      "140"
    ]
  },
  {
    "author": [
      {
        "family": "Gertz",
        "given": "M.A."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "3."
    ],
    "container-title": [
      "Am J Hematol"
    ],
    "date": [
      "2005"
    ],
    "pages": [
      "319–28"
    ],
    "title": [
      "Definition of organ involvement and treatment response in immunoglobulin light chain amyloidosis (AL): a consensus opinion from the 10th International Symposium on Amyloid and Amyloidosis"
    ],
    "type": "article-journal",
    "volume": [
      "79"
    ]
  },
  {
    "author": [
      {
        "family": "Gertz",
        "given": "M.A."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "4."
    ],
    "container-title": [
      "Amyloid"
    ],
    "date": [
      "2010"
    ],
    "issue": [
      "s1"
    ],
    "pages": [
      "48"
    ],
    "title": [
      "Definition of organ involvement and response to treatment in AL amyloidosis: an updated consensus opinion"
    ],
    "type": "article-journal",
    "volume": [
      "17"
    ]
  },
  {
    "author": [
      {
        "family": "Rajkumar",
        "given": "S.V."
      },
      {
        "family": "Gertz",
        "given": "M.A."
      }
    ],
    "citation-number": [
      "5."
    ],
    "container-title": [
      "N Engl J Med"
    ],
    "date": [
      "2007"
    ],
    "location": [
      "Further reading"
    ],
    "pages": [
      "2413–15"
    ],
    "title": [
      "Advances in the treatment of amyloidosis"
    ],
    "type": "article-journal",
    "volume": [
      "356"
    ]
  },
  {
    "author": [
      {
        "family": "Cohen",
        "given": "A.D."
      },
      {
        "family": "Comenzo",
        "given": "R.L."
      }
    ],
    "container-title": [
      "Hematology Am Soc Hematol Educ Program"
    ],
    "date": [
      "2010",
      "2010"
    ],
    "pages": [
      "287–94"
    ],
    "title": [
      "Systemic light-chain amyloidosis: advances in diagnosis, prognosis, and therapy"
    ],
    "type": "article-journal"
  },
  {
    "author": [
      {
        "family": "Gertz",
        "given": "M.A."
      },
      {
        "others": true
      }
    ],
    "container-title": [
      "Curr Hematol Malig Rep"
    ],
    "date": [
      "2009"
    ],
    "pages": [
      "91–8"
    ],
    "title": [
      "Treatment of immunoglobulin light chain amyloidosis"
    ],
    "type": "article-journal",
    "volume": [
      "4"
    ]
  },
  {
    "author": [
      {
        "family": "Gertz",
        "given": "M.A."
      }
    ],
    "container-title": [
      "Am J Hematol"
    ],
    "date": [
      "2011"
    ],
    "pages": [
      "180–6"
    ],
    "title": [
      "Immunoglobulin light chain amyloidosis: 2011 update on diagnosis, riskstratification, and management"
    ],
    "type": "article-journal",
    "volume": [
      "86"
    ]
  },
  {
    "container-title": [
      "NCCN Guidelines on Amyloidosis. Version 1.2013. M"
    ],
    "type": "chapter",
    "url": [
      "www.NCCN.org."
    ]
  },
  {
    "author": [
      {
        "family": "DiPersio",
        "given": "J."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "1."
    ],
    "date": [
      "2009"
    ],
    "pages": [
      "5720–6"
    ],
    "title": [
      "Plerixafor and G-CSF versus placebo and G-CSF to mobilize hematopoietic stem cells for autologous stem cell transplantation in patients with multiple myeloma Blood"
    ],
    "type": null,
    "volume": [
      "113"
    ]
  },
  {
    "author": [
      {
        "family": "Tanhehco",
        "given": "Y.C."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "2."
    ],
    "container-title": [
      "Transfusion"
    ],
    "date": [
      "2013"
    ],
    "issue": [
      "10"
    ],
    "pages": [
      "2314–26"
    ],
    "title": [
      "The evolving role of plerixafor in hematopoietic progenitor cell mobilization"
    ],
    "type": "article-journal",
    "volume": [
      "53"
    ]
  },
  {
    "citation-number": [
      "412"
    ],
    "title": [
      "CHAPTER 9 Haematopoietic stem cell transplantation"
    ],
    "type": null
  },
  {
    "author": [
      {
        "family": "Aschan",
        "given": "J."
      }
    ],
    "citation-number": [
      "1."
    ],
    "container-title": [
      "Best Practice Res Clin Haematol"
    ],
    "date": [
      "2007"
    ],
    "pages": [
      "295–310"
    ],
    "title": [
      "Risk assessment in haematopoietic stem cell transplantation: conditioning"
    ],
    "type": "article-journal",
    "volume": [
      "20"
    ]
  },
  {
    "author": [
      {
        "family": "Apperley",
        "given": "J."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "2."
    ],
    "date": [
      "2012"
    ],
    "edition": [
      "revised"
    ],
    "location": [
      "Paris"
    ],
    "publisher": [
      "EBMT"
    ],
    "title": [
      "The EBMT-ESH Handbook on Haemopoietic Stem Cell Transplantation"
    ],
    "type": "book"
  },
  {
    "author": [
      {
        "family": "Apperley",
        "given": "J."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "1."
    ],
    "date": [
      "2012"
    ],
    "edition": [
      "revised"
    ],
    "location": [
      "Paris"
    ],
    "publisher": [
      "EBMT"
    ],
    "title": [
      "The EBMT-ESH Handbook on Haemopoietic Stem Cell Transplantation"
    ],
    "type": "book"
  },
  {
    "author": [
      {
        "family": "Filipovich",
        "given": "A.H."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "2."
    ],
    "container-title": [
      "Blood"
    ],
    "date": [
      "2005",
      "2007"
    ],
    "note": [
      "Blood Marrow Transplant II: 945–56 Further reading Deeg, J."
    ],
    "pages": [
      "4119–26"
    ],
    "title": [
      "National Institute of Health consensus development project on criteria for clinical trials in chronic graft versus host disease: I Diagnosis and staging Working Group report",
      "How I treat GVHD"
    ],
    "type": "article-journal",
    "volume": [
      "109"
    ]
  },
  {
    "author": [
      {
        "family": "Hildebrandt",
        "given": "G.C."
      }
    ],
    "container-title": [
      "Bone Marrow Transplant"
    ],
    "date": [
      "2011"
    ],
    "issue": [
      "10"
    ],
    "pages": [
      "1283–95"
    ],
    "title": [
      "Diagnosis and treatment of pulmonary chronic GVHD: report from the consensus conference on clinical practice in chronic GVHD"
    ],
    "type": "article-journal",
    "volume": [
      "46"
    ]
  },
  {
    "author": [
      {
        "family": "Jagasia",
        "given": "M."
      }
    ],
    "container-title": [
      "Blood Marrow Transplant"
    ],
    "date": [
      "2013"
    ],
    "issue": [
      "7"
    ],
    "pages": [
      "1129–33"
    ],
    "title": [
      "Extracorporeal photopheresis versus anticytokine therapy as a second-line treatment for steroid-refractory acute GVHD: a multicenter comparative analysis"
    ],
    "type": "article-journal",
    "volume": [
      "19"
    ]
  },
  {
    "author": [
      {
        "family": "Ullmann",
        "given": "A.J."
      },
      {
        "others": true
      }
    ],
    "container-title": [
      "N Engl J Med",
      "Erratum in: N Engl J Med"
    ],
    "date": [
      "2007"
    ],
    "issue": [
      "4",
      "4"
    ],
    "pages": [
      "335–47",
      "428"
    ],
    "title": [
      "Posaconazole or fluconazole for prophylaxis in severe graft-versushost disease"
    ],
    "type": "article-journal",
    "volume": [
      "356",
      "357"
    ]
  },
  {
    "author": [
      {
        "family": "Corbaciogly",
        "given": "S."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "1."
    ],
    "container-title": [
      "Bone Marrow Transplant"
    ],
    "date": [
      "2010"
    ],
    "issue": [
      "Suppl 2"
    ],
    "pages": [
      "1"
    ],
    "title": [
      "Defibrotide prevents hepatic VOD and reduces significantly VOD-associated complications in children at high risk: final results of a prospective phase II/ III multicenter study"
    ],
    "type": "article-journal",
    "volume": [
      "45"
    ]
  },
  {
    "author": [
      {
        "family": "Ho",
        "given": "V.T."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "2."
    ],
    "container-title": [
      "Bone Marrow Transplant"
    ],
    "date": [
      "2008"
    ],
    "pages": [
      "229–37"
    ],
    "title": [
      "Hepatc VOD after HSCT: update on defibrotide and other current investigational therapies"
    ],
    "type": "article-journal",
    "volume": [
      "41"
    ]
  },
  {
    "author": [
      {
        "family": "Herbrecht",
        "given": "R."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "1."
    ],
    "container-title": [
      "Eur J Cancer"
    ],
    "date": [
      "2007"
    ],
    "issue": [
      "Suppl"
    ],
    "pages": [
      "49–59"
    ],
    "title": [
      "Treatment of invasive candida and invasive aspergillus infections in adult hematological patients"
    ],
    "type": "article-journal",
    "volume": [
      "5"
    ]
  },
  {
    "author": [
      {
        "family": "Prentice",
        "given": "A.G."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "2."
    ],
    "container-title": [
      "M"
    ],
    "date": [
      "2008"
    ],
    "title": [
      "BCSH Guidelines on the Management of Invasive Fungal Infections during Therapy for Hematological Malignancy"
    ],
    "type": "article-journal",
    "url": [
      "http://www.bcshguidelines.com/"
    ]
  },
  {
    "author": [
      {
        "family": "Laffan",
        "given": "M."
      },
      {
        "others": true
      }
    ],
    "container-title": [
      "Organization. Haemophilia"
    ],
    "date": [
      "2004"
    ],
    "issue": [
      "3"
    ],
    "pages": [
      "199–217"
    ],
    "title": [
      "The diagnosis of von Willebrand disease: a guideline from the UK Haemophilia Centre Doctors"
    ],
    "type": "article-journal",
    "volume": [
      "10"
    ]
  },
  {
    "author": [
      {
        "family": "Pasi",
        "given": "K.J."
      },
      {
        "others": true
      }
    ],
    "container-title": [
      "Organization. Haemophilia"
    ],
    "date": [
      "2004"
    ],
    "issue": [
      "3"
    ],
    "pages": [
      "218–31"
    ],
    "title": [
      "Management of von Willebrand disease: a guideline from the UK Haemophilia Centre Doctors"
    ],
    "type": "article-journal",
    "volume": [
      "10"
    ]
  },
  {
    "author": [
      {
        "family": "Sadler",
        "given": "J.E."
      }
    ],
    "container-title": [
      "Blood"
    ],
    "date": [
      "2003"
    ],
    "issue": [
      "6"
    ],
    "pages": [
      "2089–93"
    ],
    "title": [
      "Von Willebrand disease type 1: a diagnosis in search of a disease"
    ],
    "type": "article-journal",
    "volume": [
      "101"
    ]
  },
  {
    "citation-number": [
      "476"
    ],
    "title": [
      "CHAPTER 10 Haemostasis and thrombosis"
    ],
    "type": null
  },
  {
    "author": [
      {
        "family": "D.",
        "given": "Keeling"
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "1."
    ],
    "container-title": [
      "Brit J Haematol"
    ],
    "date": [
      "2006"
    ],
    "pages": [
      "259–69"
    ],
    "title": [
      "on behalf of the Haemostasis and Thrombosis Task Force of the British Committee for Standards in Haematology. The management of heparin-induced thrombocytopenia"
    ],
    "type": "article-journal",
    "volume": [
      "133"
    ]
  },
  {
    "author": [
      {
        "family": "Baglin",
        "given": "T.P."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "2."
    ],
    "container-title": [
      "Br J Haematol"
    ],
    "date": [
      "2006"
    ],
    "location": [
      "Further reading"
    ],
    "pages": [
      "590–5"
    ],
    "title": [
      "Guidelines on use of vena cava filters"
    ],
    "type": "article-journal",
    "volume": [
      "134"
    ]
  },
  {
    "author": [
      {
        "family": "Keeling",
        "given": "D.M."
      },
      {
        "others": true
      }
    ],
    "container-title": [
      "Brit J Haematol"
    ],
    "date": [
      "2004"
    ],
    "pages": [
      "15–25"
    ],
    "title": [
      "The diagnosis of deep vein thrombosis in symptomatic outpatients and the potential for clinical assessment and D-dimer assays to reduce the need for diagnostic imaging"
    ],
    "type": "article-journal",
    "volume": [
      "124"
    ]
  },
  {
    "author": [
      {
        "family": "Allwood",
        "given": "M."
      },
      {
        "others": true
      }
    ],
    "date": [
      "2002"
    ],
    "edition": [
      "4th"
    ],
    "location": [
      "Oxford"
    ],
    "publisher": [
      "Radcliffe Medical Press"
    ],
    "title": [
      "Cytotoxics Handbook"
    ],
    "type": "book"
  },
  {
    "author": [
      {
        "family": "Dougherty",
        "given": "L."
      },
      {
        "family": "Lister",
        "given": "S."
      }
    ],
    "date": [
      "2011"
    ],
    "edition": [
      "8th"
    ],
    "location": [
      "London"
    ],
    "publisher": [
      "Wiley-Blackwell"
    ],
    "title": [
      "The Royal Marsden Hospital Manual of Clinical Nursing Procedures"
    ],
    "type": "book"
  },
  {
    "author": [
      {
        "family": "Society",
        "given": "European Oncology Nursing"
      }
    ],
    "date": [
      "2007"
    ],
    "location": [
      "Brussels"
    ],
    "pages": [
      "1"
    ],
    "publisher": [
      "EONS"
    ],
    "title": [
      "Extravasation Guidelines 2007"
    ],
    "type": "book",
    "volume": [
      "M www.cancerworld.org/CancerWorld/moduleStaticPage.aspx?id=3891&id_sito=2&id"
    ]
  },
  {
    "author": [
      {
        "family": "Gault",
        "given": "D.T."
      }
    ],
    "container-title": [
      "Br J Plast Surg"
    ],
    "date": [
      "1993"
    ],
    "pages": [
      "91–6"
    ],
    "title": [
      "Extravasation injuries"
    ],
    "type": "article-journal",
    "volume": [
      "46"
    ]
  },
  {
    "author": [
      {
        "family": "Mouridsen",
        "given": "H."
      },
      {
        "others": true
      }
    ],
    "container-title": [
      "Ann Oncol"
    ],
    "date": [
      "2007"
    ],
    "pages": [
      "546–50"
    ],
    "title": [
      "Treatment of anthracycline extravasation with Savene (dexrazoxane): results from two prospective clinical multicentre studies"
    ],
    "type": "article-journal",
    "volume": [
      "18"
    ]
  },
  {
    "date": [
      "XXXX"
    ],
    "title": [
      "The National Extravasation Information Service",
      "Protocol for Management of"
    ],
    "type": null
  },
  {
    "author": [
      {
        "family": "Marsh",
        "given": "J.C."
      },
      {
        "family": "Bevan",
        "given": "D.H."
      }
    ],
    "container-title": [
      "Br J Haematol"
    ],
    "date": [
      "2002"
    ],
    "note": [
      "This page intentionally left blank Chapter 18 783"
    ],
    "pages": [
      "25–37"
    ],
    "title": [
      "Haematological care of the Jehovah’s Witness patient"
    ],
    "type": "article-journal",
    "volume": [
      "119"
    ]
  },
  {
    "title": [
      "and immunemodulators (thalidomide) have been used with varying success"
    ],
    "type": null
  },
  {
    "author": [
      {
        "family": "Dispenzieri",
        "given": "A.",
        "particle": "Further reading"
      },
      {
        "others": true
      }
    ],
    "container-title": [
      "Am J Hematol"
    ],
    "date": [
      "2012"
    ],
    "issue": [
      "11"
    ],
    "pages": [
      "997–1002"
    ],
    "title": [
      "• In HIV patients HAART should be commenced or optimized. • High relapse rates",
      "The clinical spectrum of Castleman’s disease"
    ],
    "type": "article-journal",
    "volume": [
      "87"
    ]
  },
  {
    "author": [
      {
        "family": "Ramasamy",
        "given": "K."
      },
      {
        "others": true
      }
    ],
    "container-title": [
      "Br J Haematol"
    ],
    "date": [
      "2012"
    ],
    "issue": [
      "3"
    ],
    "pages": [
      "421–3"
    ],
    "title": [
      "Rituximab and thalidomide combination therapy for Castleman disease"
    ],
    "type": "article-journal",
    "volume": [
      "158"
    ]
  },
  {
    "author": [
      {
        "family": "Roca",
        "given": "B."
      }
    ],
    "container-title": [
      "A Review. AIDS Rev"
    ],
    "date": [
      "2009"
    ],
    "issue": [
      "1"
    ],
    "pages": [
      "3–7"
    ],
    "title": [
      "Castleman’s disease"
    ],
    "type": "article-journal",
    "volume": [
      "11"
    ]
  },
  {
    "author": [
      {
        "family": "Talat",
        "given": "N."
      },
      {
        "others": true
      }
    ],
    "container-title": [
      "Oncologist"
    ],
    "date": [
      "2011"
    ],
    "issue": [
      "9"
    ],
    "pages": [
      "1316–24"
    ],
    "title": [
      "Castleman’s disease: systematic analysis of 416 patients from the literature"
    ],
    "type": "article-journal",
    "volume": [
      "16"
    ]
  },
  {
    "author": [
      {
        "family": "Uldrick",
        "given": "T.S."
      },
      {
        "others": true
      }
    ],
    "container-title": [
      "Curr Opin Oncol"
    ],
    "date": [
      "2012"
    ],
    "issue": [
      "5"
    ],
    "pages": [
      "495–505"
    ],
    "title": [
      "Recent advances in Kaposi sarcoma herpesvirus-associated multicentric Castleman disease"
    ],
    "type": "article-journal",
    "volume": [
      "24"
    ]
  },
  {
    "author": [
      {
        "family": "Balwani",
        "given": "M."
      },
      {
        "others": true
      }
    ],
    "container-title": [
      "Hematology Am Soc Hematol Educ Program"
    ],
    "date": [
      "2012",
      "2012"
    ],
    "pages": [
      "19–27"
    ],
    "title": [
      "The porphyrias: advances in diagnosis and treatment"
    ],
    "type": "article-journal"
  },
  {
    "author": [
      {
        "family": "Stein",
        "given": "P."
      },
      {
        "others": true
      }
    ],
    "container-title": [
      "Ann Clin Biochem"
    ],
    "date": [
      "2013"
    ],
    "issue": [
      "Pt 3"
    ],
    "pages": [
      "217–23"
    ],
    "title": [
      "Best practice guidelines on clinical management of acute attacks of porphyria and their complications"
    ],
    "type": "article-journal",
    "volume": [
      "50"
    ]
  },
  {
    "note": [
      "792 CHAPTER 18 Rare diseases"
    ],
    "type": null
  },
  {
    "author": [
      {
        "family": "Donadieu",
        "given": "J."
      },
      {
        "others": true
      }
    ],
    "container-title": [
      "Expert Opin Pharmacother"
    ],
    "date": [
      "2013"
    ],
    "issue": [
      "9"
    ],
    "pages": [
      "1309–22"
    ],
    "title": [
      "Medical management of Langerhans cell histiocytosis from diagnosis to treatment"
    ],
    "type": "article-journal",
    "volume": [
      "13"
    ]
  },
  {
    "author": [
      {
        "family": "Haupt",
        "given": "R."
      },
      {
        "others": true
      }
    ],
    "container-title": [
      "Pediatr Blood Cancer"
    ],
    "date": [
      "2013"
    ],
    "issue": [
      "2"
    ],
    "pages": [
      "175–84"
    ],
    "title": [
      "Langerhans cell histiocytosis (LCH): guidelines for diagnosis, clinical work-up, and treatment for patients till the age of 18 years"
    ],
    "type": "article-journal",
    "volume": [
      "60"
    ]
  },
  {
    "author": [
      {
        "family": "Hirasaki",
        "given": "S."
      },
      {
        "others": true
      }
    ],
    "container-title": [
      "Intern Med"
    ],
    "date": [
      "2012"
    ],
    "issue": [
      "1"
    ],
    "pages": [
      "119–20"
    ],
    "title": [
      "Multifocal Langerhans cell histiocytosis in an adult"
    ],
    "type": "article-journal",
    "volume": [
      "51"
    ]
  },
  {
    "note": [
      "794 CHAPTER 18 Rare diseases"
    ],
    "type": null
  },
  {
    "genre": [
      "XII RiCoF 45–150IU/dL vWF: Ag 50–150IU/dL Protein C 80–135U/dL Protein S 80–135U/dL Antithrombin III 80–120U/dL Table A3.2 Biochemistry and immunology Serum urea 3.0–6.5mmol/L 11.5–16.5g/dL Serum creatinine 60–125 micromol/L Serum sodium 135–145mmol/L Serum potassium 3.5–5.0mmol/v Serum albumin 32–50g/L Serum bilirubin <17micromol/L Serum alk phos 100–300IU/L Serum calcium 2.15–2.55mmol/L Serum LDH 200–450IU/L Serum phosphate 0.7–1.5mmol/L Serum total protein 63–80g/L Serum urate 0.18–0.42mmol/L Serum γ-GT 10–46IU/L Serum iron 14–33mcmol/L"
    ],
    "location": [
      "Factors II, V, VII, VIII, IX"
    ],
    "note": [
      "♀"
    ],
    "pages": [
      "50–150",
      "11–28"
    ],
    "title": [
      "Adult normal ranges Table A3.1 Haematology Haemoglobin 130–180g/L (♂) 115–165g/L (♀) Haematocrit 0.40–0.52 (♂) 0.36–0.47 (♀) RCC 4.5–6.5 × 1012/L (♂) 3.8–5.8 × 1012/L (♀) MCV 77–95fL MCH 27.0–32.0pg MCHC 32.0–36.0g/dL WBC 4.0–11.0 × 109/L Neutrophils 2.0–7.5 × 109/L Lymphocytes 1.5–4.5 × 109/L Eosinophils 0.04–0.4 × 109/L Basophils 0.0–0.1 × 109/L Monocytes 0.2–0.8 × 109/L Platelets 150–400 × 109/L Reticulocytes 0.5–2.5% (or 50–100 × 109/L) ESR 2–12mm/1st hour (Westergren) Red cell mass 25–35mL/kg (♂) 20–30mL/kg (♀) Serum B12 150–700ng/L Serum folate 2.0–11.0mcg/L Red cell folate 150–700mcg/L Serum ferritin 15–300mcg/L (varies with sex and age) 14–200mcg/L (premenopausal ♀) INR 0.8–1.2 PT 12.0–14.0sec APTT ratio 0.8–1.2 APTT 26.0–33.5sec Fibrinogen 2.0–4.0g/L Thrombin time ± 3sec of control XDPs <250mcg/L D-dimer <500ng/mL"
    ],
    "type": null,
    "volume": [
      "X",
      "XI",
      "♂"
    ]
  },
  {
    "author": [
      {
        "given": "Serum"
      }
    ],
    "genre": [
      "TIBC 45–75mcmol/L Serum ALT 5–42IU/L Serum AST 5–42IU/L Serum free T4 9–24pmol/L Serum TSH 0.35–5.5mU/L Immunology IgG 5.3–16.5g/L IgA 0.8–4.0g/L IgM 0.5–2.0g/L Complement: C3 0.89–2.09g/L C4 0.12–0.53g/L C1 esterase 0.11–0.36g/L CH50 80–120% C-reactive protein <6mg/L Serum β2-microglobulin 1.2–2.4mg/L CSF proteins: IgG 0.013–0.035g/L Albumin 0.170–0.238g/L Urine proteins:"
    ],
    "type": null
  }
]
